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ABSTRACT 
 
The limited reparative capacity of the skin after injury and the drawbacks of current 
therapeutic approaches represent the major challenges in the treatment of cutaneous 
wounds. Despite the advances on the development of novel biomaterials for wound 
dressings and bioengineered skin substitutes, key limitations such as poor vascularization, 
delayed cell infiltration, scarring, and poor mechanical properties still persist. Bioprinting 
holds the promise to overcome these challenges by the automated deposition of material 
formulations loadable with cells and/or bioactive molecules, termed as bioinks, into multilayer 
three-dimensional (3D) skin constructs both in vitro and in vivo. Although several hydrogels 
have been adapted as bioinks, a major bottleneck in skin bioprinting is the limited number of 
bioinks exhibiting suitable printability, fast crosslinking and cell-instructive properties. Thus, 
the main aim of this doctoral thesis was to develop novel photocrosslinkable pectin hydrogels 
as cell-responsive bioinks for the extrusion bioprinting of cellularized 3D constructs for skin 
tissue engineering. Optimal bioink properties were based on the ability to print 3D constructs 
with high shape fidelity, supporting the functions of embedded cells, the deposition of 
extracellular matrix (ECM) components and the in vitro skin formation.  
The first part of the work focused on the synthesis and formulation of a dual-
crosslinked pectin hydrogel bioink for the bioprinting of dermal 3D constructs. Pectin was 
modified with methacrylate groups via reaction with methacrylic anhydride (MA) to form 
chemical hydrogels through ultraviolet (UV) photopolymerization. Pectin methacrylate 
(PECMA) with different degrees of modification (21.7–50.2 %) was synthetized without 
compromising the ionic gelation ability. A base-catalysed thiol-Michael addition reaction was 
applied to conjugate a thiolated cell-adhesive peptide (CGGGGRGDSP) to the methacrylate 
groups in pectin backbone, promoting the attachment of dermal fibroblasts embedded within 
the gel network. Suitable printability and rheological properties were obtained through the 
ionic gelation of a low concentration PECMA solution (1.5 wt%) using 5 mM calcium chloride. 
The physically crosslinked bioink loaded with dermal fibroblasts was printed into 3D 
constructs that supported viable and metabolically active cells throughout 14 days of culture, 
providing a suitable cell microenvironment that stimulated the deposition of dermal ECM 
components, including fibronectin and type-I collagen.   
To develop bioinks with controllable cell-degradation properties, in the second part, 
novel photocrosslinkable pectin macromers were synthetized to form protease-degradable 
hydrogels through UV photoinitiated thiol-norbornene click chemistry. Pectin was firstly 
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converted to its tetrabutylammonium (TBA) salt for solubilization in dimethyl sulfoxide 
(DMSO) and then modified with carbic anhydride (CA), yielding norbornene-modified pectin 
(NorPEC). To mimic both cell-adhesion and cell-mediated remodelling properties of the skin, 
enzymatically-degradable hydrogels were formed by reaction between a peptide crosslinker 
sensitive to cell-secreted proteases (CGPQGIWGQC) flanked with biscysteine and the 
norbornene groups in pectin backbone upon exposure to UV light (20 s) in the presence of 
VA-086 as photoinitiator. The thiolated cell-adhesive peptide (CGGGGRGDSP) was also 
tethered to the norbornene groups during the photopolymerization, promoting the adhesion 
and spreading of embedded fibroblasts. Mechanical properties of hydrogels (2.5 wt%) were 
tailored in a broad range (70.03 ± 10.39 Pa to 446.75 ± 35.66 Pa) by varying the bulk 
concentration of the peptide crosslinker (4–6 mM). Fibroblasts embedded within these 
hydrogels displayed spread morphology and secreted matrix metalloproteinases (MMP-2 and 
MMP-9) involved in the cutaneous wound healing. Histological and immunofluorescence 
analysis showed the ability of the developed hydrogels to support the in vitro formation of 
skin consisting of a dermal compartment containing elongated fibroblasts surrounded by 
ECM proteins (fibronectin and type-I collagen) and a well-defined epidermal compartment 
with thickness (120 μm) within the range of the human epidermis (60–150 μm).  
To develop advanced bioinks with tuneable biochemical and biophysical properties, in 
the third part of the work, NorPEC macromer was converted into a protease-degradable 
bioink through calcium (Ca2+)- or barium (Ba2+)-mediated ionic crosslinking and applied for 
the bioprinting of ECM-like microenvironments. Rheological characterization revealed that a 
higher concentration of Ba2+ (15 mM) is needed to achieve suitable bioink printability 
compared to Ca2+ (13 mM). Bioinks displayed a shear thinning behaviour and fast recovery 
post-printing, regardless the cation used for ionic gelation. The response of fibroblasts within 
the developed bioinks was evaluated by the printing of cell-laden 3D constructs with low (30 
s UV curing) and high (90 s UV curing) elastic modulus. Extensive cell spreading and 
fibronectin deposition were observed in all constructs with exception to the stiffer Ba2+-
crosslinked bioink, in which lower metabolic activity, DNA content, and ECM deposition were 
verified probably due to the mechanical constrains imposed by the hydrogel.  
Overall, in this research work, novel photocrosslinkable and cell-responsive pectin 
bioinks were developed for skin bioprinting as a result of an original combination of chemical 
modification strategies, crosslinking reactions and bioprinting approaches. Both PECMA and 
NorPEC bioinks showed suitable printability and cytocompatible gelation mechanisms, 
allowing the printing of cellularized 3D constructs that support the deposition of ECM 
components of the native skin. The proposed bioinks address important limitations in the field 
and show promising properties for applications in skin tissue engineering as 3D constructs 
for cutaneous wound healing, in vitro testing models and bioinks for in situ skin bioprinting.  
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RESUMO 
 
A limitada capacidade de reparação da pele após lesão e as desvantagens das 
atuais abordagens terapêuticas representam os principais desafios no tratamento de lesões 
cutâneas. Apesar dos avanços no desenvolvimento de novos biomateriais para curativos e 
substitutos biológicos de pele, importantes limitações ainda persistem, tais como a limitada 
vascularização, infiltração celular tardia, formação de tecido fibroso e fracas propriedades 
mecânicas. A bioimpressão 3D assume-se como uma alternativa promissora para 
ultrapassar estas limitações através da deposição automática de materiais contendo células 
e/ou moléculas bioativas, designados de bioinks, em estruturas tridimensionais (3D) 
multicamada de pele quer in vitro quer in vivo. Apesar de vários hidrogéis terem vindo a ser 
adotados para utilização como bioinks, um dos principais desafios em bioimpressão 3D de 
pele consiste no limitado número de bioinks apresentando propriedades reológicas 
adequadas, rápida gelificação e capacidade de estimular as células a desempenhar as suas 
funções. Deste modo, o principal objetivo desta tese de doutoramento consistiu no 
desenvolvimento de novos hidrogéis fotopolimerizáveis baseados em pectina para a 
bioimpressão por extrusão de estruturas 3D celulares para a engenharia de tecidos da pele. 
As propriedades ótimas das bioinks tiveram como base a possibilidade de criar estruturas 
3D com elevada definição geométrica capazes de estimular as funções das células 
incorporadas, a deposição de componentes da matriz extracelular (ECM) e a formação de 
pele in vitro. 
A primeira parte do trabalho incidiu na síntese e desenvolvimento de uma bioink 
baseada em pectina para a bioimpressão de estruturas 3D da derme. Para tal, a pectina foi 
modificada com grupos metacrilato através da reação com metacrilato anidrido (MA) de 
forma a permitir a formação de géis químicos através da fotopolimerização por radiação 
ultravioleta (UV). Pectina funcionalizada com grupos metacrilato (PECMA) foi sintetizada 
com diferentes graus de substituição (21,7–50,2 %) sem comprometer a capacidade de 
gelificação iónica. A reação de adição de Michael catalisada por uma base foi utilizada para 
conjugar uma sequência peptídica (CGGGGRGDSP) aos grupos metacrilato na pectina 
através de uma cisteína terminal, promovendo a adesão de fibroblastos da derme no interior 
do gel. Propriedades reológicas adequadas para bioimpressão foram obtidas através da 
reticulação iónica de soluções de PECMA a baixa concentração (1,5 m/v%) na presença de 
5 mM de cloreto de cálcio. A bioink contendo fibroblastos da derme foi utilizada na 
bioimpressão de estruturas 3D capazes de suportar a viabilidade celular durante os 14 dias 
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de cultura celular, fornecendo um microambiente celular adequado e capaz de estimular a 
produção de componentes da ECM, incluindo fibronectina e colagénio tipo-I.  
Com o objetivo de desenvolver bioinks com propriedades de degradação 
controladas, na segunda parte do trabalho de investigação, novos derivados 
fotopolimerizáveis de pectina foram sintetizados para a formação de hidrogéis degradáveis 
por ação de protéases secretadas pelas células através de uma reação de tiol-norborneno 
iniciada por fotopolimerização por radiação UV. A pectina foi inicialmente convertida no seu 
sal de tetrabutilamónio (TBA) para solubilização em dimetilsulfóxido (DMSO) e modificada 
por reação com carbic anhydride (CA), resultando em derivados de pectina funcionalizados 
com grupos norborneno (NorPEC). De forma a mimetizar a adesão e remodelação celulares 
características da pele, hidrogéis degradáveis através de processos enzimáticos foram 
obtidos através da reação de tiol-norborneno entre um péptido como agente reticulante 
susceptível à degradação por parte de protéases (CGPQGIWGQC) contendo dois grupos 
sulfidrilo terminais e os grupos norborneno na pectina, após irradiação UV (20 s) e na 
presença de VA-086 como fotoiniciador. Um péptido capaz de promover a adesão celular e 
contendo um grupo sulfidrilo terminal (CGGGGRGDSP) foi também conjugado aos grupos 
norborneno durante a fotopolimerização, promovendo a adesão e alongamento dos 
fibroblastos no interior do gel. As propriedades mecânicas dos hidrogéis (2,5 %m/v) foram 
manipuladas numa ampla gama (70,03 ± 10,39 Pa to 446,75 ± 35,66 Pa) através da 
variação da concentração do péptido reticulante (4–6 mM). Fibroblastos incorporados no 
interior destes hidrogéis apresentaram uma morfologia alongada com secreção de 
metaloproteinases de matriz, MMP-2 e MMP-9, envolvidas no processo de cicatrização da 
pele. Análises histológicas e de imunofluorescência mostraram a capacidade dos hidrogéis 
desenvolvidos em suportar a formação de pele in vitro, constituída por uma camada 
equivalente à derme contendo fibroblastos com uma morfologia alongada envoltos numa 
ECM rica em proteínas (fibronectina e colagénio tipo-I) e uma camada bem definida 
equivalente à epiderme com uma espessura (120 μm) compreendida no intervalo de valores 
da pele humana (60–150 μm). 
De forma a desenvolver bioinks com propriedades bioquímicas e biofísicas definidas, 
na terceira parte do trabalho de investigação, a solução de NorPEC foi convertida numa 
bioink degradável pela ação de metaloproteinases de matriz através de gelificação iónica 
mediada por iões cálcio (Ca2+) ou bário (Ba2+) e utilizada na bioimpressão de 
microambientes que mimetizam as propriedades da ECM. A caracterização reológica 
revelou a necessidade de se utilizar uma concentração superior de Ba2+ (15 mM) para obter 
níveis similares de consistência do filamento comparativamente ao Ca2+ (13 mM). 
Independentemente do tipo e concentração do catião utilizado na reticulação iónica, as 
bioink apresentaram comportamento reológico similar. A resposta dos fibroblastos no interior 
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das bioink desenvolvidas foi avaliada através da bioimpressão de estruturas 3D celulares 
reticuladas com luz UV de forma a apresentarem baixo (30 s de irradiação UV) ou elevado 
(90 s de irradiação UV) módulo de elasticidade. Foi possível observar que as células no 
interior dos hidrogéis apresentaram extenso alongamento e deposição de fibronectina com 
exceção da bioink reticulada com Ba2+, na qual se verificou uma redução na atividade 
metabólica, teor em DNA e deposição de ECM, provavelmente devido aos constrangimentos 
físicos impostos pela rigidez do hidrogel.  
De uma forma sucinta, neste trabalho de investigação foram desenvolvidas novas 
bioink fotopolimerizáveis baseadas em pectina para a bioimpressão de pele através de uma 
combinação original de estratégias de modificação química, reações de reticulação e 
abordagens de bioimpressão. Ambas as bioink desenvolvidas com base PECMA e NorPEC 
demonstraram propriedades reológicas adequadas e mecanismos de reticulação 
biocompatíveis, permitindo a bioimpressão de estruturas 3D celulares que estimularam a 
deposição de componentes da ECM da pele. As bioink propostas resolvem importantes 
limitações na área e apresentam propriedades promissoras para aplicações em engenharia 
de tecidos da pele como estruturas 3D para a reparação de lesões cutâneas, modelos de 
teste in vitro e bioinks para a bioimpressão de pele in situ.  
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1.1. Overview 
1.1.1. Skin wound care: facts and numbers  
The skin is the largest organ of the human body, located at the interface between the 
internal organs and the external environment, performing protective, sensory, metabolic and 
aesthetic functions. It encompasses a surface area of 1.8 m2 and comprises approximately 
16% of the total body weight [1]. Skin acts as an efficient barrier that prevents dehydration 
and the entrance of exogenous organisms into the body. Anatomically, it is a multilayered 
organ composed by three functional layers of epidermis, dermis and hypodermis, containing 
distinct cell populations (e.g., stem cells, fibroblasts, keratinocytes, adipocytes) surrounded 
by an intricate extracellular matrix (ECM). The interplay between resident cell populations 
and their niches ensures tissue homeostasis, barrier properties and wound repair [2, 3].  
As the outermost organ of the human body, skin is under permanent interaction with 
the outside environment, which can result in different types of damage caused by injury or 
disease. Skin damage causes a disruption in tissue organization, leading to wound formation 
and initiating the process of wound healing to restore the tissue function. Depending on the 
underlying cause, wounds can be classified into acute (e.g., surgical wounds, burns, 
abrasions) and chronic (e.g., diabetic foot ulcers, pressure ulcers, leg ulcers). Acute wounds 
proceed orderly and timely throughout the cascade of the healing phases until repair, while in 
chronic wounds the excessive protease activity and reactive oxygen species (ROS) 
production, unbalanced ECM turnover, and wound colonization and infection have been 
identified as major biological events [4-6]. These events, together with the underlying 
pathophysiology (e.g., venous insufficiency, diabetes mellitus, arterial occlusion), are 
responsible for the wound healing arrest, often in the inflammatory phase, resulting in a 
failure of granulation tissue formation and subsequent re-epithelialization for a period longer 
than three months [7]. While most of the acute wounds (e.g., surgical wounds, abrasions) 
often heal without major complications, extensive burn injuries and chronic wounds are often 
associated with expensive treatments and eventually long hospitalization times, increasing 
the total health expenditure. 
For small areas of full-thickness skin loss (<1 cm), wound closure spontaneously 
occurs through contraction and cell ingrowth. However, in larger or difficult-to-heal wounds, 
the innate self-healing ability of the skin is insufficient to restore its native architecture, 
composition and functions [8]. In these cases, immediate wound covering is needed to 
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prevent local and systemic infections. Conventional full-thickness or split-thickness 
autografting are the ‘gold standard’ treatment for full skin reconstruction, though they present 
several drawbacks such as the limited availability, patient morbidity, scarring at the donor 
sites and lengthy hospitalization times [9]. Although the application of meshing technique 
maximizes the wound area covered by the grafts [10], in patients with extensive injury (e.g., 
burns), difficult-to-heal acute wounds or chronic wounds, advanced wound care products and 
therapies are required. In order to address these needs, researchers have explored 
interdisciplinary approaches to develop alternative therapeutic options, including advanced 
dressings (e.g., foams, hydrogels, films, alginate), genetically modified grafts, bioengineered 
skin substitutes (e.g., epidermal and/or dermal), active wound care (e.g., growth factors, 
protease inhibitors), and therapy devices (e.g., electrical stimulation therapy, negative wound 
pressure therapy) [11-14]. Despite the fact that dressings provide a temporary solution for 
wound coverage and can maintain a moist environment in the wound bed, some wounds 
require a more permanent form of coverage. Bioengineered skin substitutes refers to wound 
care products manufactured based on cells, ECM-like biomaterials or their combination. 
These products are composed of dermal and/or epidermal components, providing a solution 
to the reconstruction of both epidermal and dermal skin layers. They are mostly 
manufactured from collagen and glycosaminoglycans (GAGs), being available as either 
acellular or cellular products. Skin substitutes are the most advanced wound care products 
available in the market, but they still present important limitations such as the inability of 
complete regeneration of functional skin (e.g., adnexal structures, pigmentation, 
vascularization), lack of underlying connective tissue (dermal and subcutaneous), peripheral 
scarring and high cost [15, 16].  
Wound treatment represents a substantial economic burden to the healthcare system 
of a country due to increased health care costs, aging population, and higher incidence of 
diabetes and obesity. In the United States (US), it was estimated that the total direct cost of 
skin disease was about $75 billion in 2013, compared to $29 billion in 2004. Nearly $40 
billion were devoted to the top 10 skin disease categories with the largest economic burden, 
including wounds, burns, ulcers and cutaneous infections [17]. According to data from the 
United Kingdom (UK), annual costs with wound treatment accounts for approximately 
£5billion, corresponding to hospital stay (~50%), nursing time (~35%) and dressing materials 
(~15%) [18]. In US, it is estimated that each year 35.2 million cases of significant skin loss 
require major therapeutic intervention, while about 6.5 million of these wounds become 
chronic [18]. Every year there are about 3 million cases of pressure and leg ulcers, and 2 
million cases of chronic diabetic ulcers, resulting in approximately $9.5 billion of total direct 
health care costs [19]. Among acute wounds, burns represent the most devastating and 
CHAPTER I 
 5
debilitating injuries. I was estimated that 486,000 burn patients were treated in emergency 
departments, resulting in 40,000 hospitalizations in 2016 [20] and representing an annual 
expenditure higher than $2 billion in direct costs. In Europe, it is estimated that 1.5–2 million 
people suffer from acute or chronic wounds, while between 22.7% and 50% of hospital beds 
are occupied by patients requiring wound management [18]. Together, these data indicate a 
growing trend in the global wound care market and rising demand for innovative and 
advanced wound management products. According to the “Wound Care Market - Global 
Forecast To 2022” report from Markets and Markets, the segments of advanced wound 
management products and chronic wounds are foreseen to account for the largest share of 
the global wound care market. 
1.1.2. Hydrogels in wound healing 
Hydrogels are water-swollen three-dimensional (3D) crosslinked networks of insoluble 
macromolecular polymers obtained by the formation of chemical or physical bonds between 
polymer chains. Depending on the polymer origin and chain crosslinking mechanism, 
hydrogels can be designed with a broad range of physicochemical and mechanical properties 
[21], making them suitable for wound healing applications. They are used to maintain a moist 
environment in the wound bed and promote autolytic debridement, while allowing the 
passage of water vapour and oxygen to the wound surface [22, 23]. Hydrogel dressings are 
available as either a sheet or an amorphous gel, which is covered by a secondary dressing 
(e.g., film, foam or hydrocolloid). Major advantages of hydrogels as dressings include the 
smooth nature and the ability to be applied and removed from the wound with minimal pain or 
trauma [24]. In order to extent their efficacy, several factors such as antimicrobial agents, 
growth factors and cells, can be loaded in the porous network and topically released into the 
wound bed to modulate the wound microenvironment through several biological pathways 
[25-27].  
Photocrosslinkable hydrogels are promising for wound healing as they can be rapidly 
formed in situ, i.e., directly into the wound bed upon exposure to cytocompatible doses of 
ultraviolet (UV) or visible light. In addition, they conform to the shape of the defect and 
provide unique control over the spatiotemporal formation of the gel network [28, 29]. These 
hydrogels can be crosslinked in the presence of cells, bioactive molecules and biological 
tissues, allowing the design of advanced formulations capable of instructing the function of 
embedded cells and establishing dynamic interactions with the wound microenvironment [25, 
30]. ECM components like collagen and elastin have been the first choice in the synthesis of 
hydrogels for wound healing due to their intrinsic biological activity [29, 31, 32]. However, the 
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limited control over the biochemical composition of the gel network, source variability, risk of 
infection and purity has driven the research for alternative sources of biomaterials.  
Polysaccharides are natural polymers obtained from animals, plants or 
microorganisms widely used in wound healing due to their biocompatibility, availability, 
versatile chemical composition and bioactive properties [33, 34]. Pectin is a structural 
heteropolysaccharide extracted from the cell walls of plants (mostly from citrus peel and 
apple pomace) extensively employed in the food industry as a jellifying agent. It has also 
been investigated for biomedical applications owing its biocompatibility, chemical versatility, 
anionic nature and ionic crosslinking ability [35]. Pectin is a branched polysaccharide 
composed of a linear chain of α-(1,4)-linked galacturonic acid (GaIA) residues, in which part 
of the carboxyl groups are in either methyl ester or acetyl-ester form. The content of methyl-
esterified residues defines the degree of esterification (DE) and determines polymer 
properties such as the hydrogel formation and the strength of the crosslinked network [36]. 
Pectin backbone is comprised of approximately 65-70% of GaIA residues that constitute the 
homogalacturonan domain. This domain has regions without side chains (known as “smooth 
regions”) and regions flanked with a variety of neutral sugars (termed as “hairy regions”) such 
as arabinose, galactose and rhamnose. Rhamnogalacturonan-I (RG-I) and 
rhamnogalacturonan-II (RG-II) are other two prominent domains in pectin that contain side 
chains of different sugars and are believed to be alternately linked to the homogalacturonan 
domain, though their exact arrangement still remains unknown [35, 37]. The complex 
chemical composition of pectin is responsible not only for its bioactive properties (e.g., 
mucoadhesiveness, wound healing, antitumor activity), but it also provides a multitude of 
functional groups amenable to chemical modification. These groups have been explored for 
the synthesis of pectin derivatives with tailored chemical, biophysical and biological 
properties [38-40]. Pectin and its derivatives have been converted into physical or chemical 
hydrogels using a variety of crosslinking mechanisms and evaluated as drug delivery 
carriers, cell delivery systems or matrices for tissue repair [41-46], extending their application 
to the fields of tissue engineering and regenerative medicine.    
1.1.3. Biofabrication of hydrogels for skin reconstruction  
Biofabrication is a multidisciplinary field that combines the principles of biology, 
engineering and material science to generate constructs with biological function. In the 
context of tissue engineering and regenerative medicine, biofabrication is defined as “the 
automated generation of biologically functional products with structural organization from 
living cells, bioactive molecules, biomaterials, cell aggregates such as micro-tissues, or 
hybrid cell-material constructs, through bioprinting or bioassembly and subsequent tissue 
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maturation processes” [47]. Bioprinting employs additive manufacturing technologies and 
building blocks down to molecular level (bioactive molecules, biomaterials, living single cells 
or cell-aggregates) to create functional constructs with prescribed organization, holding the 
potential to automatically generate patient-specific skin substitutes [48, 49]. Recently, a 
disruptive strategy involving the in situ bioprinting of bioinks, which consist of material 
formulations and biological molecules or cells directly onto the wound bed, was proposed for 
skin repair and reconstruction [50, 51]. Despite the developments in the bioprinting of skin 
constructs, major bottlenecks in the field are related to the lack of bioinks exhibiting both 
tuneable rheological properties for high printing resolution and cell-instructive capabilities [52, 
53]. 
1.2. Motivation 
In situ forming hydrogels have been designed to mimic specific features of the native 
ECM, including the fibrous nature, ability to promote cell adhesion, proteolytic degradation or 
growth factor delivery and sequestration [54]. These biofunctional hydrogels have become an 
important tool for novel wound care therapies as their biochemical and biophysical properties 
can be tailored to engineer physiologically relevant cellular microenvironments. While in situ 
forming hydrogels are widely used as both acellular or cellularized injectable formulations 
that can be crosslinked in vitro or in vivo, a limited number of hydrogels can be applied for 
the extrusion bioprinting of cell-laden 3D hydrogels for skin repair due to the narrow 
processing window.   
Extrusion bioprinting dispenses continuous filaments of hydrogel materials through 
nozzles by the action of a piston, a screwing system or pneumatic pressure. Viscous 
materials with high cellular densities can be printed into 3D constructs of complex 
architectures, making extrusion bioprinting the most affordable technology to print biological 
constructs at clinically relevant dimensions [55]. However, the printing of functional skin 
constructs using this technology requires the design of hydrogel bioinks with specific 
rheological properties that simultaneously provide an instructive environment for printed cells 
and exhibit fast and cytocompatible crosslinking mechanisms. These strict requirements 
significantly limit the number of available bioinks for the bioprinting of skin tissue equivalents. 
The majority of hydrogel bioinks are based on protein-derived materials (e.g., collagen, 
gelatin and fibrinogen), eventually combined with alginate to explore its ionic crosslinking 
ability [56-59]. Some of the limitations of these material systems include the difficulty in 
decoupling the contribution of biochemical and biophysical cues to cell behaviour, limited 
mechanical properties, and poor control over the biochemical composition of bioinks. Thus, 
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there is an unmet need for alternative hydrogel materials with tuneable biochemical and 
biophysical properties that can be printed into complex 3D constructs holding the prescribed 
shape and rapidly form, both in vitro and in vivo, under cytocompatible conditions.  
1.3. Objective and Specific Aims 
The main aim of this doctoral thesis was to develop novel photocrosslinkable pectin 
hydrogels as cell-responsive bioinks for the 3D bioprinting of cell-laden constructs for skin 
tissue engineering. In order to successfully print functional 3D cellularized skin constructs, 
several challenges need to be addressed. First, the bioink must be printable under cell-
compatible conditions and hold the desired shape during the deposition, allowing for high 
printing resolution. For this purpose, ionic gelation was explored to design a printable pectin 
bioink that allows for homogeneous cell suspension and maintains the shape after 
deposition, without the need for support structures or additional materials for viscosity 
modulation. Second, the bioink must be rapidly crosslinked under mild and cytocompatible 
conditions for preserving the viability and function of printed cells. To this end, 
photocrosslinkable pectin macromers were synthetized by chemical modification with 
methacrylate or norbornene end groups for rapid hydrogel formation through UV 
photopolymerization via a chain-growth or a step-growth mechanism, respectively. Third, the 
bioink should allow the biofunctionalization with relevant biochemical cues and exhibit 
tunable biophysical and rheological properties. For the functionalization of pectin macromers, 
two bioconjugation chemistries (thiol-Michael addition and photoinitiated thiol-ene reactions) 
were selected for the coupling of cell-adhesive and protease-degradable peptide sequences, 
by exploring the reactivity between thiols and alkene functional groups. Finally, the printed 
constructs should provide a cell-responsive microenvironment capable of instructing 
embedded cells to secret new ECM components, ultimately supporting in vitro skin formation 
and promoting in vivo skin repair. The development of a single-component bioink platform 
fulfilling those requirements will provide new opportunities in the bioprinting of 3D skin 
constructs that could be explored as in vitro testing models and matrices for skin repair.    
The specific aims of this thesis were:  
i) Design a dual-crosslinked pectin hydrogel bioink for the extrusion bioprinting 
of 3D cell-laden dermal constructs.  
ii) Synthetize pectin macromers by functionalization with norbornene end groups 
for the one-pot formation of step-growth hydrogels that support full-thickness 
skin formation.   
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iii) Bioprinting a protease-degradable pectin bioink into 3D constructs 
photocrosslinked by bioorthogonal thiol-norbornene chemistry. 
1.4. Thesis Outline  
This thesis is divided in six chapters that provide a detailed review of literature, 
present the developed work, and discuss the findings and their implications for the field.  
Chapter II provides a detailed overview regarding the most recent developments in 
the biofabrication of hydrogel constructs for skin repair and regeneration. Skin anatomy and 
wound healing physiology are firstly described along with the available therapeutic options. 
Major limitations and unmet needs are highlighted. A general overview of biofabrication 
processes is also provided with emphasis on bioprinting technologies that allow the 
deposition of cellularized bioinks and design strategies to synthetize and print 
photocrosslinkable hydrogels. Finally, the applications of bioprinted skin constructs are 
illustrated and future directions discussed in order to summarize required developments in 
the field.  
 Chapter III describes the design of a dual-crosslinkable pectin hydrogel that can be 
explored as a platform to study the influence of biophysical and biochemical cues on the 
behaviour of embedded dermal fibroblasts, or as a printable bioink to create cellularized 
dermal constructs. Pectin was chemically modified with methacrylate groups to allow the 
formation of hydrogels via UV photopolymerization, while retaining its ionic crosslinking 
ability. The sequential application of both crosslinking mechanisms allowed the design of a 
biofunctional bioink that stimulated printed cells to secret new dermal ECM components. 
Chapter IV presents a novel chemical route for the modification of pectin with 
norbornene end groups to create chemical hydrogels through UV photoinitiated thiol-
norbornene click chemistry via a step-growth mechanism. The introduction of norbornene 
groups allowed the rapid formation of protease-degradable hydrogels using a matrix 
metalloproteinase (MMP)-sensitive peptide as a crosslinker. The photocrosslinkable hydrogel 
system was able to support the in vitro formation of bilayered full-thickness skin constructs.  
Chapter V focuses on the formulation and bioprinting of a protease-degradable bioink 
based on the pectin macromers functionalized with norbornene end groups. Suitable 
printability was achieved by ionic crosslinking using two different cation sources namely 
calcium chloride or barium chloride. Both cations allowed the design of bioinks with tuneable 
rheological and viscoelastic properties that were printed into highly elastic 3D structures. 
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Bioprinted cell-laden constructs with tuneable properties were produced by simply changing 
the photocrosslinking time, leading to distinct behaviour of embedded dermal fibroblasts.       
Chapter VI discusses the results and main findings of the work, establishing 
correlations with the knowledge in the field. This chapter also provides main conclusions of 
the developed work and highlights new directions for future research. 
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Abstract 
Skin is the largest organ of the human body, acting as a barrier with protective, 
immunologic and sensory functions. The reconstruction of functional skin remains a huge 
challenge due to its multilayer structure and the organized presence of different cell types 
within an intricate extracellular matrix (ECM). Bioprinting comprises one main strategy of 
biofabrication that allows the additive manufacturing of cellular 3D constructs for skin tissue 
engineering by precisely printing biocompatible materials, cells and biochemicals in 
predesigned spatial positions. This unique feature, combined with the computer controlled 
printing and medical imaging techniques, enable researchers and clinicians to generate 
patient-specific constructs partly replicating the compositional and architectural organization 
of the skin. Bioprinting has been used to automatically dispense hydrogels with skin cells 
located in prescribed sites to promote skin formation in vitro and in vivo. Current skin 
bioprinting approaches mostly rely on the sequential printing of fibroblasts and keratinocytes 
embedded within a homogeneous hydrogel. Recent works have also focused on the printing 
of additional cells, including melanocytes, amniotic fluid-derived stem cells (AFSs), 
endothelial progenitor cells (EPCs), and adipose-derived stem cells (ASCs). Although some 
of these approaches have already been translated to pre-clinical scenarios, they still present 
limitations in terms of fully replicating the cellular and ECM heterogeneity of native skin. The 
success of bioprinting for skin repair depends on the design of bioinks that exhibit suitable 
printability and fast crosslinking schemes, support the function of printed cells and stimulate 
the production of cell-secreted ECM components. Photocrosslinkable hydrogels are attractive 
materials for the design of bioinks as they provide fast polymerization under cytocompatible 
conditions and exceptional spatiotemporal control over the gelation process. To better mimic 
the human skin, novel developments in dedicated bioprinting technologies are necessary, 
namely for the design of advanced bioinks and the printing of vascularised tissue constructs.  
 
Keywords: bioprinting; bioink; hydrogel; photopolymerization; skin tissue engineering.
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2.1. Introduction 
The integumentary system comprises the skin and respective appendages, 
being responsible for many vital functions in the body, such as the homeostasis, 
protection and transmission of sensorial information [1-3]. The skin is the most 
superficial and the largest organ of the human body, acting as an efficient barrier at the 
interface between the internal organs and the external environment. However, the 
permanent exposure to environmental stresses may result in a variety of skin injuries 
induced by acute trauma, thermal, chemical, mechanical, microbial or radiation effects. 
Additional causes of skin loss also include genetic disorders, chronic wounds and 
surgical interventions [2, 4]. Depending on the lesion type, extension and depth, both 
superficial and deep skin layers may be damaged and the innate healing ability of skin 
may be dramatically reduced or inhibited. In the most critical clinical scenarios (e.g., 
deep dermal or third degree burns and full-thickness wounds) hypodermal adipose 
tissue, fascia, internal tissues and organs may also be injured, leading to significant 
morbidity, dysfunction and potentially death [3]. Skin burns and chronic wounds 
represent one of the most debilitating, painful and costly health conditions, with 
tremendous economic and social impact. Typically, these wounds require extensive 
hospitalization, labour intensive clinical procedures and costly wound care products, 
representing a major burden over total world healthcare expenditure [5-7].  
Several skin therapies and wound care products have been developed and 
tested through pre-clinical and randomized controlled clinical trials with the ultimate 
goal of promoting the repair of functional skin [8-17]. Traditional treatments are based 
on the use of grafts (which includes auto-, allo- and xenograft varieties), herbal and 
animal-derived compounds, and traditional dressings. These therapies have been used 
since ancient times mainly due to their acceptable clinical efficacy, simplicity and 
affordability, offering a broad range of therapeutic effects, such as anti-inflammatory, 
cell stimulatory, antimicrobial and wound debridement [18-23]. However, in certain 
types of wounds, such as deep burns and chronic wounds, more sophisticated and 
effective treatments are usually needed [15, 24-26]. Advanced therapies assume a 
prominent role in the management of such wounds, as they explore the basic principles 
and elements of tissue engineering to produce both cellular and acellular constructs for 
skin reconstruction [1, 2, 27]. In the most classical approach, known as scaffold-based 
or top-down, scaffolds are fabricated through either conventional or additive 
manufacturing processes, and subsequently seeded with autologous or allogeneic 
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cells. The cellular scaffold is then cultured in vitro to produce a tissue-engineered 
construct for subsequent implantation into the lesion site [28-31]. Although this 
approach allows for good control over the scaffold characteristics (when additive 
manufacturing processes are used) and cell-scaffold interactions, it fails to place 
individual cells at specific locations throughout the scaffold, thereby not mimicking the 
intricate cellular organization of natural tissues at micro- and nanoscale. Other 
important drawbacks are related with the limited cell density and insufficient 
vascularization, which may lead to tissue malformation and heterogeneous tissue 
growth [32, 33]. To address these limitations, an alternative approach, termed scaffold-
free or bottom-up approach, has been used to generate 3D structures resembling the 
biological and functional organization of human tissues [34-38]. In this approach, one 
strategy of biofabrication, termed bioassembly, is applied to generate hierarchical 
constructs with a prescribed two-dimensional (2D) or 3D organization. Larger and 
complex tissue constructs are obtained through the automated assembly of pre-formed 
cell-containing fabrication units (e.g., cell aggregates, cell fibres, cell sheets or 
microtissues) produced by different techniques, such as self-assembled aggregation, 
microfabrication or microfluidics [34, 39, 40]. Bottom-up approach addresses some of 
the limitations of the top-down approach by the creation of tissue constructs with 
multiple cell types placed at specific 3D locations with a high cell density [32, 41, 42].  
Bioprinting, another main strategy of biofabrication, is attracting significant 
interest from researchers working in the field of tissue engineering and regenerative 
medicine due to their unique ability to print single cells or cell-aggregates, bioactive 
molecules and biomaterials into structurally organized constructs, in a layer-by-layer 
fashion, with high resolution and accuracy [39, 40, 43, 44]. Bioprinting provides a 
powerful tool to arrange such components within a 3D environment on a length scale 
comparable to the complex heterogeneity found in natural tissue (10-100 μm), enabling 
new perspectives as well as unmatched possibilities in the design of biomimetic 
substitutes for tissue regeneration [39, 45, 46]. In the context of skin tissue 
engineering, bioprinting has been explored for the fabrication of 3D constructs 
containing skin cells positioned in distinct layers to resemble the anatomy of native skin 
[47, 48].  
2.2. Skin structure and composition 
The skin serves as a protective layer against the invasion of pathogens and 
external agents, playing a critical role in thermal regulation, homeostasis and 
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transmission of sensory information [3, 49, 50]. From an anatomical point, skin consists 
of three sequential layers of epidermis, dermis and hypodermis (Figure 2.1), each 
having distinct functions, biomechanical properties and cellular constituents (Table 
2.1).  
Epidermis is the most superficial skin layer, being composed of keratinized 
stratified squamous epithelium and organized into four or five main layers containing 
keratinocytes in different stages of proliferation, differentiation and keratinization [49, 
51]. Although the epidermis is an avascular layer, it is under constant renewal due to 
the presence of epidermal basal cells and stem-like cells in the basal layer and hair 
follicles [52]. The main cellular constituents include keratinocytes, melanocytes, Merkel 
cells and Langerhans cells [1, 53]. The underlying dermis, separated from the 
epidermis by a basement membrane, is mainly composed of ECM molecules arranged 
in a dense matrix of connective tissue, rich in collagen and elastin fibres, that provides 
structural and mechanical support to the skin [54]. It is a highly dynamic, vascularized 
layer that supports the epidermis, provides flexibility and strength to the skin, and also 
contains blood vessels, sweat and sebaceous glands, hair follicles and sensory 
receptors [53, 55]. The predominant cells in dermis are heterogeneous subpopulations 
of fibroblasts, which are responsible for the production of ECM components [56]. Other 
cell types like mast cells and macrophages are also present, playing important roles in 
immune and inflammatory responses [52, 53]. Two distinct regions are present in the 
dermis, namely the papillary dermis and reticular dermis. The papillary region is the 
most superficial and is composed of higher cellular density along with less organized 
type I and type III collagen bundles and fine elastic fibres. The reticular dermis is a 
thicker and deeper region consisting of highly organized type I collagen and elastic 
fibres. It also contains hair follicles, sebaceous glands, sweat glands, cutaneous 
sensory receptors and blood vessels. The hypodermis, which acts as an energy source 
and heat insulator, is located just below the dermis and is mainly composed of adipose 
tissue and collagen, attaching the dermis to underlying tissues [53, 55]. Adnexal skin 
structures such as sweat, apocrine and sebaceous glands, nails and hair follicles 
display cosmetic, protective, and temperature regulation functions. These structures, 
together with the dermal vasculature, makes challenging the development of wound 
care products and therapies capable of fully restoring the skin anatomy and functions. 
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Figure 2.1. Schematic representation of the multi-layered structure of human skin. 
Emphasis is given to the four main layers of epidermis and its cellular constituents, including 
keratinocytes, Langerhans cells and melanocytes. Two distinct regions of dermis are also 
represented along with fibroblasts and zonal organization of both collagen and elastin fibres. 
Specialized elements, such as sweat glands, hair roots, sensory cells, blood, and lymph vessels 
are also presented. Skin structures are not to scale for simplification (image from Servier 
Medical Art freeware image bank).  
 
Table 2.1. Skin cells: location and main functions. 
Skin layer Cell type Main functions 
Epidermis 
Keratinocytes 
Production of keratin (provides strength and protection 
to the skin) and lamellar granules (secret several 
compounds like lipids, proteins and hydrolytic enzymes, 
that contribute to the barrier function)  
Melanocytes 
Production of melanin, a pigment that confers skin 
coloration and protects cell nucleus from UV radiation 
Merkel and 
Langerhans cells 
Sensing and immunological defence 
Basal cells and 
stem cells 
Located in the basal layer and hair follicle bulge, ensure 
tissue renewal 
Dermis 
Fibroblasts Production of ECM components 
Mast cells and 
macrophages 
Immune and inflammatory response 
Hypodermis Adipocytes 
Energy storage and secretion of molecules that 
regulate processes beyond metabolism 
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The human skin ECM, a gel-like matrix secreted by fibroblasts and epidermal 
cells as an intricate structural scaffold, contains several macromolecules (Table 2.2). It 
surrounds the cells and is composed of a variety of polysaccharides, collagen proteins, 
and water. ECM molecules can be divided into (1) fibrous structural proteins, which 
provide strength, and (2) proteoglycans that confer hydration and controlled 
permeability. Ideally, the composition of wound care products should contain ECM 
molecules present in the native skin. However, despite the efforts in the extraction, 
isolation and purification of these ECM molecules, the extraction yield is often low and 
the associated costs still remain too high. 
 
Table 2.2. Examples of extracellular matrix molecules present in the human skin [51]. 
ECM molecule Location and functions 
Collagen I, III and 
IV 
Structural components of the ECM, responsible for the dermis integrity 
Collagen III is prominent in the early proliferation phase of the healing 
process, being replaced by collagen I in the remodelling phase   
Type IV associates with specialized molecules like laminin and 
proteoglycans to form the basement membrane 
Elastin and fibrillin 
Main components of the elastic fibres located in deeper dermis  
Provide skin resilience, allowing flexibility and recoil after stretching 
Fibronectin 
Found in dermis and basement membrane 
Plays an important role in cell adhesion and communication 
Laminin 
Cell adhesion molecules found in the basal lamina 
Multiple roles throughout the healing process, including angiogenesis  
Hyaluronic acid 
Distributed throughout the epidermis and dermis 
Provides hydration to the dermis 
Dermatopontin 
Distributed throughout the ECM 
Involved in cell attachment and collagen fibril formation 
Periostin 
Present around hair follicles 
Stimulates keratinocyte proliferation  
2.3. Wound healing process  
Wounds can be defined as an injury or disruption to the anatomical structure 
that compromises tissue function. Depending on the underlying cause, wounds can be 
classified into acute or chronic. Major causes of acute wounds include mechanical and 
chemical injuries, burns and surgical incisions. Chronic wounds exhibit a slow healing 
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rate and often involve significant tissue loss, ultimately affecting internal tissues and 
organs. They are mostly caused by vascular insufficiency, diabetes mellitus, local-
pressure effects and arterial occlusion.  
From the onset of injury, the human body initiates a series of complex and 
coordinated signalling pathways, involving the interaction between several ECM 
components, cells, cytokines and growth factors, aimed at tissue repair and 
reconstruction of lost cutaneous tissue [51, 57]. The healing of an acute wound 
proceeds in a sequence of overlapping and well-orchestrated events throughout 
different phases of haemostasis, inflammation, migration, proliferation and maturation 
(Figure 2.2). The transition between these phases is tightly regulated by wound 
healing mediators such as cytokines, chemokines and growth factors, which are 
produced by several cell types. Acute wounds proceed orderly and timely throughout 
these phases until repair, while in chronic wounds underlying pathophysiology or 
microbial invasion arrests the wound healing process, usually in the inflammatory 
phase, resulting in the failure of granulation tissue formation and subsequent 
reepithelialisation for a period longer than three months [58]. 
2.3.1. Acute wound healing 
2.3.1.1. Haemostasis 
The first response of the human body to an injury is haemostasis, which is 
mediated by platelets, and involves the formation of a fibrin clot that circumvents the 
bleeding, acts as a provisional ECM for cell migration, and loosely joins the wound 
edges [59, 60]. In an early stage, platelets release several factors (e.g., platelet factor 
4, angiostatin) that sequester various growth factors and promote initial inhibition of 
angiogenesis [61]. In a later stage, platelets trapped within the clot suffer degranulation 
and release a plethora of cytokines and growth factors (e.g. transforming growth factor-
β (TGF-β), fibroblast growth factor (FGF), transforming growth factor-α (TGF-α), 
vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), and 
epidermal growth factor (EGF)) that are responsible for attracting fibroblasts, 
inflammatory and vascular cells to the wound site [57, 59, 62].  
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2.3.1.2. Inflammation 
Inflammation is essential in wound healing, allowing not only tissue breakdown 
and removal of non-functional cells and pathogens, but also stimulating keratinocytes, 
fibroblasts and endothelial cells [57, 59, 62]. Early inflammatory response mobilizes 
several cells to the wound site for wound cleaning and removal of contaminants. 
Neutrophils are the first cells to arrive in the wound site, playing a key role in host 
defence and debridement of damaged tissues, by generating free radicals and 
releasing proteolytic enzymes (e.g., serine proteases). Neutrophils also release 
inflammatory mediators like tumour necrosis factor alpha (TNF-α) and interleukin-1 (IL-
1), which recruit and activate fibroblasts and epithelial cells. After neutrophils are 
depleted in the wound, circulating monocytes are attracted to the wound site by soluble 
mediators and degraded ECM components (e.g., collagen and fibronectin fragments), 
bind to the ECM via integrin receptors, and differentiate into tissue macrophages. 
These macrophages display a phagocytic function and produce collagenases and 
elastase to facilitate the breaking down of devitalised tissues. They also produce 
inhibitors for these enzymes, which is essential for the regulation of their proteolytic 
activity. In addition, macrophages regulate the transition between the inflammatory and 
proliferative phases of the wound healing through the release of a variety of growth 
factors and cytokines, including the PDGF, FGF, VEGF, IL-1, interleukin-6 (IL-6), 
insulin-like growth factor-one (IGF-1), TGF-α and TGF-β [63]. These soluble mediators 
are responsible for stimulating angiogenesis and the recruitment and activation of 
fibroblasts.   
2.3.1.3. Proliferation 
In the proliferative phase, the wound healing proceeds with the formation of a 
scab and the migration, proliferation and differentiation of epithelial cells, dermal 
fibroblasts, and vascular endothelial cells from the adjacent healthy tissue. 
Keratinocytes, located at the wound periphery, are stimulated to migrate and proliferate 
into the lesion site to promote re-epithelialization by the synthesis of new epidermis 
[57]. Fibroblasts and endothelial cells are also recruited to initiate the synthesis of ECM 
components, the formation of granulation tissue, and the growth of new blood vessels 
from existing ones [51, 59, 64]. The movement of fibroblasts through the ECM and the 
provisional matrix depends on the concentration gradient of chemotactic factors and 
the alignment of fibrils. Fibroblasts initially bind to the ECM components (e.g., collagen, 
fibronectin, vitronectin and fibrin) via cell-surface integrin receptors and then extend a 
cytoplasmic projection to find another binding site. At this moment, MMPs, mostly 
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MMP-1, MMP-2, MMP-3, and MMP-9 are secreted by the cells to breakdown the 
attachment to the original ECM site, allowing the migration. MMPs degrade denatured 
collagen and other ECM components, which is essential for cells to interact with 
functional ECM. However, their activity must be tightly regulated by tissue inhibitors of 
metalloproteinases (TIMPs) to prevent degradation of functional matrix. Fibroblasts that 
migrate into the provisional matrix proliferate and produce granulation tissue, rich in 
collagen, elastin and proteoglycans. Some of fibroblasts are converted into 
myofibroblasts, which are involved in wound contraction and re-epithelialization [57, 62, 
64].  
2.3.1.4. Remodelling  
At the final stage, the wound healing involves a long maturation phase, in which 
the wound edges move towards the centre (wound contraction), and the new tissue is 
continuously remodelled in order to approximate its properties to those of the native 
skin. This phase can take several weeks to months, and is marked by changes in the 
ECM composition, with re-organization of collagen fibres and collagen crosslinking [57, 
65]. Despite the continuous remodelling process, adult wound healing predictably 
results in a scar tissue with a tensile strength that only achieves 80% of its native 
properties, and also impairs the flexibility, mobility and esthetical outcomes [51]. 
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Figure 2.2. Acute wound healing process. Classical stages of wound healing are divided into 
four phases of (A) haemostasis, (B) inflammation, (C) proliferation, and (D) remodelling [63]. 
Abbreviations: PDGF – platelet-derived growth factor; TGF – transforming growth factor; FGFs 
– fibroblast growth factors; IL-1 – interleukin-1; TNF – tumour necrosis factor; KGF – 
keratinocyte growth factor; IGF – insulin-like growth factor; IFN – interferon; VEGF – vascular 
endothelial growth factor; HGF – hepatocyte growth factor; MMP – matrix metalloproteinase; 
TIMP – tissue inhibitor of metalloproteinase. 
2.3.2. Chronic wound healing 
Chronic wounds are often associated with microbial contamination, persistent 
infection, excessive production of exudate and repeated tissue trauma, failing to 
achieve tissue repair. Although the molecular mechanisms that lead to impaired wound 
healing are not fully understood, the healing failure in chronic wounds is attributed, in 
part, to both prolonged inflammation and deregulation of proteases and their inhibitors, 
which leads to an imbalance between ECM deposition and degradation [66].  
Chronic wounds are characterized by increased levels of proinflammatory 
cellular infiltrates (e.g., polymorphonuclear leukocytes, neutrophils, macrophages, 
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foreign body giant cells) and deregulation of proinflammatory cytokines [67, 68]. 
Increased infiltration of poly and mononuclear cells results in excessive production of 
proteases (e.g., elastase, MMP-8, MMP-9) and ROS, which cause extensive tissue 
damage and contribute to prolong the inflammatory phase [69, 70]. Elevated levels of 
certain MMPs (e.g., MMP-9) can also ablate important growth factors and other pro-
healing molecules, arresting the healing process and stimulating inflammation. Another 
important feature of chronic wound healing is the premature cell senescence due to the 
excessive production of ROS that can cause direct damage to cell membranes [71]. 
Depending on the level and length of ROS exposure, as well as on the physiologic 
state of the cell, oxidative stress can induce either senescence or apoptosis, leading to 
alterations on the cell phenotype and functions or dead, respectively [72]. These 
alterations were observed in senescent fibroblasts derived from chronic wounds, which 
showed compromised migratory capacity [71]. Although the mechanisms underlying 
cell senescence in chronic wounds are poorly understood, premature aging can affect 
not only the deposition of ECM molecules and granulation formation, but also impair 
the ability of cells to secret and release factors for cell recruitment [73].  
Another important feature of chronic wounds is the common presence of high 
levels of bacteria in the wound bed, which results in direct tissue damage and 
stimulates the continual recruitment of inflammatory cells (e.g., neutrophils and 
macrophages) with consequent release of cytokines and ROS that contribute to trigger 
and maintain inflammatory cascades [74]. Pathogens in the wound bed contribute not 
only to altered ECM homeostasis and increased protease levels, but can also secrete 
proteolytic enzymes that can activate host MMPs [66]. Bacteria that colonise chronic 
wounds often form polymicrobial biofilms composed of an ECM containing several 
types of extracellular polymeric substances that provides an optimal microenvironment 
in which embedded bacteria develop higher resistance to both the host immune 
response and the action of antibiotics [75]. The main distinctive features between acute 
and chronic wounds are summarized in Table 2.3. 
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Table 2.3. Main events of the wound healing process and distinctive characteristics between 
acute and chronic wounds [76, 77]. 
Healing 
phase 
Target Acute wound Chronic wound 
Haemostasis 
and 
inflammation 
Haemostasis  
Bacteria load 
Activation of 
keratinocytes and 
inflammatory cells 
Deposition of fibrin matrix 
Neutrophil invasion  
Deposition of fibrin matrix 
Hyperinflammation with 
increased proteolytic 
activity  
Proliferation 
Proliferation and 
migration of 
keratinocytes  
Proliferation of 
fibroblasts 
ECM deposition  
Angiogenesis 
Provisional matrix 
composed of collagen, 
proteoglycans, and elastin 
Migration of fibroblasts and 
endothelial cells into the 
wound 
Inflammation resolved 
Constant matrix 
degradation by proteolytic 
activity 
Non-migratory epidermis 
Reduced fibroblast 
migration and blood 
vessel formation 
Persistent inflammation 
Remodelling 
ECM remodelling 
Restoration of the 
barrier properties 
Reorganization of collagen 
fibres  
Minimal scarring 
Failure to progress to the 
remodelling phase 
Persistent inflammation 
Deficient vascularization 
Formation of immature 
matrix  
2.4. Therapeutic options for skin reconstruction 
The most suitable therapeutic treatment for skin wounds depends on numerous 
factors including the wound type, number of affected skin layers, level of exudate, 
extension of injury, and the overall health status of the patient [59]. Wound healing 
therapies can be broadly classified into conventional and advanced therapies, which 
have distinct levels of efficacy, clinical acceptance, and side effects. 
2.4.1. Conventional therapies 
Conventional wound care therapies comprise autografts and allografts, 
traditional dressings, solutions, creams, ointments and therapies based on traditional 
medicine.  
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Practices and compounds arising from traditional and complementary medicine 
(T&CM) have been used to create alternative therapies for wound healing due to their 
therapeutic activities, availability, affordability and relative low cost [78]. According to 
the World Health Organization (WHO), traditional medicine (TM), also referred as 
"alternative" or "complementary" medicine, underlies the use of traditional therapies 
towards the maintenance of health and the prevention, diagnosis, improvement or 
treatment of physical and mental illness [78]. More recently, the WHO proposed new 
definitions for the terms TM,1 complementary medicine (CM),2 and T&CM3 based on 
their history and integration into the dominant health-care system [79]. These therapies 
comprise practices, products, and knowledge from different countries, involving the use 
of living organisms and natural compounds obtained from a wide range of sources (e.g. 
animals, plants, fungi, minerals). Recent developments on extraction procedures, 
purification methods, processing methodologies, and clinical treatments allowed a 
significant increase in the quality, efficacy and safety of traditional therapies. However, 
the use of some therapies is largely supported by wisdom and experience acquired 
over years, rather than by strong scientific evidence. In the last few years, several 
laboratories focused on the mechanisms behind the therapeutic efficacy of traditional 
healing compounds, increasing the knowledge about their action mechanisms and 
biological activities. 
2.4.1.1. Autografts and allografts 
In the case of patients with skin lesions extended to the dermis or hypodermis, 
a complex treatment procedure is required. In these cases, the clinical ‘gold standard’ 
procedure relies on the use of split-thickness skin autografts or allografts, which 
contain all of the epidermis and marginal parts of the dermis [1, 2, 4]. For severe burns 
like deep partial- and full-thickness injuries, the early excision of the necrotic tissue 
followed by autologous skin grafting constitute the most effective treatment. Although 
the meshing technique maximizes the wound area covered by the grafts, autografts are 
naturally limited in their extent, induce scarring at donor sites and patient morbidity, and 
are associated to lengthy hospital stays, while allografts present ethical and safety 
issues related with disease transmission and may lead to immune rejection [80]. 
                                               
1 “Traditional medicine has a long history. It is the sum total of the knowledge, skill, and practices based on 
the theories, beliefs, and experiences indigenous to different cultures, whether explicable or not, used in 
the maintenance of health as well as in the prevention, diagnosis, improvement or treatment of physical 
and mental illness.” 
2 “The terms “complementary medicine” or “alternative medicine” refer to a broad set of health care 
practices that are not part of that country’s own tradition or conventional medicine and are not fully 
integrated into the dominant health-care system. They are used interchangeably with traditional medicine 
in some countries.” 
3 “T&CM merges the terms TM and CM, encompassing products, practices and practitioners.” 
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2.4.1.2. Herbal-derived compounds 
Herbal-derived compounds are the most commonly used traditional therapies 
for the treatment of skin lesions. They include the application of herbs, herbal 
preparations and finished herbal products, containing biologically active compounds 
that stimulate the healing process. A variety of plants, native form different regions of 
the world, have been investigated and applied for the treatment of skin lesions [81, 82]. 
Examples include Aloe vera, Calendula officinalis, Angelica sinensis, and Rosmarinus 
officinalis L [83-85]. Herbal-based products are applied as extracts, emulsions, creams 
and ointments, being administrated through topical, systemic and oral routes. 
Alternatively, some of these products have also been incorporated within dressings or 
nanoparticles in order to improve their stability and achieve a more controlled release 
[86, 87]. Aloe vera, also known as Aloe barbadensis Miller, is the most popular herb in 
wound healing. The gel extracted from the plant leafs is the most valuable product for 
the treatment of skin lesions, containing several biologically active compounds with 
anti-inflammatory, anti-septic and antimicrobial properties [83, 88]. Although the use of 
both topical and oral Aloe vera preparations is considered safe without serious side 
effects [89], some adverse reactions have been experienced by the patients. Topical 
preparations are commonly associated to skin itching, irritation, contact dermatitis, 
erythema and photodermatitis, while oral administration can lead to diarrhea and 
vomiting [83, 90].   
2.4.1.3. Animal-derived products 
Animal origin products, like honey and propolis, have been used in wound care 
since ancient times due to their therapeutic properties. Honey is a highly viscous and 
super concentrated acidic sugar solution (pH ~4.0) derived from nectar and modified by 
the honeybee, Apis melífera. Its chemical composition includes carbohydrates (e.g., 
fructose, glucose, and sucrose), water, amino-acids, antioxidants, vitamins, minerals, 
and enzymes [81, 91]. Several therapeutic activities have been assigned to honey, 
including antibacterial, anti-inflammatory, antifungal, and the ability to stimulate 
angiogenesis, granulation, wound contraction and epithelialization. It also provides 
debriding effect, reduces edema and deodorizes the wound [92]. The administration of 
honey as a natural healing agent is considered safe, rarely resulting in allergic 
reactions or adverse effects. However, there are clinical trials reporting that the use of 
honey may result in itching, while the contact between honey and the wound site can 
be painful for the patient due to its acidic nature [93]. Propolis, also known as bee glue, 
is a resinous-like substance collected by honeybees from several tree species. It has a 
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complex composition, containing resin and balsam, wax, essential and aromatic oils, 
pollen and other substances [94, 95]. Among these constituents, the most 
representative are polyphenols like flavonoids (e.g. quercetin, galangin, chrysin), 
phenolic acids (e.g. !-Coumaric acid, caffeic acid, ferulic acid), and aromatic 
compounds, which play an important role in the pharmacological activities of propolis 
[95]. Propolis has been used in traditional medicine due to the wide range of biological 
properties (e.g., anti-oxidant, anti-inflammatory and antibacterial activity) and low 
toxicity [94]. Although the adverse reactions related to the use of propolis in wounds 
are poorly documented in the literature, contact dermatitis is referred as the most 
common side effect [96].  
2.4.1.4. Living organisms 
Living organisms like maggots and leeches are used in wound care to provide 
wound debridement and treat venously congested wounds, respectively. Maggot 
debridement therapy, also termed larval therapy or biosurgery, is rapidly growing due 
to its therapeutic effects such as wound debridement, capacity to inhibit or even 
eradicate the biofilm formation, and antimicrobial activity [97, 98], Medicinal maggots 
are used for the debridement of diverse types of wounds (e.g., chronic, non-healing 
traumatic wounds) through the digestion and removal of devitalized or necrotic tissue, 
due to the secreted powerful proteolytic enzymes (e.g. collagenase, trypsin-like and 
chymotrypsin-like enzymes) [99]. Sterile maggots are introduced into the wound with 
the support of traditional bandages (e.g. gauzes) or modern dressings (e.g. Le Flap™), 
providing either free or constrained access to the lesion site [100]. The clinical use of 
maggot therapy is considered safe without significant side effects or allergic reactions 
for the patients. The most common adverse reactions include pain and discomfort 
associated to escaping maggots [101]. Leech therapy or hirudotherapy, is an 
alternative therapeutic treatment for diverse skin disorders that involves the 
administration of medicinal leeches (Hirudo medicinalis) into the injured site. 
Hirudotherapy has been used in plastic and reconstructive surgery since the ancient 
times to promote the healing of a wide range of lesions, including venously congested 
tissues, free flaps, pedicled flaps, replanted tissues and glaucoma [102]. The action 
mechanism underlying the medicinal leeches relies on the secretion of a complex 
mixture of compounds (e.g. vasodilators, anti-coagulants, anaesthetics, analgesics) 
with relevant biological and pharmacological properties from the salivary glands into 
the lesion site, locally stimulating the healing process. The main constituent of leech 
saliva is hirudin, which is a potent natural anticoagulant that inhibits the blood 
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coagulation through the binding to thrombin, allowing the ingestion of blood by the 
leeches. Hirudin also acts as a bacteriostatic and bactericidal agent [102, 103]. 
Possible side effects include bacterial infections, bleeding, local itching, allergies and 
anaemia [102-104]. 
2.4.1.5. Solutions, creams and ointments 
Liquid and semi-solid preparations, such as creams (e.g. silver sulphadiazine) 
and solutions (e.g. povidone-iodine, sodium hypochlorite), have also been used as 
supportive anti-infective wound care products in daily clinical practice. They are 
commonly used as cleaning and antimicrobial agents, allowing wound bed preparation 
and decontamination [105, 106]. To extend their efficacy and facilitate their handling, 
most of these therapeutic compounds have been embedded within gauzes or 
incorporated within dressing materials [107, 108]. 
2.4.1.6. Traditional dressings 
Traditional dressings like gauzes, cotton wool and natural or synthetic 
bandages are commonly used in wound care [109]. When applied to the wound, these 
products absorb high volumes of exudate, which may lead to the drying of the wound 
bed, and ultimately result in cell death and inhibition of the healing process. 
Additionally, traditional dressings are not able to provide a moist wound environment 
and may also adhere to the wound bed, which can cause trauma and removal of new 
epidermis [110]. As a result of these limitations, traditional dressings are commonly 
applied as secondary dressings or combined with other products such as hydrocolloid 
and alginate dressings, protecting the wound from the entrance of pathogens and 
absorbing exudates. 
2.4.2. Advanced therapies 
Advanced wound care therapies comprise modern wound dressings, 
bioengineered skin substitutes, and therapy devices. These therapies involve the use 
of biomaterials to design interactive dressings for wound management, biofabrication 
technologies to produce matrices for skin reconstruction, or devices to assist in the 
wound bed preparation and wound healing. Advanced therapies are usually applied in 
difficult-to-heal wounds (e.g., infected wounds), chronic wounds and extensive burns. 
Although these therapies are more effective, the costs associated to their 
manufacturing and treatments are generally higher when compared to conventional 
therapies.  
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2.4.2.1. Modern wound dressings 
Lesions involving the loss of high amounts of skin require the immediate use of 
a dressing to protect the wound. Wound dressings are widely used due to their 
relatively low cost, ease of use, and effectiveness to clean, cover and protect the 
wound from the external environment. An ideal wound dressing should provide a moist 
environment to the wound bed, remove the excess of exudate, avoid maceration, 
minimize scar formation, protect the wound from infection and maintain an adequate 
exchange of gases. They must be flexible, permeable to water vapour, fit the lesion 
region, exhibit good adhesion to the wound bed and adequate mechanical properties 
[111, 112]. Some dressings also act as drug delivery systems, incorporating and 
releasing therapeutic agents into the wound bed [113, 114]. 
Modern dressings represent a viable alternative to traditional dressings and are 
often applied in the management of burns and chronic wounds. They are designed to 
provide wound coverage, prevent infection and skin desiccation, and create favourable 
conditions for the healing. A fundamental requirement of modern wound dressings is 
the ability to maintain a moist environment in the wound bed to promote cellular 
proliferation and migration, while absorbing the excess of exudate to avoid periwound 
damage [110]. Modern dressings can be obtained from natural and synthetic polymers 
or a combination of both [115, 116]. There are hundreds of wound dressings in the 
market available in different physical forms and material formulations. Depending on 
the application, dressings can perform additional functions such as wound hydration, 
release of bioactive agents and autolytic debridement [117]. As the wound healing is a 
dynamic process that leads to alterations in the wound bed and exudate levels in a 
time-dependent manner, changing the dressing type is often required along the healing 
process. Major categories of wound dressings commercially available are summarized 
in Table 2.4.  
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Table 2.4. Selected examples of commercially available wound dressings, main properties, and 
indications for use. 
Dressing  Key characteristics Indications Products 
Alginate 
Soft, conformable, 
haemostatic 
Irregular-shaped wounds, 
pressure ulcers, infected 
wounds, and venous 
insufficiency ulcers 
CarboFLEX® 
(ConvaTEC) 
Suprasorb® 
(L&R USA, Inc) 
Antimicrobial 
Modify the wound bed 
bioburden 
Wounds with risk of infection 
or infected* 
AQUACEL® Ag 
Foam 
(ConvaTEC) 
Collagen 
Component of the skin; 
can form a gel on 
contact with the wound 
exudate 
Partial- and full-thickness 
chronic wounds, surgical 
wounds, second-degree 
burns, abrasions and 
traumatic wounds 
ColActive® Plus 
(Covalon 
Technologies) 
Foam 
dressings 
Absorption of high 
exudate volumes, 
provide a barrier to 
bacterial contamination 
Partial- and full-thickness 
wounds 
ALLEVYN* LIFE 
(Smith & Nephew, Inc) 
Hydrocolloids 
Absorb exudate, 
autolytic debridement, 
lower wound pH 
Partial- and full-thickness 
wounds with or without 
necrotic tissue 
DuoDERM®  
(ConvaTEC) 
Hydrogels 
Donate moisture to the 
wound bed; autolytic 
debridement 
Sloughy or necrotic wounds; 
partial- and full-thickness 
wounds, necrotic wounds 
and minor burns 
DermaSyn™  
(DermaRite Industries, 
LLC) 
Medical 
Grade Honey 
Manuka honey reduces 
edema, lowers wound 
pH, and debriding 
slough and eschar 
Partial- and full-thickness 
wounds, pressure ulcers, leg 
ulcers, burns, donor sites, 
and surgical wounds 
MANUKAhd lite® 
(ManukaMed USA, 
LLC) 
Silicone Gel 
Sheets 
Prevent or improve 
hypertrophic and keloid 
scars 
Scar wounds CICA-CARE
® 
(Smith & Nephew, Inc) 
Transparent 
Films 
Wound inspection, 
impermeable to liquids, 
permeable to oxygen 
and moisture vapour 
Partial-thickness wounds 
with little or no exudate 
Suprasorb® F 
(L&R USA, Inc) 
*Exudate absorption depends on each specific product. 
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2.4.2.2. Bioengineered skin substitutes 
Bioengineered skin substitutes are manufactured wound care products based 
on cells, ECM-like biomaterials or their combination, being the most sophisticated 
products available for skin wounds. Skin substitutes are available as either cellular or 
acellular products, allowing the reconstruction of both epidermal and dermal skin layers 
(Table 2.5). They consist of a temporary or permanent scaffold material that serves as 
a template for cell adhesion, proliferation and differentiation, guiding the new tissue 
formation [118]. Skin substitutes are used in the treatment of difficult-to-heal wounds, 
chronic wounds and extensive burns, where the available donor skin is extremely 
limited (e.g., patients with >50% total body surface area). These products perform 
several key functions such as protecting the wound, reducing inflammatory responses, 
providing the dermal component to the wound bed, and reducing scarring [80, 118]. 
They can be classified as biological substitutes, synthetic substitutes or a combination 
of both. Biological substitutes can be further categorized into (1) natural scaffolds (e.g., 
decellularized matrix), (2) constructed scaffolds (e.g., crosslinked collagen matrix) or 
(3) cultured scaffolds (e.g., cultured epithelial graft) [80]. Skin substitutes are also 
classified based on the number of skin layers and the degree of functional similarity to 
the native skin, into epidermal, dermal and dermo-epidermal (composite) products. 
Commercially available skin substitutes are mainly composed of natural materials (e.g., 
collagen, chondroitin-6-sulfate, elastin, hyaluronic acid, and fibrin), with only few of 
them using synthetic materials (e.g., silicon, poly(ethylene oxide)–poly(butylene 
terephthalate (PEO/PBT), polyglycolic acid/poly(lactic acid) (PGA/PLA)). Most of the 
skin substitutes are made of decellularized allogeneic tissue derived from cadaver skin 
or xenogeneic tissue mainly of porcine and bovine origin. Allogenic biological products 
are associated to the risk of disease transmission and reduced skin graft take or 
rejection. Synthetic materials are free from the risk of disease transmission and 
contamination with biological molecules [80]. Major limitations are the permanent 
wound closure, poor vascularization, high manufacturing costs and lack of skin 
appendages [1, 24].  
Epidermal skin substitutes 
Epidermal substitutes are used in the treatment of epidermal lesions, and 
generally comprise a sheet of autologous keratinocytes isolated from the patient 
through a small biopsy (2–5 cm2). The fabrication of stratified cultured epithelial 
autografts (CEAs) is time-consuming and costly, resulting in a fragile sheet (difficult to 
handle and apply) with a shelf life of less than 24 hours [4]. CEAs have been 
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associated to variable clinical outcomes, which could be related to the confluency of 
cell layers. Subconfluent keratinocytes have also been investigated and can be applied 
to the wound bed through an aerosol of the cell suspension (e.g., CellSpray), in either 
culture medium or fibrin glue, showing better outcomes. Alternatively, subconfluent 
keratinocytes can also be cultured on delivery membranes (e.g., MySkin), precluding 
enzymatic detachment. 
Dermal skin substitutes 
Dermal substitutes are used to replace lost dermis, playing a major role in the 
treatment of chronic wounds and full-thickness burns. Dermal replacements consist of 
a 3D matrix, from natural or synthetic origin, that must be covered by a permanent 
epidermal substitute, usually an autologous split-thickness skin graft [118]. The majority 
of these substitutes are based on decellularized human cadaveric skin that closely 
mimics the composition and organization of native tissue, providing a natural ECM and 
a basement membrane. Amniotic membrane has also been explored for the 
development of human-derived products (FlōGraft® Amniotic Fluid-Derived Allograft), 
allowing temporary wound coverage. Animal-derived products have also been used, 
including collagen from cadaveric skin of foetal bovine, porcine small intestinal 
submucosa, porcine urinary bladder (e.g., Keramatrix®, Integra® PriMatrix®, Matristem®) 
and skin fish (e.g., Kerecis™ Omega3 Wound). Dermal substitutes are available as 
acellular or cellularized products. The presence of viable cells in the dermal matrix 
provides the wound bed with several growth factors that stimulate the host cells, 
promoting faster cellular infiltration, angiogenesis and reepithelialisation [119]. Despite 
these outcomes, there is a general consensus about the need for clinical evidence 
regarding the efficacy of cellular substitutes compared to acellular matrices.   
Dermo-epidermal skin substitutes 
Dermo-epidermal substitutes comprise both epidermal and dermal layers in 
order to better mimic the anatomical structure of the skin. They are the most 
sophisticated and expensive tissue-engineered products for skin reconstruction. Most 
of these products contain allogeneic skin cells incorporated into a dermal matrix, acting 
as a temporary scaffold that provides growth factors, cytokines and ECM components 
to stimulate host cells in the wound bed. Dermo-epidermal substitutes are often 
associated to host rejection as allogeneic keratinocytes do not survive for long periods 
of time in the wound [4].  
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Table 2.5. Selected examples of commercially available bioengineered skin substitutes. 
Skin substitute Matrix Cells 
Epidermal 
CellSpray® 
(Clinical Cell Culture) 
None 
Autologous cultured 
keratinocytes (subconfluent 
cell suspension) 
Epicel® 
(Genzyme Biosurgery) 
None 
Autologous cultured 
keratinocytes (confluent cell 
sheet) 
MySkin® 
(CellTran Ltd) 
Silicone support layer 
Autologous cultured 
keratinocytes (subconfluent 
cell sheet) 
Dermal 
(single layer) 
Alloderm® 
(LifeCell Corporation) 
Human acellular 
lyophilized dermis 
None 
Dermagraft® 
(Advanced BioHealing) 
PGA/PLA, ECM 
Allogeneic neonatal 
foreskin fibroblasts 
Hyalograft 3D® 
(Fidia Advanced 
Biopolymers) 
Hyaluronic acid 
membrane 
Cultured fibroblasts 
Permacol® 
(Tissue Science 
Laboratories) 
Porcine acellular 
diisocyanite 
crosslinked dermis 
None 
Dermal 
(double 
layer) 
Integra® 
(Integra LifeSciences 
Corp) 
Polysiloxane, bovine 
cross-linked tendon 
collagen, GAG 
None 
Hyalomatrix™ 
(Fidia Advanced 
Biopolymers) 
Silicone membrane, 
hyaluronic aci 
None 
TransCyte® 
(Advanced BioHealing) 
Silicon film, porcine 
dermal collagen-
coated nylon mesh 
Allogeneic neonatal 
foreskin fibroblasts 
Dermo-
epidermal 
Apligraf® 
(Organogenesis Inc) 
Bovine collagen 
Cultured allogeneic 
keratinocytes and 
fibroblasts 
OrCel® 
(Ortec International) 
Bovine collagen 
sponge 
Xenogeneic cultured 
keratinocytes 
and fibroblasts 
PolyActive® 
(Symatese) 
Synthetic 
PEO/PBT matrix 
Autologous cultured 
keratinocytes and 
fibroblasts 
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2.4.2.3. Growth factor therapy 
Growth factors are endogenous signalling molecules that regulate several 
cellular processes required for wound healing such as migration, proliferation and 
differentiation. The topical delivery of growth factors into the wound bed is promising to 
improve the treatment of chronic wounds, which have shown deregulation on the levels 
of several growth factors, including PDGF and VEGF [120].  
Platelet-derived growth factors play numerous roles in wound healing such as 
mediating cell infiltration during the inflammatory phase and stimulating fibroblasts to 
secret ECM components. Becaplermin, a recombinant human PDGF, was approved in 
1997 by the Food and Drug Administration (FDA) for the treatment of diabetic foot 
ulcers and commercialized as Regranex® becaplermin Gel 0.01% (Smith & Nephew, 
Inc). It has shown to accelerate the wound closure of diabetic foot ulcers in randomized 
clinical trials [121, 122] and the healing of pressure ulcers [123]. However, in 2008, 
FDA warned that patients who have received three or more tubes of Regranex® have 
an increased risk of cancer. Alternative approaches involve gene therapy to target 
PDGF expression to venous leg ulcers [124]. Granulocyte macrophage-colony 
stimulating factor (GM-CSF) is a cytokine that stimulates neutrophils during the 
inflammatory phase and upregulates the proliferation and migration of several cells 
(e.g., keratinocytes, fibroblasts, and endothelial cells). Sargramostim (tradename 
Leukine), an injectable recombinant human-GM-CSF (rh-GM-CSF), was approved in 
1991 by the FDA as an immune-stimulator following chemotherapy and bone marrow 
transplantation. Sargramostim and its analogue molgramostim (tradename Leucomax) 
are commercially available as injectable formulations. The topical application of rh-GM-
CSF and GM-CSF showed positive effects on the healing of venous leg and diabetic 
foot ulcers of a small number of patients in randomized, controlled studies [125]. 
Clinical studies in deep, partial-thickness burn wounds also showed improved wound 
healing with topical application of rh-GM-CSF [15]. Vascular endothelial growth factor A 
(VEGF-A) has been investigated as a potential target for wound healing due to its 
ability to promote angiogenesis. Topical application of a recombinant human-VEGF (rh-
VEGF), Telbermin, was tested in a Phase I clinical trial in patients with neuropathic 
diabetic foot ulcers, showing positive indications in the wound healing [126]. Growth 
factors have been tested in animal models to promote healing, with satisfactory 
outcomes. However, the overall efficacy of topical growth factors in humans has been 
limited, probably due to the highly proteolytic environment in chronic wounds. 
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2.4.2.4. Biophysical agents 
Biophysical technologies are usually used in the treatment of difficult-to-heal, 
chronic and infected wounds, including the following therapies: electrical stimulation, 
electromagnetic, oxygen (hyperbaric and transcutaneous), phototherapy, shockwave, 
ultrasound and negative pressure wound therapy (NPWT) [127, 128]. Electrical 
stimulation devices deliver an exogenous electrical current to facilitate wound healing, 
while in electromagnetic therapy an electromagnet is used to generate electric current 
to improve the wound healing. Oxygen therapy devices provide oxygen to the wound 
bed via transdermal, systemic, or topical routes. Phototherapy provides wound 
treatment by using energy from the electromagnetic light spectrum. Depending on the 
selected light wavelength, phototherapy can be used to control wound bioburden (UVC 
200–280 nm) or to stimulate the wound healing. Shockwave therapy is indicated for 
diabetic foot ulcers and utilizes non-invasive high-energy shock waves to trigger 
cellular response and improve micro-circulation. Ultrasound therapy employs high- or 
low-frequency ultrasound to enhance wound healing outcomes. NPWT is employed to 
convert an open wound into a temporarily closed environment to promote faster healing 
and reduce complications (e.g., infection, dehydration), removing fluids like wound 
exudate, irrigation fluids, or infectious materials.   
2.5. Biofabrication technologies 
Biofabrication is a multidisciplinary field that combines the principles of 
engineering, biology and materials science for the automated fabrication of biologically 
and structurally functional products using living cells, bioactive molecules, biomaterials, 
cell aggregates like micro-tissues, or hybrid cell-material constructs. Bioprinting or 
bioassembly approaches are used to generate functional constructs for subsequent 
tissue maturation processes [40, 129]. Bioprinting produces bioengineered structures 
through computer-aided transfer processes that allow the patterning and assembly of 
living and non-living materials. It also encompasses the additive manufacturing of cell-
instructive 3D scaffolds capable of directing cells to develop into a tissue mimetic or 
tissue analogue structure. Bioassembly involves the fabrication of hierarchical 
constructs with prescribed 2D or 3D organization by the automated assembly of 
preformed cell-containing units. These fabrication units are often created using 
microfabricated moulds or microfluidics [129]. 
Biofabrication technologies can be broadly classified according to the printing 
principle into: (i) light-based technologies, (ii) fused deposition modelling, (iii) 3DTM 
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printing, (iv) wet-spun automated extrusion systems, (v) electrospinning, (vi) inkjet 
bioprinting, and (vii) extrusion bioprinting. Among these technologies, light-based 
processes like vat photopolymerization (single- and two-photon stereolithography) and 
laser-assisted bioprinting, inkjet bioprinting and extrusion bioprinting allow the direct 
processing of living and non-living materials into 3D constructs, being described in the 
next sections.  
2.5.1. Light-based technologies 
Light-based technologies comprise additive manufacturing processes that use 
light energy to trigger the photocrosslinking of a photosensitive solution or the ejection 
of a bioink from a print ribbon. Bioinks consist of hydrogel precursor solutions or 
decellularized ECM, loadable with cells and/or bioactive factors, playing a pivotal role 
on the reproducibility of the printing process and quality of the constructs [130-133].  
2.5.1.1. Vat photopolymerization  
Vat photopolymerization or stereolithographic processes produce 3D solid 
objects in a layer-by-layer procedure through the selective photoinitiated curing 
reaction of a liquid photosensitive material. The curing reaction is triggered by the 
incidence of light with an appropriate wavelength (UV, visible, or near-infrared (near-IR) 
light), intensity and duration. The curing reaction can be induced by either single-
photon polymerization or two-photon polymerization (2PP). Although the chemical 
principle of these processes is similar, single-photon polymerization involves the 
absorption of a sole photon, while in 2PP the molecule simultaneously absorbs two 
photons with relatively low intensity, and is excited to a higher singlet state. As the 
probability of the electronic excitation of a molecule by simultaneous absorption of two 
photons depends quadratically on the incident light intensity, 2PP allows a submicron 
3D resolution (~200 nm) with greater depth and ultrafast fabrication [134, 135].  
Stereolithographic processes produce 3D constructs in a layer-by-layer fashion 
using two fundamental irradiation approaches: (i) direct or laser writing and (ii) mask-
based writing (Figure 2.3A). The first employs a focused laser beam to selectively 
induce the polymerization of a liquid photopolymer, while the second transfers an entire 
image to a liquid prepolymer by irradiating through a patterned mask that contains 
transparent zones corresponding to the sections of the model to be built. The major 
advantage of the mask-based approach is the fast processing and the low-density flux 
of light over the prepolymer, which avoid undesirable polymerizations [135, 136]. 
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Although conventional stereolithography has superior resolution than other 
technologies, advances in photonics have led to the development of alternative 
processes with higher resolution, such as the microstereolithography and 2PP 
stereolithography. In microstereolithography the laser beam is more precisely focused, 
which reduces the spot size to a few micrometers in diameter and improves the 
resolution of the process. For example, in digital micromirror devices (DMDs) based 
microstereolithography, the achievable lateral and vertical resolutions are ~2 µm and 
~1 µm, respectively [137]. 2PP stereolithography is the most advanced technique, 
allowing ultra-fast fabrication of constructs with 3D submicron resolution (> 65 nm), by 
using a focused femtosecond near-IR (~800 nm wavelength) to induce polymerization 
[138]. Polymerization can occur under the material surface, but is limited to the focal 
point of the femtosecond laser, due to the strong decrease in the number of excited 
molecules as the distance from this region increases. As a result, 2PP 
stereolithography allows for a fine control over polymerization in a 3D environment 
[138]. However, 2PP systems are very expensive and operate with a single material, 
which precludes the fabrication of multi-material constructs [134, 139]. To circumvent 
these limitations, Bártolo and coworkers developed a mask-based multi-photon and 
multi-material stereolithographic system, designated as micro stereo-thermal-
lithography (µSTLG) [140]. This system can operate in three distinct modes by using 
UV and near-IR radiation effects, alone or simultaneously, to generate free radicals for 
polymerization (Figure 2.3B). Rather than processing one material at a time, the 
µSTLG apparatus includes a multi-vat system that enables the fabrication of multi-
material constructs [139, 141, 142]. Projection-based stereolithography represents 
another useful variant of traditional stereolithography, in which 2D patterns generated 
by DMDs are projected over the liquid resin through a transparent, non-adhering plate. 
In this setup, the support platform dips into the resin, and the structure is not exposed 
to oxygen during light irradiation, significantly reducing the oxygen inhibition [135, 143]. 
Vat photopolymerization technologies have been explored to create 3D 
scaffolds with intricate microarchitectures for direct implant into the lesion or for cell 
seeding and subsequent implantation. The range of processable materials is very 
broad, including biodegradable thermoplastic polymers, such as propylene fumarate 
(PPF) [144], poly(ε-caprolactone) (PCL) [145], poly(D,L-lactide) (PDLLA) [146], and 
poly(trimethylene carbonate) (PTMC) [147]. The ability of vat photopolymerization to 
allow the incorporation of cells into the biofabrication process provides the possibility of 
engineering complex 3D microenvironments in vitro that resemble the structural and 
compositional characteristics of the natural ECM. Such environments are fabricated by 
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the selective photopolymerization of cell-laden hydrogel precursors, and provide a 
useful tool the study of cell response to biochemical cues and the elucidation of 
mechanisms underlying cell-cell and cell-material interactions [148, 149]. 
 
 
Figure 2.3. Stereolithographic processes for tissue engineering. (A) Illustration of light 
irradiation approaches in stereolithography. (B) Micro stereo-thermal-lithography system and 
examples of produced 3D structures. 
2.5.1.2. Laser-assisted bioprinting 
Laser-assisted bioprinting (LAB) evolved from the conventional laser-induced 
forward transfer process, originally developed to the direct writing of metals [150]. Its 
operation principle involves the application of a high-energetic pulsed laser (often a 
near-IR laser) onto a donor ribbon coated with the bioink to be printed in order to 
generate the local ejection of small droplets (Figure 2.4A). The incident laser light is 
primarily focused on a laser-transparent substrate (e.g. glass or quartz substrate), 
which is coated with a thin metal (e.g. gold, titanium) layer that absorbs the light energy 
and promotes its transfer to the bioink. At this moment, a high-pressure bubble is 
generated, and a small droplet is propelled towards a receiving platform [45, 151, 152]. 
The mechanisms of droplet formation and the effects of biofabrication parameters on 
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the printing resolution and cell functions are well documented in the literature [152-
156]. Deleterious effects to the cells mainly result from the thermal heating, interaction 
with laser light and impact with the receiving substrate [151, 153]. However, several 
works showed that these effects can be significantly reduced, or even eliminated, by 
controlling the laser pulse characteristics, the bioink viscosity, the thickness of 
absorbing layer and the substrate properties [153, 157, 158]. LAB is one of the most 
promising technologies for cell printing applications (Figure 2.4B) due to its unique 
resolution (10-100 μm), high-throughput, reproducibility, and possibility of printing 
multiple biomaterials and cell types by incorporating those compounds in the same 
ribbon or having multiple parallel ribbons [43]. Its nozzle-free nature precludes clogging 
issues and affords the deposition of bioinks with a large range of viscosities (1-300 
mPa/s) and cell concentration (108 cells/ml) [45]. For printing 3D constructs maintaining 
the prescribed resolution in the positioning of cells and biomaterials, LAB requires the 
development of biomaterials exhibiting fast crosslinking mechanisms compatible with 
the light-wavelengths emitted by the laser sources. LAB was also employed for the in 
situ bioprinting of mesenchymal stromal cells, associated with collagen and nano-
hydroxyapatite, into a calvaria defect model in mice [159]. The biofabrication of 
clinically relevant constructs through LAB takes long periods of time and eventually the 
preparation of multiple ribbons containing different materials and cell types. 
 
 
Figure 2.4. Laser-assisted bioprinting for tissue engineering. (A) Illustration of the LAB 
technology and main components. (B) Fluorescence images of ring and disk printed tomato-
positive multipotent mouse bone marrow stromal precursor cells using LAB technology [159]. 
2.5.2. Inkjet bioprinting 
Inkjet is a high-throughput printing technology based on the dispensing of small 
drops (typically 1-100 picolitres) of a liquid bioink onto a collector substrate (Figure 
2.5A) [160]. Drops can be generated by either continuous inkjet or drop-on-demand 
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(DOD) inkjet printing [161]. DOD printing is the most popular method affording a rapid 
and fully controlled generation of droplets (20-50 μm) through the application of a 
pressure pulse to the bioink loaded into a reservoir placed just behind the printing 
nozzle [161-163].  
DOD printing can be further categorized according to the mechanism used for 
the droplet formation and ejection as thermal inkjet (vapour bubble formation) or 
piezoelectric inkjet (mechanical actuation). Thermal inkjet printers use a heating 
element to vaporize a small volume of fluid, generating a bubble that expands and 
ejects a controlled volume of fluid as a single droplet. The main concern associated to 
thermal inkjet relies on the high temperatures generated close to the heating element 
during the printing process, which may affect the biomolecules and cells to be printed 
[160, 162, 164]. However, it has been demonstrated that, due to the short duration of 
the heating pulses (~2 µs), the increase in temperature of the bioink is only a few 
degrees, allowing the printing of viable cells with a low percentage of cell dead [165]. In 
piezoelectric inkjet, the droplet generation and ejection is achieved through the 
mechanical deformation of a piezoelectric transducer controlled by the application of 
external voltage, which precludes the temperature increase to supraphysiological levels 
[161, 162, 166]. In order to prevent clogging issues, bioinks for inkjet bioprinting must 
exhibit low viscosity (1-10 mPa/s) and limited cell densities (typically <106 cells/ml), 
which causes additional constrains in the printing process, such as cell settling and 
sedimentation, droplet spreading, loss of resolution, and limited fabrication of 3D 
constructs with controlled architectures [43, 45, 163, 167]. Despite these challenges, 
inkjet bioprinting has been explored for several tissue engineering applications, 
including the generation of hollow structures for vascularization (Figure 2.5B).  
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Figure 2.5. Illustration of inkjet bioprinting technology. (A) Piezoelectric and thermal inkjet 
bioprinting. (B) Acellular alginate bifurcated structures generated by inkjet bioprinting (scale 
bars: 3mm) [168]. 
2.5.3. Extrusion bioprinting 
Extrusion bioprinting is the most popular method to fabricate 3D cell-laden 
constructs for tissue regeneration. In a typical setup, cells suspended in polymer 
solutions are loaded within disposable medical grade syringes or reservoirs, and 
subsequently printed onto a platform driven by pressurized air or mechanical forces 
generated by either a piston or a rotating screw (Figure 2.6A) [43, 45]. Temperature 
controlled modules are often employed to adjust the temperature of both the bioink and 
the construction platform during fabrication, which is particularly relevant to control the 
bioink viscosity and to induce the in situ gelation of temperature-sensitive polymers 
[169]. Light sources and spraying nozzles can also be coupled to the bioprinting 
system to provide additional crosslinking schemes, improving the printing fidelity and 
the structural stability of tissue constructs [170-172]. Compression forces and shear 
stresses generated during printing are the major sources of cell damage, requiring a 
careful optimization of the processing parameters (e.g. cellular density, bioink viscosity, 
temperature and air pressure) to prevent cell damage. Although there are several 
works indicating how these effects can be controlled to increase the printing accuracy 
and cell viability [173-176], there is a need for systematic studies accessing the post-
printing functionality of the cells.  
A major advantage of extrusion bioprinting is the ability to print highly viscous 
polymer solutions containing a wide range of cell densities (~ 107 cells/mL) [177, 178]. 
It also enables the biofabrication of clinically relevant 3D constructs by the deposition of 
continuous and larger hydrogel strands through a nozzle with variable diameters, 
usually in a range of 150-300 μm [43, 45, 177]. Limitations are related to the reduced 
resolution (approximately 200 µm), nozzle clogging, and difficulties in fabricating 3D 
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constructs maintaining the predesigned shape and providing a suitable environment for 
the cells [43, 45]. The printing of 3D constructs with complex and intricate 
microarchitectures still remains a huge challenge in bioprinting. Until now, the most 
common approach to address this issue involves the use of highly concentrated 
polymer solutions, which imposes severe restrictions to cell mobility within the polymer 
network and might ultimately lead to cell death [178]. More recently, alternative 
approaches based on the combination of multiple crosslinking pathways (e.g. 
photocrosslinking and thermal gelation) [169, 179], integration of bioprinting with melt 
extrusion [132, 180-182], and the use of partial crosslinked hydrogels [172, 178] have 
been explored with promising outcomes (Figure 2.6B-D).    
 
 
Figure 2.6. Extrusion bioprinting and examples of tissue engineering applications. (A) 
Extrusion bioprinting modalities and main components. (B) Bioprinted 3D vascularized tissue 
through the deposition of fugitive (vascular) bioink and cell-laden bioinks within a 3D perfusion 
chip; (i) photograph of printed construct housed within a perfusion chamber (scale bar: 5mm); 
(ii): schematic of printed heterogeneous tissue within a perfusion chip; (iii) photographs of 
printed construct within and removed from the customized perfusion chip; (iv) cross-sections of 
avascular (left) and vascularized tissue (right) after 30 days of osteogenic media perfusion with 
alizarin red stain showing the location of calcium phosphate (scale bar: 5 mm) [177]. (C) 
Extrusion bioprinting of programed bacterial cells: (i) Optical images of 3D bioprinted constructs 
of Pluronic F127 diacrylate labelled with rhodamine B (red) or fluorescein (green) (scale bars: 
5mm); (ii) confocal images of green fluorescence protein positive bacterial cell‐laden hydrogel 
scaffolds printed with varying degrees of resolution (from left to right: 200 µm, 100 µm, 50 µm, 
CHAPTER II 
47 
 
and 30 µm; scale bars: 500 µm) [183]. (D) Extrusion bioprinting of functional and perfusable 
microchannels. (i) photographs of planar bifurcated agarose fibres (green) within the 
methacrylated gelatin construct and (ii) respective network after perfusion; (iii) 3D branched 
agarose templates embedded in the gelMA hydrogel and (iv) resulting 3D branched network 
after perfusion; (v) 3D lattice template within the methacrylated gelatin network before and (vi) 
after perfusion (scale bars: 3 mm) [41]. 
2.6. Bioprinting of photocrosslinkable hydrogel bioinks  
The development of advanced bioinks exhibiting appropriate printability and 
tuneable biomechanical properties, while simultaneously providing a suitable 
microenvironment where entrapped cells can migrate, proliferate and synthetize new 
ECM remains a key challenge in bioprinting. A major bottleneck in the field consists on 
the formulation of bioinks that allow the printing of complex 3D constructs with high 
levels of shape fidelity, without compromising cell functions, which is essential to 
ensure proper resolution in the placement of cells, biological molecules and 
biomaterials. One approach to improve the printing fidelity of bioinks relies on the 
design of material formulations with tuneable rheological properties that can be rapidly 
crosslinked during or post-printing. Photocrosslinking has evolved as an attractive 
solution to achieve rapid crosslinking of photosensitive bioinks, allowing the bioprinting 
of both viscous [184] and non-viscous [185] hydrogel bioinks into complex 3D 
constructs. The application of photopolymerization reactions in bioprinting has been 
receiving a great deal of interest due to its unique spatiotemporal control over the 
hydrogel formation and fast polymerization under cytocompatible conditions. 
Photopolymerization can be employed during the bioprinting [185], or just after the 
deposition [174], in order to induce the rapid establishment of crosslinks between 
polymer chains, contributing to address current challenges in the field, including the 
fabrication of structurally stable 3D constructs with intricate architectures, enhanced 
spatial resolution and printing fidelity. 
2.6.1. Hydrogels as ECM mimics 
At a basic structural level, biological tissues are composed of cell populations 
surrounded by a fibrous ECM that displays several functions, namely by serving as a 
physical support for the cells, providing cues to regulate cellular activities and 
interactions, promoting the maintenance of differentiated tissues, and ensuring tissue 
repair upon injury [186]. From a structural point of view, the ECM is a hydrated gel 
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network composed of an intricate meshwork of structural protein fibres (e.g., collagen, 
elastin, fibrin) embedded within a ground substance made of GAGs (e.g., hyaluronic 
acid, chondroitin-sulfate), proteoglycans (e.g., aggrecan, decorin) and adhesive 
glycoproteins (e.g., fibronectin, laminin, tenascin) (Figure 2.7). It also comprises a 
myriad of soluble (e.g., growth factors, cytokines) and matrix-linked (e.g., fibronectin, 
laminin) signals, which together with the dynamic reciprocity of cell-cell and cell-ECM 
interactions are responsible for the regulation and coordination of cell fate [186, 187]. 
Rather than a static structure, ECM is a highly dynamic environment which properties 
such as composition, architecture and crosslinking degree are under constant 
remodelling (i.e., assembly and degradation), varying according to the anatomical site 
and tissue physiology [188]. Due to its instructive nature, ECM also serves as a storage 
depot for growth factors, cytokines and chemokines, regulating their spatiotemporal 
and tissue-specific presentation to cells [189]. This well-orchestrated activity dictates 
how the mechanical forces are transmitted to the cells and determines several cell 
functions such as adhesion, proliferation, migration, differentiation and remodelling 
[187]. In a reciprocal way, cells are able to sense and interact with the ECM via binding 
between adhesion motifs in ECM and transmembrane cell surface receptors (e.g., 
integrins, immunoglobulins and selectins) that result in intracellular signalling. Matrix 
anchorage is essential for cells to sense the matrix elasticity and to exert traction forces 
on the substrate towards migration [190]. As a consequence of this dynamic, 
bidirectional cell-ECM crosstalk, macromolecular components of ECM are locally 
degraded by cell-secreted and cell-activated proteases (MMPs, serine proteases, and 
cysteine proteases). This allows cells to specifically degrade components of the matrix 
(e.g., proteins, proteoglycans), which is often required for 3D cell migration, 
proliferation and invasion throughout the surrounding environment, as further 
elucidated using synthetic extracellular matrices [187, 191].   
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Figure 2.7. Schematic representation of the ECM composition and cell-ECM interactions. 
Cells are surrounded by a dynamic ECM that provides several biochemical and biophysical 
cues to regulate the cell fate [188]. 
 
Recapitulating the complexity and instructive nature of the ECM milieu is 
fundamental for the bioprinting of functional tissue constructs. However, it still remains 
a major challenge given the multiscale architecture of the ECM and the spatiotemporal 
specificity of its interaction with the surrounding cells. Due to their unique properties of 
high water content and tissue-like elasticity, hydrogels are widely used to develop 3D 
ECM analogues that closely resemble the natural microenvironment of most soft 
tissues [192]. However, the design of functional hydrogels that mimic the ECM is 
challenging, as it needs to consider a multitude of biochemical (e.g., cell adhesion 
ligands, bioactive factor immobilization and chemical functional groups) and biophysical 
(e.g., structural properties, mechanical properties, degradability and electrical 
conductivity) cues that determine cell functions (Figure 2.8). 
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Figure 2.8. Considerations on the design of hydrogels to recapitulate the 3D cell 
microenvironment. The development of such hydrogel networks requires the consideration of 
biophysical, biochemical and biological properties [188].  
 
Hydrogels are water-insoluble, hydrophilic 3D networks made of chemically or 
physically crosslinked polymer chains that exhibit high porosity and permeability to 
oxygen and nutrients, allowing effective exchange of soluble factors within the gel. 
Chemical hydrogels involve the formation of covalent bonds, while physical hydrogels 
are obtained when physical interactions are established between polymeric chains 
(molecular entanglement, ionic interaction and hydrogen bonding) [193-195]. A myriad 
of physical (e.g., thermal and ionic gelation) and chemical (e.g., radical polymerization, 
aldehyde complementation) gelation methods can be adopted to generate hydrogels 
(Figure 2.9). The thermodynamic compatibility of hydrogels with water confers them a 
soft and elastic nature that allows for a good biocompatibility and minimal inflammatory 
reactions. Hydrogels are the most commonly explored materials for the fabrication of 
cell-laden constructs through bioprinting, as they provide a soft and porous matrix for 
entrapped cells and their properties can be easily tuned [43, 196-198]. One attractive 
characteristic of hydrogels is their ability to undergo sol-gel transition in situ, under 
cytocompatible conditions, using a variety of chemistries. This feature, together with 
the tuneable rheological properties of hydrogel precursor solutions has been attracting 
increased interest to translate these materials for bioprinting. Although the intrinsic 
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properties of hydrogels resemble many features of ECM, their biochemical and 
biophysical functionality often needs to be adjusted to a particular cell and tissue 
environment. Since hydrogels are very versatile materials, their properties are easily 
modified via numerous approaches. Significantly, by combining the versatility of natural 
and synthetic polymers with the advances in chemistry and materials science, 
biofunctional hydrogels can be engineered to meet specific requisites, including cell-
adhesiveness, growth factor tethering and delivery, or ability to undergo degradation 
through hydrolysis and/or proteolytic cleavage. For instance, the biological and 
degradation properties of hydrogels can be tailored by the incorporation of cell-
adhesion motifs (e.g. Arginyl-glycyl-aspartic acid, RGD) [199, 200] and cell-proteolytic 
domains into the polymer backbone [201, 202], whereas the biomechanical 
characteristics can be adjusted by varying the polymer molecular weight or the 
crosslinking density [203, 204]. The wide spectrum of crosslinking schemes and the 
large range of network properties also give hydrogels high versatility for application in 
different tissues, including cartilage, bone, cardiovascular and skin [194, 205]. 
 
 
Figure 2.9. Examples of physical and chemical gelation methods for hydrogel 
crosslinking. (A) Thermally induced entanglement of polymer chains. (B) Molecular self-
assembly. (C) Ionic gelation. (D) Electrostatic interaction. (E) Chemical cross-linking [195].  
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2.6.2. Photopolymerization Reactions  
Photopolymerization reactions for hydrogel formation can be classified into free-
radical-initiated chain polymerization and bio-orthogonal click reactions [206].  
Free-radical photopolymerization is the most popular reaction to create 
chemically crosslinked cell-laden hydrogels through a multistep process of initiation, 
propagation and termination reactions. In the first step, a photosensitive system 
containing unsaturated prepolymers, cells and photoinitiators is irradiated with a 
sufficient dosage of light energy to excite the photoinitiators and trigger the formation of 
free radicals. Then, these reactive species propagate across vinyl moieties on 
prepolymers in solution, resulting in both generation of new free radicals and the 
establishment of crosslinks between the polymer chains. As the reaction proceeds, the 
number of crosslinks in the system increases and a highly crosslinked network 
structure is obtained via a chain-growth mechanism [193, 207]. Free-radical 
photopolymerization, based on (meth)acrylate functionalized prepolymers and 
occurring through a chain-growth mechanism, is the most popular method to crosslink 
hydrogel bioinks. It is widely accepted that acrylates possess the highest reactivity, 
followed by vinyl ester, vinyl carbonate, vinyl carbamate, methacrylate, and fumarate 
derivatives [208, 209]. Although the reactivity of acrylates enables high reaction 
kinetics and double-bond conversion, the cytotoxicity and skin irritancy of acrylates still 
remain as major pitfalls for biomedical applications [209]. On the other hand, the main 
limitation of methacrylates is the limited reactivity due to the sterical hindrance and 
inductive stabilization of radicals from the methyl group [210]. Major drawbacks of free 
radical photopolymerization include the oxygen inhibition, lack of control over the 
crosslinking kinetics, and the generation of network heterogeneities [206, 207]. These 
heterogeneities in the network resulting from the random chain polymerization have a 
significant impact in the mechanical integrity of the constructs [211].  
Recently, photopolymerization reactions based on bio-orthogonal click reactions 
are emerging in bioprinting as promising alternatives to the free radical 
photopolymerization counterpart [212, 213]. These reactions are characterized by 
orthogonal reactivity and the step-growth mechanism of the polymerization reaction 
[206, 211, 212, 214]. In addition, click chemistry is insensitive to both water and 
oxygen, can proceed under mild reaction conditions with higher efficiency, selectivity, 
and faster kinetics when compared to free-radical polymerization [213-215]. Among the 
myriad of existing bio-orthogonal click schemes, the thiol-norbornene photoclick 
reaction has emerged as a powerful method for engineering biocompatible hydrogels, 
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mostly due to the faster rate of thiol-ene conjugation of norbornene end groups 
compared to other alkenes (norbornene > vinyl ether > alkene > vinyl ester > allyl ether 
> acrylate > N-substituted maleimide > methacrylate > conjugated dienes) [216]. This 
reaction is triggered by an external light source, proceeding in a step-growth 
mechanism with the formation of structurally uniform hydrogels with minimal network 
defects, which provides better control over the gel crosslinking density and hydrogel 
properties [206, 207]. It involves the light-mediated orthogonal reactions between 
multifunctionalized macromers that are end-capped with norbornene functionalities and 
sulfhydryl-containing linkers, in the presence of low amounts of photoinitiator [206, 213, 
214, 216]. Under UV or visible light irradiation, the thiol-ene reaction promotes the rapid 
radical-mediated addition of thiols (e.g., bis-cysteine peptides and dithiothreitol, DTT) to 
carbon-carbon double bonds within functionalized prepolymers (e.g., norbornene-
functionalized 4-arm polyethylene glycol), yielding thioether bonds without inducing 
cytotoxic effects on embedded cells (Figure 2.10) [215, 217, 218]. The reaction is 
photochemically controlled and affords the localized covalent tethering of pendant 
bioactive moieties, e.g. MMP-degradable and/or adhesive peptide sequences, resulting 
in enhanced control over hydrogel degradation, cell-matrix interactions and cell fate 
[215]. Thiol-norbornene photopolymerization has numerous advantages, as it is not 
inhibited by oxygen, proceeds in a faster magnitude than chain-growth 
photopolymerization, and can be performed in the presence of cells [207, 214]. It has 
successfully been applied for the fabrication of cell-laden hydrogels using natural and 
synthetic polymers functionalized with norbornene moieties [218-220]. 
Photocrosslinkable hydrogels can also be obtained from mixed-mode polymerizations 
(e.g. thiol-acrylate) resulting in the formation of hydrogel networks by a combination of 
chain- and step-growth polymerization, due to the competing reactions between 
acrylate groups and thiol-ene coupling [207, 221]. 
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Figure 2.10. Radical-mediated step-growth thiol–norbornene reaction. (A) Incident light 
decomposes cleave-type photoinitiators (e.g., type I photoinitiator lithium arylphosphinate) into 
radicals. (B) Free radicals abstract protons from the sulfhydryl groups to form thiyl radicals that 
react with strained vinyl bonds in the norbornene moiety on functionalized polymer, yielding a 
thiol–ether bond and a carbon-centered radical capable of generating another thiyl radical [206]. 
 
Major concerns with photopolymerization reactions in the presence of cells and 
biological tissues arise from three major issues: (i) potential deleterious effects of UV 
light irradiation, (ii) cytotoxicity of radicals generated by the dissociation of 
photoinitiators, and (iii) local inflammation due to unreacted double bonds. For cell 
entrapment applications, light sources emitting either in the UV-A range (320–400 nm) 
or visible light are usually employed to reduce deleterious effects [127]. Despite several 
studies have shown that cell damage caused by UV irradiation can be significantly 
reduced or even eliminated by choosing appropriate light wavelengths, intensity and 
irradiation time, great efforts are currently being done towards the development of 
photosensitive systems (hydrogel precursors and photoinitiators) capable of 
undergoing photocrosslinking upon exposure to safe visible light wavelengths [221, 
222]. In parallel to the light source, photoinitiators are a key element for 
photopolymerization, as they generate free radicals that promote the formation of 
crosslinks between the polymer chains. However, these radicals can react with cellular 
components during photopolymerization, either via direct contact or the formation of 
reactive oxygen species, which may compromise cell viability and ultimately induce 
deoxyribonucleic acid (DNA) damage [223, 224]. To prevent cell damage and ensure 
cell functionality for new tissue formation, the wavelength of emitted light must overlap 
the absorption spectra of photoinitiator, and its concentration must be carefully 
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optimized, taking into account the compromise between the crosslinking time and cell 
viability. The selection of the most appropriated photoinitiator can be partially 
determined by the number and reactivity of functional groups in the polymer backbone. 
The functionalization of natural and synthetic polymers with reactive side groups such 
as acrylates, methacrylates, fumarates and vinyl esters, is an indispensable requisite 
for the photopolymerization. These reactive groups are introduced in the polymer chain 
through chemical reactions with functional groups already present in the native polymer 
structure. The type and number of reactive groups introduced in the polymer backbone 
is often determined by the cytotoxicity and reactivity of the functional group, being very 
important to ensure a maximal consumption of reactive groups during the 
photopolymerization in order to prevent local inflammation and non-specific side 
reactions with surrounding proteins upon implantation [207].  
2.6.3. Cytocompatible photoinitiators  
The selection of suitable photoinitiators is a prime requisite to ensure an 
adequate polymerization rate and avoid cytotoxic effects for both embedded cells and 
surrounding tissues. When selecting a photoinitiator, key characteristics should be 
considered, including water solubility, stability, absorption spectrum, molar absorptivity, 
and efficiency in generating free radicals [218, 225]. Currently available photoinitiators 
can be divided into two main categories: radical or cationic [134]. Radical 
photoinitiators are the most used due to their superior biocompatibility, while cationic 
photoinitiators result in the formation of protonic acids, making them less useful for 
biomedical applications [225]. According to the mechanism involved in the generation 
of free radicals, radical photoinitiators can be further categorized as photo-cleavable 
photoinitiators (type I) or bimolecular photoinitiators (type II). Upon light exposure, type 
I photoinitiators (e.g., benzoin derivatives, benzyl ketal, acetophenone derivatives, 
hydroxyalkylphenones and acylphosphine oxides) absorb incident photons and 
decompose into two primary radicals that initiate the crosslinking, whereas type II 
photoinitiators (e.g., benzophenone, camphorquinone, and thioxanthone) abstract the 
hydrogen from a co-initiator to generate secondary radicals for crosslinking [134, 218]. 
Although type I initiators are usually the first choice because of their superior initiation 
efficiency [214], there has been an increasing interest in type II initiators for visible 
light-mediated polymerization (Table 2.6).  
The main concern associated with the use of photoinitiators relies on the 
potential cytotoxicity of the generated free radicals. Cytotoxic effects of several 
photoinitiators on primary cells and cell-lines are well-documented and strongly depend 
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on the photoinitiator type and concentration, exposure time and light intensity [223, 
224, 226-228]. The photoinitiator 1-[4-(2-hydroxyethoxy)-phenyl]-2-hydroxy-2-methyl-1-
propane-1-one (I2959) is the most commonly used photoinitiator due to its moderate 
water solubility and low cytotoxicity. However, its low molar extinction coefficient in the 
UV-A spectral range and its low initiation efficiency boosted the research on alternative 
photoinitiators exhibiting enhanced biocompatibility and/or efficiency, such as 2,2'-
azobis[2-methyl-N-(2-hydroxyethyl)propionamide] (VA-086) and lithium phenyl-2,4,6-
trimethylbenzoylphosphinate (LAP) [174, 226, 229, 230]. In parallel, researchers also 
concentrated efforts on the formulation of photopolymerizable systems containing 
visible-light sensitive photoinitiators (e.g., camphorquinone, riboflavin, Eosin-Y, tris(2,2′-
bipyridyl)dichloro-ruthenium(II) hexahydrate with sodium persulfate), in order to 
mitigate potential deleterious effects of UV light on entrapped cells [218, 222, 231].  
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Table 2.6. Examples of the most common photoinitiators in photopolymerization reactions and examples of polymerization systems used for the fabrication of 
cell-laden hydrogels. 
Photoinitiator Photopolymerizable system Reference 
Name Type 
Chemical 
structure 
Photocrosslinking 
reaction 
Irradiation 
conditions 
Hydrogel 
precursor 
Encapsulated 
cells 
Cell viability  
I2959 I 
 
Free-radical 
polymerization 
UV light (360-480 
nm), 6.9mW/cm2, 
15s 
Gelatin 
methacrylate, 
0.5% (w/v) I2959 
NIH 3T3 
fibroblasts (5 x 
106 cells/ml) 
75-92%, 8h 
post-
encapsulation  
[232] 
Thiol-ene click 
chemistry 
UV light, 
10mW/cm2, 30s 
HA-norbornene, 
DTT, 0.05 wt% 
IR2959 
hMSCs (1 x 107 
cells/ml) 
96% (1d) and 
88% (3d) post-
encapsulation 
[219] 
LAP I 
 
Free-radical 
polymerization 
Visible light 
(405nm)/UV light 
(365nm) 10 
mW/cm2, 5 min 
PEGDA, 
2.2/0.22mM LAP 
Human neonatal 
fibroblast (1 x 106 
cells/ml) 
>95%, 24h 
post-
encapsulation 
[229] 
Thiol-ene click 
chemistry 
UV light (365 nm), 
5mW/cm2, 2min 
PEG-norbornene, 
0.05 wt% LAP 
hMSCs (5 x 106 
cells/ml) 
Cells survive, 
14d post-
encapsulation* 
[233] 
VA-086 I  
Free-radical 
polymerization 
UV light (365nm), 
2mW/cm2, 5 min 
Alginate 
Methacrylate, VA-
086 
Bovine articular 
chondrocytes (50 
x 106 cells/mL) 
>90%, 48h 
post-
encapsulation 
[226] 
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Free-radical 
polymerization 
UV light (365nm), 
4mW/cm2, 
1800mJ /cm2 
Gelatin 
methacrylamide, 
20 mol%VA-086 
HepG2 cells (1.5 
x 106 cells/ml) 
>95%, 24h 
post-
encapsulation 
[174] 
Eosin-Y II 
 
Mixed mode (chain 
and step-growth 
reactions)$  
Visible light (525 
nm), 5 mW/cm2 (7 
min) /100 
mW/cm2 (1.5 min) 
PEGDA, 
Thiolated heparin, 
TEOA, 0.01% 
Eosin-Y  
NIH 3T3 
fibroblasts (2 x 
106 cells/ml) 
>96% [234] 
Thiol-ene click 
chemistry 
Visible light (515 
nm), 10 mW/cm2, 
4 min 
PEG4NB, TEOA, 
NVP, 0.1 × 10- 3 M 
Eosin-Y 
Human 
mesenchymal 
stem cells (5 x 
106 cells/ml) 
~95%, 14h 
post-
encapsulation 
[218] 
Riboflavin II** 
 
Free-radical 
polymerization 
Visible light: (780 
nm femtosecond 
laser, followed by 
1min at 570nm 
light)  
PEGDA, TEOA, 
200 µM riboflavin 
Bovine aortic 
endothelial cells 
(1 x 106 cells/ml) 
>90%, after 
24h$$ 
[235] 
Free-radical 
polymerization 
Visible light 400-
500 nm), 300 
mW/cm2, 120-
600s 
Methacrylated 
glycol 
chitosan/HA, 6 
µM Riboflavin 
Auricular 
chondrocytes (2 x 
106 cells/ml) 
60-90%, 24h 
post-
encapsulation # 
[236] 
Abbreviations:  Irgacure 651 (2,2-dimethoxy-2-phenylacetophenone); PEG4NB (Poly(ethylene glycol)-tetra-norbornene); PEG (Poly(ethylene glycol)); PEGDA (Poly(ethylene 
glycol) Diacrylate); HA (Hyaluronic acid); TEOA (Triethanolamine); NVP (1-vinyl-2 pyrrolidinone); hMSCs (Human mesenchymal stem cells); DTT (Dithiothreitol); HepG2 
(hepatocarcinoma cell line).*Quantitative data about cell viability is not available, but authors reported that cells survived and retain differentiation ability. $Authors state a 
predominance of thiol-ene reaction and negligible acrylate polymerization rates. **Riboflavin can form either singlet or triplet-excited states upon light absorption. $$Cell viability 
was assessed by culturing cells in the presence of photopolymer extract solutions, instead of cell encapsulation #Depending on the irradiation time and presence of HA. 
CHAPTER II 
  59
2.6.4. Photocrosslinkable bioinks 
In addition to the classical properties that biomaterials should present for tissue 
engineering [39, 237], bioinks must fulfil additional requirements, such as enable printing 
under cell-compatible conditions, exhibit fast gelation, allow the material to maintain 
structural integrity after deposition, and provide an interactive microenvironment for 
entrapped cells [43, 45, 178]. In contrast to traditional hydrogel materials, which often display 
low viscosity, bioinks must possess enough viscosity (paste-like consistency) to allow the 
deposition of stable filaments, and exhibit shear-thinning behaviour and fast recovery after 
extrusion to avoid deformation of the 3D bioprinted construct (Figure 2.11A). Rather than 
simply providing a suitable environment for supporting cells viability and function, advanced 
bioinks must be capable of providing specific spatiotemporal cues to embedded cells towards 
directing cellular activities such as adhesion, proliferation, differentiation and morphogenesis 
(Figure 2.11B). Approaches already applied in modern biomaterials, such as incorporation of 
cell-adhesion sites for cell anchorage, and proteolytically sensitive domains for cell-mediated 
matrix remodelling [197, 198, 238], can now be applied in the design of advanced bioinks.  
 
 
Figure 2.11. Main requisites of advanced bioinks for 3D bioprinting. (A) Differences of traditional 
hydrogel precursors versus bioinks; (i) hydrogels are usually generated from low viscosity polymer 
solutions within constrained spaces such as well plates or moulds, as these solutions cannot hold their 
shape after deposition; (ii) bioinks often possess moderate-to-high viscosities allowing the extrusion of 
filaments that maintain the shape after deposition without need for moulds; (iii) depending on the 
purpose, bioinks can be design to act as a temporary support material (gold) during the printing, 
structural material (purple) to provide rigidity, functional material (red) that support and direct cell 
functions, and sacrificial material (orange), which is soluble or rapidly degradable and may be 
incorporated within the construct to permit the inclusion of porous regions [239]. (B) Complexity on the 
design of cell-laden bioinks: (i) biofabrication window for the design of bioinks considering the 
compromise between printability requirements and biocompatibility of printed constructs; (ii) General 
requirements of advanced bioinks [240]. 
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A multitude of natural and synthetic polymers have been modified for application as 
photocrosslinkable bioinks (Table 2.7). Although polymeric materials inherently contain 
several functional groups (e.g., carboxyl, amine, hydroxyl) in their native chemical structure, 
most do not contain photoreactive moieties, which precludes the occurrence of light-
mediated reactions [241]. Thus, the design of hydrogel precursors for light-mediated 
chemistries primarily involves the chemical modification of polymers with reactive pendant 
groups (e.g., acrylates, methacrylates, or norbornene), which must be selected according to 
the photopolymerization scheme to be used, and their inherent cytotoxicity, reactivity and 
biodegradability. The type and number of reactive groups to be introduced into the polymer 
backbone should also be carefully optimized to prevent dramatic changes in the 
physicochemical properties of the polymer (e.g., hydrophilicity, charge, water solubility, 
elasticity, mesh size and diffusivity), which may ultimately impair the hydrogel 
cytocompatibility, biodegradability and bioactivity.  
Most photocrosslinkable bioinks are crosslinked via free-radical polymerization 
through the homopolymerization of acrylate or methacrylate functional groups. One of the 
most widespread chemical modifications consists of the (meth)acrylation of polymers, 
through a reaction with glycidyl methacrylate, methacrylic anhydride or acryloyl chloride. 
Depending on the polymer chemistry and reactive agent, the esterification reaction proceeds 
predominantly through the primary hydroxyl groups [242], carboxylic groups [243] and amine 
side groups [232] of the polymer. Although non-organic solvents are usually the first choice 
for the modification of natural polymers due to their hydrophilic nature [174, 226], reactive 
agents easily hydrolyse under these conditions. Alternatively, natural polymers can be 
converted to a tetrabutylammonium (TBA) salt in order to allow dissolution in organic 
solvents [244], or reacted under heterogeneous conditions by using a co-solvent mixture that 
reduces the hydrolysis of functionalizing agents and enhances the degree of modification 
[245].  
To explore the selective reactivity and fast gelation of bio-orthogonal reactions, 
bioinks crosslinked by photoinitiated thiol-ene click chemistry were recently developed for 
bioprinting. The natural polymers hyaluronic acid and gelatin were modified with 5-
norbornene-2-carboxylic acid and allyl glycidyl ether, respectively, yielding norbornene-
modified hyaluronic acid and allylated gelatin macromers [185, 246]. The synthetic polymer 
poly(glycidol), a structural analogue of PEG, was also modified through the introduction of 
either thiol or allyl functional groups for thiol-ene reaction [247]. These macromers allow the 
formulation of bioinks that undergo thiol-ene reaction in the presence of a photoinitiator and a 
dithiol (e.g., DTT, MMP-degradable peptide crosslinkers) via UV or visible light 
photopolymerization.  
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Table 2.7. Selected examples of photocrosslinkable bioinks for 3D bioprinting. 
Bioink composition 
Photocrosslinking 
(Photoinitiator) 
Bioprinted 
cells 
Application Reference 
Decellularized hearth tissue 
ECM 
UV free-radical 
polymerization 
(Riboflavin) 
Cardiac 
progenitor cells 
Not 
specified 
[248] 
Heprasil, Gelin-S, Extralink, 
multi-arm PEG crosslinkers, 
decellularized ECM solution 
UV Thiol-ene click 
chemistry (I2959) 
Liver spheroids Liver tissue [130] 
Gelatin methacryloyl, 
alginate, gold nanorods 
UV free-radical 
polymerization 
(I2959) 
Cardiomyocytes 
and cardiac 
fibroblasts 
Cardiac 
tissue 
[249] 
Gelatin methacryloyl, 
alginate, PEGTA 
UV free-radical 
polymerization 
(I2959) 
HUVECs, 
MSCs 
Vascularized 
tissues 
[250] 
Allyl-functionalized gelatin 
UV/Visible light Thiol-
ene click chemistry 
(I2959, Ru/SPS) 
Chondrocytes 
Not 
specified 
[251] 
Heprasil or glycosil, gelin-S, 
Extralink 
UV Thiol-ene click 
chemistry (I2959) 
Amniotic fluid-
derived stem 
cells 
Skin tissue [252] 
pNIPAAM- or methacrylate-
modified hyaluronic acid 
UV free-radical 
polymerization (LAP) 
Chondrocytes 
Cartilage 
tissue 
[253] 
PEGDA, laponite XLG 
nanoclay, hyaluronic acid* 
UV free-radical 
polymerization (IR 
1173) 
Osteoblasts Bone tissue [254] 
Allyl- or thiol-modified 
poly(glycidol), hyaluronic 
acid 
UV Thiol-ene click 
chemistry (I2959) 
Human bone 
marrow-derived 
stromal cells 
Not 
specified 
[247] 
Abbreviations: Heprasil – thiolated hyaluronic acid with conjugated heparin groups; Gelin-S – thiolated gelatin; 
Extralink – poly(ethylene glycol) diacrylate (PEGDA) cross-linker; PEGTA – 4-arm poly(ethylene glycol)-tetra-
acrylate; HUVECs – Human umbilical vein endothelial cells; MSCs – Human mesenchymal stem cells; Ru/SPS – 
tris(2,2′-bipyridyl)dichloro-ruthenium(II) hexahydrate with sodium persulfate; Glycosil – thiolated hyaluronic acid; 
pNIPAAM – poly(N-isopropylacrylamide); *PEG–clay nanocomposite bioink was used as a support material, while 
the hyaluronic acid bioink was loaded with cells. 
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2.7. Bioprinting hydrogels for skin tissue engineering 
The interest in bioprinting technologies to produce cell-laden constructs for skin tissue 
engineering has been significantly increasing due to their ability to pattern heterogeneous cell 
populations, soluble factors and biomaterials in predesigned 3D locations with high degree of 
automation and reproducibility. These features provide new possibilities in the development 
of biomimetic constructs resembling the anatomical and cellular organization of the skin, with 
potential to address the limitations of current therapeutic options for skin reconstruction [1, 2]. 
Bioprinting processes also enable the integration with medical imaging techniques (e.g., 
micro-computed tomography, magnetic resonance imaging) and path-planning devices, 
allowing the design of patient-specific implants for direct printing either in vitro or in situ [47, 
255]. Despite these attributes, the bioprinting of skin constructs is a complex and 
multidisciplinary task involving knowledge and professionals from different areas (Figure 
2.12). 
   
 
Figure 2.12. Illustration of the tasks involved in the design of 3D constructs for skin repair and 
regeneration using bioprinting technologies. The development of skin substitutes through 
bioprinting is a multidisciplinary process that involves the interplay between several disciplines. 
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2.7.1. Requirements of printed skin 
Printed skin constructs are currently explored for several purposes including wound 
healing and in vitro models for pharmaceutical testing and disease studies (e.g., 
inflammatory skin disease). Advances in microfluidic and bioprinting technologies have also 
allowed the miniaturization of skin models through the development of skin-on-a-chip 
devices, which offer a valuable surrogate to animal experimentation [256]. In order to closely 
reproduce the main properties of native skin and provide reliable models for clinical 
translation, printed skin must replicate key compositional and functional characteristics of 
native skin.  
2.7.1.1. Cellular composition 
As already discussed, native skin is composed of multiple layers containing distinct 
cellular populations. The epidermal layer contains keratinocytes, melanocytes, Merkel and 
Langerhans cells. In the dermis, fibroblasts are the predominant cells, while the hypodermis 
is composed of adipocytes. To closely replicate the heterogeneous cellular composition of 
native skin, each cell type should be precisely dispensed at specific 3D locations in the 
respective layer. The density and ratio between cell populations within the construct must be 
controlled, in order to promote cell-cell interactions that regulate autocrine and paracrine 
signalling. 
2.7.1.2. Biochemical composition 
In the dermal region, cells are embedded within a rich ECM that provides cell-
adhesion and cell-remodelling sites, allowing cells to remodel and interact with the 
surrounding matrix. The basement membrane physically separates skin layers, providing 
motifs for cell anchorage, which is essential for stabilization and diffusion of molecules. In 
printed skin, the biochemical cues, their function, location and density must be precisely 
controlled. The presence of cell-adhesion sites and cell-proteolytic domains is fundamental to 
replicate the dynamic and interactive nature of ECM. Also the ability to sequester and release 
bioactive molecules, for instance via growth factor-binding domains, is of paramount 
importance for the sustained release of cytokines and growth factors during wound healing.   
2.7.1.3. Zonal organization and material composition 
Native skin is a highly complex tissue with cells surrounded by an intricate ECM, 
which composition and ratio between ECM components vary according to the region. The 
dermal layer is rich in collagens (I, III, IV, VII), fibronectin and glycosaminoglycans. Dermis is 
also organized into an upper ‘papillary’ (high ratio of collagen type III to type I) and a lower 
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‘reticular’ (low ratio of collagen type III to type I) region [257]. At the epidermal–dermal 
junction, a basement membrane mostly composed of laminin and collagen IV provides a 
physical barrier between two layers [54]. Materials for skin printing should consider the 
fibrillar and hydrated nature of ECM. Although it is difficult to develop a formulation containing 
all the skin components, it is fundamental to engineer advanced materials with tuneable 
stiffness and composition, which could be readily altered according to the location throughout 
the construct. 
2.7.1.4. Tissue architecture and shape  
Skin thickness is in the range of 1.0 to 2.5 mm, depending on the location in the body, 
with the epidermis measuring approximately 0.2 mm [258]. The thin papillary region contains 
higher cellular density along randomly orientated collagen fibre bundles, while the thicker 
reticular dermis consists of highly orientated fibre bundles. The heterogeneity of skin 
throughout the body calls for the precise control over the layer thickness in bioprinted 
constructs, in order to matching the wound depth. In addition, the thickness and fibre 
orientation in both papillary and reticular dermis should be considered to improve biomimicry. 
The shape of the printed construct should also be defined according to the specific 
application. 
2.7.1.5. Barrier function 
Epidermis contains keratinocytes at different stages of differentiation with fully 
stratified keratinocyte layers providing an efficient barrier to the penetration of external 
agents across the skin. Lamellar granules, produced by keratinocytes, secret several key 
compounds (lipids, proteins, hydrolytic enzymes) for skin barrier properties [53]. To recreate 
the barrier properties of skin, printed constructs must contain an epidermal region consisting 
of densely packed keratinocytes. Constructs need to be cultured at air–liquid interface (ALI) 
to promote stratification and the barrier properties must be carefully evaluated. Late or 
incomplete stratification and keratinization of printed constructs must be evaluated, 
particularly when immortalized keratinocytes are used.     
2.7.1.6. Appendages and pigmentation 
Skin contains adnexal structures such as nails, hair follicles, sweat, apocrine and 
sebaceous glands. Melanocytes produce melanin, a pigment that confers coloration to the 
skin and protects from UV light. Merkel and Langerhans cells participate in sensing and 
immunological defence, respectively. The development of skin appendages in printed skin is 
a major challenge in the field. Skin pigmentation can be addressed by printing melanocytes 
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in the epidermis, while sweat glands can be engineered by printing epidermal-derived 
stem/progenitor cells [259, 260].   
2.7.1.7. Vascularization 
Dermis contains numerous blood vessels that provide nutritional support to the skin. 
Vasculature includes larger blood vessels at the interface between the reticular dermis and 
hypodermis, which branch into small vessels to supply superficial plexus at the junction 
between the papillary and reticular dermis, as well as the epidermis by diffusion. The ability 
to engineer functional vasculature in 3D is critical for nutrient supply throughout thick skin 
constructs. Printing branched, perfusable channels could be a viable solution to promote 
efficient mass transfer of the skin. Complementary strategies could also involve the co-
printing of stromal and endothelial cells [177].  
2.7.2. Hydrogel bioinks for skin bioprinting 
Hydrogels are attractive materials for skin reconstruction as they provide a hydrated 
and highly permeable microenvironment in which, depending on the composition (e.g., cell-
adhesion and proteolytically sensitive motifs) and properties (e.g., stiffness), entrapped cells 
might migrate and proliferate in a similar way to what happens in the native ECM [43]. 
Hydrogels have been widely used to assist the regenerative and reparative processes of 
many tissues [205, 261, 262] and several studies were performed assessing their potential 
for wound healing [109, 263-265]. Hydrogels display many of the desired characteristics of 
an ideal skin substitute, as they promote wound debridement, while providing a suitable 
moist environment to stimulate the healing process. In addition, they can absorb wound 
exudates, allow gaseous exchanges and prevent bacterial invasion. Hydrogels also provide 
thermal isolation and display low adherence to the wound bed, which facilitates dressing 
change without trauma to the patient. Furthermore, the fine-tuning of hydrogel properties is 
easy to achieve, allowing control over stiffness, biodegradability rates and permeability to 
either cells or soluble factors. Transparent hydrogels also allow to follow-up the wound 
healing process without removal.  
A major challenge in skin bioprinting is the design of suitable bioinks to produce 3D 
cellular constructs with intricate geometries, shape fidelity, and high resolution in the 
placement of cells. Traditional approaches to generate such constructs often involve (i) the 
sequential printing of cell-laden hydrogels or melt extruded thermoplastic fibres, (ii) the 
formulation of viscous bioinks by adding high molecular weight polymers (e.g., hyaluronic 
acid), or (iii) the use of increased polymer concentrations and crosslinking densities [182, 
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266-268]. The combination of hydrogel bioprinting with melt extrusion has been successfully 
explored to design well-defined 3D constructs with improved mechanical properties, which is 
of special interest for load-bearing tissues [46], but of limited application in soft tissues. The 
printing process of viscous bioinks might affect the distribution of cells throughout the 
construct, ultimately leading to tissue heterogeneity, while highly crosslinked hydrogels may 
lead to excessively stiff matrices that impose severe restrictions to cell spreading, migration 
and proliferation [232, 269, 270]. Thus, it is crucial to ensure that the bioink has the 
appropriate rheological properties to be printed and, at the same time, is able to maintain the 
shape upon deposition. Alternative strategies have been tested to improve the printing fidelity 
without compromising the bioink cytocompatibility, including the printing of partially 
crosslinked hydrogels, the crosslinking of hydrogel solutions during bioprinting, and the 
deposition of biocompatible sacrificial materials that provide initial support for the printed 
hydrogel pattern [185, 271].  
The development of hydrogel bioinks is a complex and multidisciplinary process that 
involves knowledge about the principles of printing mechanisms and the fluid properties 
required for a given liquid to be printable. The interactions between the bioink and the 
receiving substrate, as well as its rheological properties, are important parameters 
determining the resolution and accuracy of printed constructs [43, 151, 161, 272, 273]. By 
placing suitable cell types in appropriate positions, the tissue construct may then mature into 
a tissue/organ and late achieve functionality either inside a bioreactor or in vivo [274]. The 
ideal properties of hydrogels for bioprinting include stability, sterilization, biodegradability, 
adequate mechanical properties and swelling characteristics, but it is also required that both 
hydrogel chemistry and crosslinking mechanisms promote cell function [275]. For extrusion 
bioprinting, in which the bioink flows through a nozzle towards the substrate, rheological 
properties are particularly relevant. The rheological behaviour of bioink determines how the 
viscosity is affected during the printing as a response to the shear stress. Printing cells 
embedded in a hydrogel precursor solution also requires careful selection of the viscosity in 
order to ensure homogenous distribution of cells and prevent nozzle clogging. Moreover, the 
bioink should also undergo a fast and cytocompatible gelation after deposition in order to 
maintain the prescribed shape and spatial location of cells at high resolution.  
Despite recent advances in the design of printable bioinks for various applications the 
number of bioinks for bioprinting cellular skin substitutes is still limited to a restricted number 
of natural hydrogels including alginate, collagen, gelatin, fibrin and hyaluronic acid (Table 
2.8). The interest in these materials mainly relies on the fact that their composition and 
structure resembles the ECM properties of native tissues [276]. These polymers can also be 
easily converted into either physical or chemical hydrogels under cell-compatible conditions 
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through a myriad of crosslinking pathways [194]. In addition, certain natural polymers (e.g., 
collagen) also present cell-proteolytic domains and/or adhesion motifs, providing recognition 
sites for embedded cells and allowing the cell-mediated degradation of the hydrogel network 
in a similar way to the remodelling of native ECM. Natural hydrogels, in particular protein-
derived hydrogels, usually present concerns regarding their weak mechanical properties, 
high immunogenicity and virus/disease transmission, though they retain their biological 
activity being the most widely used ECM-mimicking materials [136, 197]. Synthetic hydrogels 
constitute an interesting alternative due to their controlled chemical composition and tuneable 
mechanical properties. The drawback of synthetic materials is the lack of cell-adhesion 
moieties, which can be solved by the incorporation of cell instructive cues into the polymer 
backbone, as already discussed [186]. 
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Table 2.8. Bioinks for 3D bioprinting of skin constructs. 
Bioink composition Crosslinking Bioprinted cells Bioprinting strategy 
Bioprinting 
technology 
Reference 
Decellularized skin-derived 
ECM 
Thermal gelation 
Keratinocytes, fibroblasts, 
EPCs, ASCs 
In vitro bioprinting Extrusion [277] 
Gelatin methacrylamide and 
collagen doped with tyrosinase 
Enzymatic and UV free-
radical polymerization 
Keratinocytes, melanocytes, 
fibroblasts 
In vitro bioprinting, followed 
by 3 days of culture and in 
vivo implantation 
Extrusion [278] 
Heprasil or glycosil, gelin-S, 
Extralink 
UV Thiol-ene click 
chemistry 
Amniotic fluid-derived stem 
cells 
In situ bioprinting 
Inkjet 
bioprinting 
[252] 
Gelatin, alginate, fibrinogen 
Ionic gelation and 
polycondensation 
Fibroblasts and seeded 
keratinocytes 
In vitro bioprinting Extrusion [279] 
Collagen 
Sodium bicarbonate 
neutralization 
Keratinocytes, melanocytes, 
fibroblasts 
In vitro bioprinting 
Inkjet 
bioprinting 
[280] 
Gelatin, alginate, mouse plantar 
dermis components, EGF 
Ionic gelation Epidermal progenitor cells 
In vitro bioprinting, followed 
by in vivo implantation 
Extrusion [260] 
Collagen 
Sodium bicarbonate 
neutralization 
Keratinocytes, fibroblasts In vitro bioprinting LAB [281] 
Collagen, fibrinogen Polycondensation 
Amniotic fluid-derived stem 
cells, bone marrow-derived 
MSCs 
In situ bioprinting 
Inkjet 
bioprinting 
[47] 
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2.7.3. Bioprinted constructs for skin repair 
One application of printed skin constructs is to promote wound repair and 
regeneration. Functional skin is an important need in the medical field to treat patients with a 
variety of injuries, including (i) burn wounds that lack the skin barrier and are more 
susceptible to infection, (ii) chronic wounds that are difficult to heal and are associated to 
high healthcare costs, and (iii) scars that cause severe aesthetic limitations and movement 
disabilities. To address these needs, bioprinting has been explored to create sophisticated bi-
layered skin substitutes containing dermal and epidermal components. 
In a pioneer work, LAB was used to produce multi-layered cellular skin constructs for 
in vivo regeneration of full-thickness skin wounds in nude mice [48] (Figure 2.13A). Skin 
substitutes were created by printing 20 layers of NIH3T3 fibroblasts followed by 20 layers of 
HaCaT keratinocytes suspended in collagen onto a sheet of Matriderm®, and subsequently 
incubated under submerged conditions overnight. After 11 days of in vivo implantation, skin 
substitutes showed a good integration into the native tissue with small blood vessels being 
detected in the printed skin substitutes. Immunohistochemistry assays confirmed the 
presence of E-cadherin between the keratinocytes, indicating the establishment of cell-cell 
contacts. This work demonstrated the capability of LAB to produce 3D skin substitutes 
capable of developing functional tissues in vitro and promote skin regeneration in vivo, which 
represents an exciting advance in the field of 3D skin bioprinting.  
In a recent work, a skin-derived ECM bioink was used to print in vitro 3D full-thickness 
skin models and 3D pre-vascularized skin patches for in vivo skin reconstruction (Figure 
2.13B) [277]. Skin models were generated by the bioprinting of dermal fibroblasts in the 
dermal region, followed by the printing of human neonatal epidermal keratinocytes to 
recreate the epidermal region. Bioprinted skin models showed little contraction during culture, 
supporting the deposition of collagen type I in the dermal layer and showing expression of 
differentiation makers (keratin 10 and involucrin) on the epidermal layer. Pre-vascularized 
skin patches were created through the bioprinting of a bioink loaded with EPCs and ASCs, 
cultured in vitro for 3 days, and subsequently implanted in full-thickness excisional wounds 
created on BALB/cA-nu/nu mice. Results showed that bioprinted skin patches resulted in 
superior wound closure and re-epithelialization compared to the control groups. Laser 
Doppler perfusion imaging also indicated that skin patches improved the blood flow in the 
early phase of wound healing, enhancing neovascularization.  
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Figure 2.13. Bioprinted 3D constructs for in vivo skin repair. (A) Bilayered skin substitute 
produced by LAB through the printing of fibroblasts and keratinocytes: (i) schematics of used dorsal 
skin fold chambers in mice; (ii-iv) fluorescent microscopy images showing the presence of 
keratinocytes (red) and fibroblasts (green) after 11 days of in vitro ALI culture; (v-vii) masson’s 
trichrome staining of sections containing collagen (green) and cells (reddish), indicating the formation 
of a dense epidermis on day 5; (viii) construct in the dorsal skin fold chamber in nude mice 
immediately upon implantation (left) and after 11 days (right); (ix) histological section of the tissue 
construct stained with Masson’s trichrome showing a dense epidermis (empty asterisks) and a corneal 
layer [48]. (B) Extrusion bioprinting of human skin equivalents and 3D pre-vascularized patches for in 
vivo skin reconstruction: (i) photographs of printed skin equivalents using type I collagen (C-HSE) and 
skin-derived bioink (S-HSE) (scale bar: 2 mm); expression of proteins in C-HSE (ii, iii) and S-HSE (iv, 
v) on day 10 after ALI culture (Involucrin (IVL): early epidermal differentiation marker, keratin 10 (K10): 
late epidermal differentiation marker) (scale bars: 50 μm); (vi) photographs of skin wounds throughout 
21 days of treatment with 1) Hank's Balanced Salt Solution (HBSS), 2) cell-free skin patch using 
dECM (dECM), 3) ASCs + EPCs injection (ASC + EPC), 4) ASC-printed skin patch using dECM 
(dECM-ASC), 5) ASCs + EPCs-printed skin patch using dECM (dECM-ASC + EPC) [277].  
2.7.4. Bioprinted constructs as in vitro skin models 
The interest in bioprinting human skin models as platforms for toxicity and efficacy 
testing of topical medications and cosmetics has been significantly increasing due to the 
need for cost-effective alternatives to animal experimentation. Although there are several 
works demonstrating the printing and characterization of bilayered skin constructs [279, 282], 
there is a lack of studies exploring their applicability for pharmaceutical or cosmetic testing. 
The majority of these studies employ skin equivalents exclusively created by manual 
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methods [283, 284] or fabricated using components obtained by 3D printing technologies 
combined with manual deposition of cell-laden solutions [256].   
Lee et al [285] used a robotic cell dispensing technology to fabricate 3D cell-laden 
constructs mimicking the native skin anatomy. Their approach involved the printing of 
collagen hydrogel precursor solutions and keratinocytes or fibroblasts in suspension, 
followed by the crosslinking of each printed layer using a nebulized sodium bicarbonate 
solution as a gelation agent (Figure 2.14A). No significant differences on the viability of 
printed cells were found between printed and manually plated cells, while confocal 
microscope images of printed 3D constructs showed distinct layers of fibroblasts and 
keratinocytes after 4 days of in vitro culture. This strategy was further explored and optimized 
by the same group, where particular attention was given to the optimization of printing 
parameters, cell densities and histological characterization of skin constructs [286]. Printed 
multi-layered constructs were cultured under submerged conditions followed by exposure to 
the air-liquid interface to stimulate proliferation of keratinocytes. At day 14, printed constructs 
exhibited a dense epidermal layer and a sparsely populated dermal layer without cell 
invasion and migration across the two regions. Histological analysis revealed epidermis 
compaction along the period of ALI culture, accompanied by the formation of terminally 
differentiated stratum corneum and thigh junctions between keratinocytes. Printed constructs 
maintained the shape and dimensions without shrinkage during the culture period, while 
conventional constructs obtained by manual deposition presented continuous shrinkage and 
shape modification (Figure 2.14B). Further improvements on the density of fibroblasts in the 
dermis, as well as on the stratification and keratinization, are required to better mimic the 
native skin.  
LAB was also explored to produce 3D skin grafts consisting of a collagen matrix 
containing fibroblasts and keratinocytes in two main regions, aiming at mimicking the 
anatomic organization of native skin [155]. The bilayered 3D skin substitute was created by 
printing 20 layers of fibroblasts followed by 20 layers of keratinocytes. Both cell types were 
embedded in a collagen matrix and transferred onto a receiving slide coated with 
MatridermTM. After 10 days of in vitro culture, cells remained viable and located at the printed 
positions, without mixing between fibroblasts and keratinocytes. Immunohistochemical 
analyses revealed the formation of a laminin layer between the fibroblasts and keratinocytes 
layers. In another study, Cubo et al [287] used an extrusion-based bioprinter to create a 
human plasma-derived bilayered skin using fibroblasts and keratinocytes. The dermal 
component was created by printing fibroblasts embedded within a plasma-derived fibrin 
hydrogel, which was allowed to polymerize for 30 minutes before the seeding of 
keratinocytes to generate the epidermal component. For in vitro testing, skin constructs were 
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printed on Transwell inserts, allowed to differentiate at the air–liquid interface for 17 days, 
and evaluated for their resemblance to the native tissue. Histological analysis showed the 
formation of skin equivalents with structural resemblance to the human skin. To evaluate the 
in vivo differentiation capability of printed constructs, the substitutes were printed, incubated 
overnight, and immediately grafted on full-thickness wounds created on the backs of 
immunodeficient athymic mice. Immunofluorescence results indicated the presence of 
stratum basal, stratum spinosum, stratum granulosum and stratum corneum on the 
epidermal component, as well as the formation of the dermo-epidermal junction at the 
interface with the dermal component. Recently, Kim et al [288] developed a hybrid bioprinting 
approach to fabricate a human skin model with a functional Transwell system in a single-step 
process. In their strategy, an extrusion module capable of printing hydrogel bioinks and 
thermoplastics was used to print the dermal compartment and a PCL mesh to reduce 
collagen shrinkage during the construct maturation, respectively. The fibroblast-loaded 
collagen bioink was printed onto the PCL mesh to create the dermal region, while an inkjet 
module was subsequently applied to print the epidermal region through the deposition of 
keratinocytes on top of the dermis-like layer. The dermal region exhibited smaller shrinkage 
compared to the control group (fibroblasts in collagen gel), while keratinocytes displayed a 
more uniform distribution and higher proliferation rate when compared to manually deposited 
cells.  
 
 
Figure 2.14. Bioprinting of 3D human skin constructs as in vitro models. (A) Extrusion bioprinting 
of 3D skin models: (i) schematic illustration of bioprinting strategy and composition of skin constructs; 
(i) immunofluorescent images of multi-layered skin constructs and its projection of (iii) keratin-
containing keratinocytes layer and (iv) β-tublin-containing keratinocytes and fibroblasts [285]. (B) In 
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vitro skin models generated by bioprinting: (i) histological images of printed skin construct using 
haematoxylin and eosin and (ii) nuclear staining at day 14 of ALI culture; (iii-vi) macroscopic images of 
constructs produced by bioprinting and manual deposition at day 0 or day 7 of submerged culture 
[286]. 
2.7.5. Bioprinted constructs with skin appendages and pigmentation 
To create biomimetic skin constructs, the complexity of the tissue must be addressed 
behind generating the two major macro-structures of the skin, i.e., dermal and epidermal 
layers. Thus, a great deal of interest has recently been focused on the integration of 
appendage structures into skin constructs, including sweat glands and pigmentation.  
The regeneration of sweat glands using 3D printed ECM-mimic environments was 
addressed by Huang et al [260] using a gelatin-based bioink. The bioink composed of gelatin, 
alginate, mouse plantar dermis components (collection of protein molecules with bone 
morphogenetic protein (BMP-4)), and EGF was designed to provide a 3D niche to promote 
differentiation of epidermal progenitors into sweat gland cells. Several bioink compositions 
(with or without EGF and with plantar or dorsal dermis components) were printed using an 
extrusion system, crosslinked with calcium chloride, and their properties evaluated regarding 
cell viability and differentiation. In vitro tests showed that cells embedded within the hydrogel 
containing EGF and plantar dermis components differentiated into sweat gland cells, as 
observed by expression of luminal epithelial markers. After in vitro characterization, 3D 
constructs were implanted into mice burned paws to access their performance. Printed 
hydrogels containing both EGF and plantar dermis components restored the sweat gland 
function upon 14 days, performing better than the other tested groups (Figure 2.15A). 
Histological analysis also revealed the formation of sweat glands in regenerated skin and 
degradation of the hydrogel network. Although this study did not reveal the mechanisms of 
sweat gland restoration, this bioprinting strategy could be a useful tool for further research on 
the restoration of skin appendages. In a later study, the same research group demonstrated 
that the 3D architecture of printed constructs determines the sweat gland morphogenesis 
[289]. 3D porous constructs (20 × 20 × 5 mm3) were printed using different bioinks (with and 
without plantar dermis components) and printing nozzles (300 and 400 µm) (Figure 2.15A) 
and their effect on sweat gland cell differentiation and morphogenesis was evaluated. After 
14 days of culture, epithelial progenitors in constructs produced with the 300 µm nozzle 
showed higher expression of luminal epithelial markers, which is characteristic of 
differentiation into sweat gland cells. At later culture period (28 days), specific morphology of 
sweat gland tissue was only present in constructs printed with the 300 µm nozzle and the 
plantar dermis-containing bioink. The authors suggest that the larger pore size of constructs 
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produced with the 300 µm nozzle together with the release of plantar dermis components 
(inductive factors) from the constructs might influence and guide the differentiation of printed 
cells. However, the mechanisms and cues that regulate cell response to the 3D architecture 
and drive cell differentiation and sweat gland formation still remain unknown.  
Skin pigmentation is associated to the production of melanin from melanocytes and its 
transfer to the surrounding keratinocytes, being an important requirement of skin constructs. 
Min et al [280] used a micro-valve based bioprinter that deposits small liquid droplets to 
create full-thickness skin constructs containing pigmentation. The dermal component was 
created by printing five layers of collagen precursor solution, which was crosslinked through 
neutralization with sodium bicarbonate. During the fabrication, a suspension of fibroblasts 
was printed and embedded in the layers 2-4. After 1 day of culture, a suspension of 
melanocytes was printed on top of the dermal layer in two different configurations (Figure 
2.15B). After 4 days of culture, a suspension of primary keratinocytes was then printed on 
top of the constructs, followed by submerged culture (1 day) and ALI culture for 4 days. 
Histological characterization showed the formation of distinct dermal and epidermal layers 
with terminal differentiation of keratinocytes, as shown by loricrin staining. Printed 
melanocytes in the epidermal layer formed multiple clusters of dark pigmentation, as 
observed by visual inspection and bright-field microscopic images. However, constructs 
exhibited non-uniform pigmentation, being necessary further optimization to improve the 
homogeneity in skin pigmentation. 
 
 
Figure 2.15. Bioprinted skin constructs with appendages. (A) Regeneration of sweat glands on 
burned paws of mice with bioprinted skin constructs: (i) iodine/starch-based sweat test on paws of 
mice 14 days after implantation of the constructs (dark spots, indicative of sweat secretion, were only 
detected in the foot paw pads of Eps + PD + EGF group) [260]; (ii) photographs and cell distribution 
within bioprinted 3D porous constructs with different architectures (300 μm or 400 μm nozzle 
diameters) after 24 hours of culture [289]. (B) Bioprinted skin constructs containing melanocytes: (i-iv) 
macroscopic images of constructs with melanocytes printed in the area model or spot model before 
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(i,ii) and after ALI culture (iii,iv) (scale bars: 5 mm) [280]. Abbreviations: PD – mouse plantar dermis; 
EGF – epidermal growth factor; Eps – epithelial progenitors; DD – mouse dorsal dermis. 
2.7.6. Bioprinted vascularized skin constructs 
The formation of biologically relevant constructs containing a functional, perfusable 
vascular network is a major hurdle towards the full implementation and clinical translation of 
skin bioprinting. Vascularization of bioprinted skin constructs is essential to recapitulate the 
vasculature of dermis and to provide nutrients and oxygen to the embedded cells. It also 
plays a key role in the integration of implanted constructs with the host tissue, which remains 
a limitation of current skin substitutes. In the absence of a functional vascular network, 
nutrients, oxygen and soluble factors are supplied to the cells by diffusion, which is a slow 
and inefficient process that may lead to suboptimal cell nutrition, cell necrosis or delayed new 
tissue formation [290]. In vivo, vascularized tissues contain an organized system of larger 
blood vessels that branch into smaller vessels, which ultimately branch into capillaries 
distributed throughout the tissue. Capillaries are in the close proximity (maximum ~200μm) to 
the cells allowing nutrition, oxygenation and removal of waste products [291]. The natural 
formation of a vascular network in vivo is regulated by two underlying processes of 
vasculogenesis and angiogenesis. The first predominates during early embryonic 
development to form a primitive capillary network, while the second takes place in adults 
aiming at the revascularization of damaged or diseased tissues from existing blood vessels 
[291, 292]. Recapitulating these biological processes in printed tissues is challenging and 
requires a proper spatiotemporal interplay between vascular cells, resident cells and 
surrounding ECM. Although several strategies have been explored to promote 
vascularization in skin constructs [11, 293], engineering branched vascularization in 3D 
hierarchical architectures remains a great challenge. Bioprinting technologies are attractive to 
engineer a vascular tree within thick constructs by the precise layer by layer deposition of 
multiple cell types and ECM-like bioinks into prescribed spatial locations at high resolution 
[294]. Promising approaches to generate vascular networks have been reported using inkjet 
[295, 296], LAB [297], and extrusion bioprinting [41, 177, 298]. In general, these approaches 
are based on four main strategies: (i) direct patterning of vascular cells onto a receiving 
substrate [297], (ii) continuous printing of polymeric bioink loaded with endothelial cells 
followed by polymer removal [299], (iii) printing of perfusable channels in a 3D construct for 
subsequent injection of a cell suspension into the empty channel [177], and (iv) printing of 
multicellular spheroids [298].  
To address the need for vascularization in skin substitutes, Yanez et al [296] used the 
inkjet technology to fabricate capillary-like endothelial networks into a dermo-epidermal skin 
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graft consisting of neonatal human dermal fibroblasts and neonatal human epidermal 
keratinocytes embedded in a fibrin-collagen matrix. Human dermal microvascular endothelial 
cells (HMVECs) were mixed with thrombin and inkjet printed on top of a manually plated 
layer of collagen-neonatal human dermal fibroblasts cells containing fibrinogen. After 
formation of the fibrin hydrogel, a layer of collagen containing neonatal human epidermal 
keratinocytes cells was pipetted on top of it to produce bilayered structures. These structures 
were then implanted into skin full-thickness wounds on the back of athymic nude mice to 
investigate healing properties and integration with the native tissue. Wounds treated with 
printed substitutes required 14-16 days to heal, contrasting with 21 days in the control group 
(no skin graft) and 28 days in the group implanted with Apligraf®. Histological characterization 
of the wounds treated with the printed substitutes on post-operative day 14 showed the 
formation of dermal and epidermal skin layers similar to the native skin, accompanied by the 
presence of new micro-vessels in the mouse tissue. It was suggested that new blood vessel 
formation was stimulated by the presence of endothelial cells, indicating partial integration of 
the skin graft into the host tissue, which was further confirmed by the presence of human 
cells in the mouse tissue. More recently, Abaci et al [300] developed an integrated strategy to 
generate perfusable vascular networks in human skin equivalents using primary and induced 
pluripotent stem cell (iPSC)-derived endothelial cells (iECs). 3D printing technology was 
explored to create moulds with the desired vasculature pattern and functional components for 
the fabrication of embedded vasculature. Sacrificial channels composed of crosslinked 
alginate were printed and embedded with dermal fibroblasts embedded with a collagen 
matrix. After 7 days of culture, keratinocytes were seeded on the top of the dermal 
compartment, cultured under submerged conditions for 7 days and subsequently maintained 
at ALI interface for additional 7 days. After this period of time, perfusable channels were 
created by removing the alginate using a sodium citrate solution, followed by the injection of 
either human umbilical vein endothelial cells (HUVECs) or iECs, which established proper 
endothelial barrier function. Vascularized skin constructs grafted on the back of 
immunodeficient mice for 14 days were perfused with blood, while both non-vascularized 
constructs and constructs with acellular channels remained non-perfused, which suggest that 
engineered vasculature promotes and guides neovascularization of skin constructs. Although 
the skin construct was created by manual deposition of cell-laden solutions rather than using 
bioprinting technologies, this study reports an integrated approach to generate vascularized 
skin equivalents for tissue engineering applications. A similar approach to fabricate 
perfusable vascular channels within skin equivalents was recently reported by Mori et al 
[256], who demonstrated the applicability of vascularized skin equivalents for dermatological 
studies and drug testing. 
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2.7.7. In situ bioprinting of skin substitutes 
In addition to the bioprinting of 3D skin constructs in vitro for subsequent implantation, 
key advances have also been achieved on the development of integrated bioprinting 
strategies for the in situ printing of cellular skin substitutes. In situ skin bioprinting is 
challenging as it requires the development of dedicated bioprinting devices, the integration 
with imaging systems to obtain data from the wound site, and the design of bioinks capable 
of instructing printed cells to perform their native functions. In a pioneer work, Binder et al 
[47, 301] developed a device for in situ skin printing composed of a cartridge delivery system 
containing a series of inkjet nozzles and a laser scanning system, both mounted on a 
portable XYZ plotting system. The data obtained from the laser was used to reconstruct a 3D 
model of the wound, which was subsequently employed to determine the skin area that was 
missing from the wound. Afterwards, the printheads filled the wound site with a bioink 
containing skin cells. The potential of the system to promote skin reconstruction was firstly 
evaluated through the printing of human keratinocytes and fibroblasts suspended in a 
fibrinogen-collagen precursor solution into full thickness skin lesions (3.0 × 2.5 cm2) created 
on nu/nu mice [301]. After printing each layer, a thrombin solution was sprayed on top of the 
deposited layer to induce hydrogel formation. Results showed the complete closure of the 
wound in 3 weeks and the formation of new skin with similar properties to the native tissue. 
Histological analyses also revealed that the newly formed skin contained organized dermal 
collagen and a fully developed epidermis. The same research group used a similar 
procedure and bioprinting technique to print AFSs and bone marrow-derived mesenchymal 
stem cells (MSCs) suspended in a fibrinogen-collagen gel into full-thickness skin wounds in 
mice [47]. The bioink was dispensed to the skin wounds (2.0 × 2.0 cm2) with uniform cell 
distribution. The closure and re-epithelialization of wounds treated with printed AFSs and 
MSC were superior to those of wounds treated only with the fibrin-collagen hydrogel. 
Histological sections of skin samples harvested 2 weeks after printing showed well-defined 
and organized epidermal layers of the regenerated skin in MSC and AFSs-treated wounds, 
which was accompanied by increased neovascularization and blood vessel maturation, 
particularly in the case of AFSs-treated wounds. However, findings also demonstrated that 
cells only remained transiently at the lesion site and did not permanently integrate with the 
host tissue. Another limitation of this bioprinting approach relies on the slow crosslinking time 
of the bioink system, which increased the overall length of the procedure. 
Besides suitable mechanical, swelling and biodegradation characteristics, bioinks for 
in situ skin bioprinting should exhibit fast crosslinking to reduce the printing time, support cell 
activity, and eventually act as a delivery vehicle of biological factors. In order to meet such 
requirements, Skardal et al [252] recently developed a photocrosslinkable heparin-
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conjugated hyaluronic acid (HA-HP) hydrogel capable of sequestering and releasing cell-
secreted growth factors. The bioink system, composed of thiolated hyaluronic acid with 
conjugated heparin, thiolated gelatin, PEGDA crosslinker and I2959 as photoinitiator, was 
loaded with AFSs and printed directly onto full thickness skin wounds (2.0 × 2.0 cm2) in a 
nu/nu murine model (Figure 2.16). After printing, the bioink was crosslinked in situ via thiol-
ene photopolymerization upon exposure to UV light. In vitro tests indicated the effectiveness 
of heparin-mediated growth factor binding in modulating the release of proangiogenic AFS-
secreted FGF and VEGF from HA-HP hydrogels. Wounds treated with cell-laden HA-HP 
hydrogels showed slightly higher closure rate and re-epithelialization compared to both 
hyaluronic acid-treated and non-treated wounds, though the differences between groups 
were not statistically significant after 14 days post-printing. Histological characterization of 
the harvested skin tissue indicated that HA-HP hydrogels promoted higher microvessel 
density, which may be due to the sequestration of and release of AFS cell-secreted growth 
factors as well as increased deposition of elastin. Although this work demonstrates the 
potential of photopolymerizable heparin-containing hyaluronic acid based bioinks combined 
with AFSs for in situ skin printing, further characterization regarding the effectiveness of this 
strategy on the wound healing and quality of new skin is necessary.  
 
 
Figure 2.16. In situ bioprinting of a photocrosslinkable heparin-conjugated hyaluronic acid 
hydrogel system loaded with AFSs into full-thickness skin wounds in a nu/nu murine model. 
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(A) Schematic representation of UV light photoinitiated thiol-ene polymerization of the hydrogel 
system. (B) Illustration of the in situ bioprinting strategy. (C) Macroscopic images of the wounds over 
the study, showing enhanced closure of wounds treated with the hydrogel system compared to the 
control groups (HA: hyaluronic acid). (D) Immunohistochemistry analysis of tissue sections stained for 
collagen type I (red), collagen type III (green), and DAPI (blue) [252]. 
2.8. Conclusions 
 The field of skin bioprinting has experienced exciting advances in the direct printing 
of cellularized hydrogel constructs as effective alternatives to current therapies for skin repair 
and regeneration. Bioprinting technologies have been applied to create 3D constructs that 
recapitulate, to some extent, the architecture and cellular composition of native skin. 
Although those processes allow the precise patterning of skin cells and ECM components in 
the form of 3D constructs capable of promoting in vitro and in vivo skin formation, the field of 
skin bioprinting is still in an early stage, facing numerous challenges in diverse areas.  
A critical issue is the availability of bioprinters capable of producing constructs that 
replicate the intricate ECM composition of skin. Since most of the bioprinters currently used 
in laboratories result from technical modifications of available technologies and/or equipment, 
they usually have limited resolution and accuracy, which imposes serious restrictions to the 
processing conditions, range of printable biomaterials and characteristics of the printed 
construct. Despite the existence of dedicated bioprinting technologies capable of processing 
biologically relevant biomaterials and living cells already available in the market (e.g., 3D 
Bioplotter®, 3DDiscovery®), the printing speed and resolution should be increased in order to 
better reproduce the heterogeneity found in natural tissues and produce constructs with 
clinically-relevant dimensions in acceptable periods of time. Another important aspect relies 
on the inclusion of physical and chemical crosslinking methods in the bioprinting process to 
induce rapid gelation during biofabrication, in order to maintain shape fidelity and prevent 
loss of resolution. The development of hybrid bioprinting approaches for skin tissue 
engineering, through the combination of bioprinting and other biofabrication techniques with 
different scales of resolution, is also an important challenge that could enhance the functional 
outcomes of constructs and overcome technical limitations.  
Another important limiting factor in skin bioprinting is the lack of printable bioinks 
exhibiting appropriate rheological, mechanical and biological properties. As a result of the 
distinctive requisites of each bioprinting strategy, most of the natural and synthetic hydrogels 
that have been applied for skin wound healing need to be re-engineered to allow adequate 
processing through bioprinting. Besides printability, such materials must exhibit a plethora of 
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characteristics, including biocompatibility, biodegradability, ability to preserve cell viability and 
function during/upon printing, appropriate immunological properties and the ability to promote 
integration with host tissue. Bioinks should also allow the introduction of cell adhesion sites 
and cleavable moieties to control cell behaviour and biomaterial degradation rate, 
respectively. Current bioinks for skin bioprinting are essentially limited to the use of alginate, 
collagen, hyaluronic acid and fibrin, which restricts the range of mechanical and biological 
properties of the fabricated constructs. Although the ability of bioprinting approaches to 
generate 3D constructs with complex architectures, while allowing control over the spatial 
location of biomaterials, cells and biologically active compounds, has already been 
demonstrated, replicating the complexity of native skin has not yet been successfully 
achieved.  
To improve the level of biomimicry, efforts should be made to consider additional 
aspects regarding the skin appendages, gradients of ECM components, and functional 
vascular networks. Skin appendages are responsible for several important functions, 
including protection, sensing and temperature regulation, while the gradients of ECM 
components play a primordial role in both cell behaviour and biomechanical properties of the 
skin. Novel bioinks allowing the reproduction of ECM gradients present in different skin layers 
should be designed and their effects on cell viability and function well characterized and 
documented towards regulatory approval. Although vascularization is essential for the long-
term viability of the construct, it remains a huge challenge in almost all tissue engineering 
strategies. Recent developments in bioprinting of functional vascular networks can be 
explored to design 3D hierarchical skin constructs with embedded vascular cells, which will 
represent an important advance in the field.  
Finally, efforts should be concentrated in the translation of bioprinting therapies into 
clinical practice. This is a long and difficult issue that depends on several factors, including 
the scale-up of the process, and many regulatory and commercialization aspects. Since 
novel bioprinting approaches for skin repair and regeneration are complex and 
multidisciplinary, aspects related to the bioprinting technology, bioinks, cell sources, 
integration with existing medical devices (e.g., robotic surgical arms, medical imaging 
systems, real-time imaging technology), automation, reproducibility and affordability must be 
considered right from an early stage to reduce the time to reach the market. Collaborative 
work should also be focused on the establishment of good manufacturing practices, 
standardization of assays to control the properties of manufactured constructs, and methods 
for the monitoring and inspection of the printing process.  
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Abstract 
Bioprinting is attractive to create cellularized constructs for skin repair. However, the 
vast majority of bioinks present limitations in the printing of chemically defined 3D constructs 
with controllable biophysical and biochemical properties. To address this challenge, a single-
component hydrogel bioink with controlled density of cell-adhesive ligands, tuneable 
mechanical properties and adjustable rheological behaviour is developed for extrusion 
bioprinting and applied for the fabrication of 3D dermal constructs. A methacrylate modified 
pectin bioink is designed to allow the tethering of integrin-binding motifs and the formation of 
hydrogels by UV photopolymerization and ionic gelation. The rheological behaviour of a low 
polymer concentration (1.5 wt%) solution is adjusted by ionic crosslinking, yielding a printable 
bioink that holds the predesigned shape upon deposition for postprinting photocrosslinking. 
Printed constructs provide a suitable microenvironment that supports the deposition of 
endogenous extracellular matrix, rich in collagen and fibronectin, by entrapped dermal 
fibroblasts. This approach enables the design of chemically defined and cell-responsive 
bioinks for tissue engineering applications and particularly for the generation of biomimetic 
skin constructs. 
 
Keywords: 3D bioprinting; dermal tissue engineering; cell-responsive bioink; dermal 
fibroblasts; pectin. 
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3.1. Introduction 
Skin is the outermost organ of the human body, providing protection, thermal 
regulation and transmission of sensory information [1]. It is composed of an epidermal layer 
located on top of a vascularized dermal layer. The dermis is a highly dynamic layer 
consisting of an intricate extracellular matrix (ECM) mainly composed of fibroblasts, which 
produce connective tissue components and several cytokines that regulate homeostasis [2]. 
As the dermis has limited self-reparative ability upon injury, bioprinted 3D cellularized 
constructs capable of instructing entrapped cells to secret new ECM components are 
attractive for dermal repair [3].  
Bioprinting has emerged as a promising technology to create hierarchical tissue 
constructs through the layer-by-layer deposition of cellularized formulations in pre-designed 
spatial locations [4-7]. Extrusion bioprinting is the most popular technology due to its low 
cost, ease of operation and ability to print several material formulations loadable with living 
cells and biological molecules, termed as bioinks, into millimetre size constructs [8-10]. 
Although extrusion bioprinting has been used to produce skin constructs, existing bioinks are 
mostly limited to collagen, gelatin and fibrin [11-13]. Protein-based bioinks are attractive 
owing their phase transition temperature and the presence of biochemical cues in native 
composition. However, to overcome shrinkage issues and limited mechanical properties of 
these materials, additional polymers like alginate are often included in the printable 
formulation [13], resulting in multimaterial bioinks of increased complexity and reduced 
control over the cellular responses. These bioinks inherently contain cell-adhesion and cell-
proteolytic cues in the native composition, which difficult to decouple macromer concentration 
and matrix mechanical properties from ligand density. Moreover, changes in macromer 
concentration inevitably alter key matrix characteristics that affect cellular responses, such as 
the density of adhesive ligands, fibre density structure and mechanical properties [14]. 
Natural polymers lacking of bioactive cues in the native composition represent an 
attractive alternative to design chemically defined bioinks, which biochemical, mechanical 
and rheological properties can be independently tailored to induce specific cellular 
responses. Pectin, an anionic heteropolysaccharide extracted from the cell walls of plants, 
has gained attention in the biomedical field due to its biocompatibility, abundancy of 
modifiable functional groups and ability to form physical hydrogels through interaction 
between calcium ions and blocks of galacturonic acid residues [15]. It is composed of a 
backbone of (1,4)-linked α-D-galacturonic acid residues, which can be partially acetylated 
and methyl esterified, and a variety of neutral sugars side chains such as rhamnose, 
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galactose and arabinose [16]. Although pectin shares key properties with alginate, its 
branched nature and complex chemical composition provide a range of bioactive properties 
(e.g., bioadhesivity, anti-cancerous effect and immunomodulatory activity) [17-19] and could 
potentially enhance the in vivo degradation/dissolution, which is useful for tissue engineering 
applications. Importantly, pectin lacks of cell-adhesive and protease-cleavable sites in native 
composition [15], acting as a “blank slate” and providing the possibility to engineer 
biofunctionalized macromers for the formation of chemically defined hydrogels. 
Biofunctionalized pectin hydrogels have been explored as vehicles for entrapment, 
supporting the viability and/or differentiation of several cell types such as MC3T3-E1 pre-
osteoblast cells, mesenchymal stromal cells and dermal fibroblasts [20-22].   
In this work, we report on the design of a novel single-component pectin bioink with 
tuneable mechanical and rheological properties that can be biofunctionalized with relevant 
peptide ligands for bioprinting of cellularized 3D dermal constructs. Contrary to other 
strategies based on the use of multiple polymers or sacrificial materials to achieve suitable 
printability [13, 23], the properties of the developed pectin bioink are exclusively tailored via 
macromer chemistry without the need for additional polymers to achieve both proper 
rheological profiles and biological responses. Conceptually, we hypothesized that the 
incorporation of methacrylate groups into the pectin backbone allows the design of a 
macromer that would undergo chemical crosslinking through UV photopolymerization, while 
retaining inherent ionic gelation ability via interaction with calcium ions. By independently 
applying these two crosslinking chemistries to the designed pectin macromer is possible to 
engineer hydrogel networks with defined biochemical composition and tuneable properties 
that can be explored as both hydrogel systems for cell entrapment and bioinks for extrusion 
bioprinting. First, to demonstrate the versatility of this hydrogel platform for tissue engineering 
applications, a low polymer concentration solution was used to generate chemical hydrogels 
that may subsequently undergo ionic gelation to further tailor the hydrogel elastic modulus 
(G’) and cell response. Second, by inverting the crosslinking sequence, a tuneable and 
printable bioink exhibiting suitable rheological behaviour was obtained by the reaction of the 
macromer solution with calcium ions. After printing, the ionically crosslinked hydrogel bioink 
undergoes chemical crosslinking by UV photopolymerization for shape fixation, yielding 
cellularized tissue constructs with high shape fidelity. Cell response within printed 3D 
constructs was characterized regarding viability, spreading and deposition of key ECM 
components. 
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3.2. Materials and Methods 
3.2.1. Synthesis of methacrylate-functionalized pectin 
Low methoxyl citrus pectin (Classic CU701) with galacturonic acid unit content of 86% 
and degree of methylation of 37%, was kindly provided by Herbstreith & Fox (Neuenbürg, 
Germany). Prior to chemical modification, raw pectin was purified using a published protocol 
[22]. Pectin methacrylate (PECMA) was synthetized by reacting purified pectin with 
methacrylic anhydride (MA, Sigma-Aldrich). Pectin was dissolved in phosphate buffered 
saline (PBS, pH 7.4) at 1.25 wt% and stirred at room temperature until complete dissolution. 
To this solution, MA was added dropwise (0.5 mL/min) and left to react protected from light 
under vigorous stirring. The pH was periodically adjusted to 8.0 by the addition of 5.0 M 
NaOH. After 24 h, pectin was collected by twice precipitation with a ten-fold excess of cold 
acetone (4°C), followed by drying at 40°C in a vacuum oven. For further purification, the 
polymer was dissolved in ultrapure water (Millipore) and dialyzed (MWCO 3500, 
Spectra/Por®, SpectrumLabs) for 5 days. The final product was sterile filtered using 0.22 µm 
filter membranes (Steriflip® fillter unit, Millipore), frozen, lyophilized, and stored at -20 °C until 
further use. The extent of methacrylate substitution was determined by 1H NMR recorded 
with a 400 MHz spectrometer AVANCE III (Bruker). Polymers were dissolved (8.5 mg/mL) in 
deuterated water (D2O, Euriso-top) and transferred to NMR tubes containing a glass capillary 
loaded with 3-(trimethylsilyl)propionic-2,2,3,3-d4 acid sodium salt (TSP-d4, Euriso-top) as 
internal standard (δ = 0 ppm).  
3.2.2. Conjugation of cell-adhesive peptide 
The custom synthetized integrin-binding peptide CGGGGRGDSP (Genscript, cell-
adhesive domain underlined) was conjugated to PECMA macromers through a base-
catalysed thiol-Michael addition click reaction. For coupling the integrin-binding peptide, a 
solution of PECMA (1.0 wt%) was dissolved in triethanolamine (0.25 M, TEOA, Acros 
Organics) buffer at pH 8.5. After the addition of cell-adhesive peptide (64 mg/g polymer), the 
solution was protected from light and allowed to react under agitation and inert atmosphere. 
After 48 h, the solution was diluted with ultrapure water, purified by dialysis, and lyophilized. 
The coupling efficiency was quantified through the colorimetric DC Protein Assay (Bio-Rad) 
according to the manufacturer’s instructions, with some modifications. Briefly, the macromer 
was dissolved in ultrapure water (1.0 wt%) and the solution (20 µL) transferred to a 96-well 
plate. To this solution, alkaline copper tartrate solution (25 µL) and dilute Folin reagent (200 
µL) were then added, followed by mixing using a multi-channel micropipette. The solutions 
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were allowed to react at RT for 30 min, and the protein content determined with a micro-plate 
reader (Synergy MX, BioTek) at 750 nm. Absorbance values were converted to peptide 
concentrations using a standard curve of free peptide in PECMA, and normalized against 
control polymer solutions that were subjected to the conjugation process but in the absence 
of peptide. 
3.2.3. Preparation of pectin hydrogels 
To produce photocrosslinked hydrogels, PECMA macromer was dissolved in 0.9 wt% 
NaCl containing 0.05 wt% of 2-hydroxy-4-(2-hydroxyethoxy)-2-methylpropiophenone (I2959, 
Sigma) as radical photoinitiator. The solution was pipetted into a teflon plate with 750 μm 
spacers, covered with a SigmaCote treated glass slide, and exposed to UV light (7 mW/cm2, 
365 nm) using a BlueWave® 200 curing spot lamp (Dymax) for different durations (40–300 s). 
For the preparation of dual-crosslinked hydrogels two strategies were adopted: (1) 
photocrosslinked hydrogel samples were incubated in Dulbecco’s Modified Eagle’s Medium 
(DMEM, Gibco) with different concentrations of calcium chloride dihydrate (0–1.8 × 10 mM), 
at 37 ºC in a humidified atmosphere of 5% CO2; (2) PECMA macromer solutions (1.5 wt%) 
dissolved in 0.9 wt% NaCl containing I2959 were mixed with calcium chloride (CaCl2) 
dihydrate at different concentrations (0–7 mM), yielding weakly crosslinked physical gels, 
followed by UV photopolymerization for 160 s. 
3.2.4. Characterization of gel fraction, swelling ratio, microstructure and in 
vitro degradation 
To determine the gel fraction, hydrogel samples (30 µL, n = 5) were lyophilized and 
weighted to determine the initial dry weight (WID). Dry samples were incubated in ultrapure 
water (1 mL) at 37 ºC for 24 h and then were carefully removed from the solution, gently 
dabbed with a tissue paper to remove superficial water, and lyophilized to determine the final 
dry weight (WFD). Gel fraction was determined based on the dry mass of hydrogels before 
(WID) and after (WFD) incubation, according to Equation (1): 
100(%) ×=
ID
FD
W
WfractionGel
   (1) 
The swelling ratio was determined by soaking freeze-dried hydrogels in ultrapure 
water (1 mL) at 37 ºC for 24 h. Samples were collected, the hydrogel’s superficial excess 
water was gently removed with a tissue paper, and the swollen weight (WS) determined. 
Swelling ratio (q) was calculated by dividing the weight of hydrated hydrogel (WS) by its initial 
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dry weight (WID). The microstructure of hydrogels was observed by cryogenic scanning 
electron microscopy (cryoSEM). Immediately after preparation, hydrogel samples were 
frozen in slush nitrogen (N2) and mechanically fractured to reveal the internal structure. After 
sublimation, samples were coated with gold/palladium and transferred to the cryoSEM 
microscope chamber (JEOL JSM 6301F/Oxford INCA Energy 350/Gatan Alto 2500). The 
degradation rate of hydrogels was enzymatically studied in vitro through the incubation of 
freeze-dried samples (n = 9) in ultrapure water (1 mL) supplemented with pectinase (0.05 
mg/mL) from Aspergillus niger (Sigma-Aldrich) at 37 ºC. At pre-determined time points, 
samples were gently washed with ultrapure water, freeze-dried and weighted (WD). The 
percentage mass loss of hydrogels was calculated using Equation (2): 
100(%) ×−=
ID
DID
W
WWLossMass
   (2) 
3.2.5. Characterization of hydrogel stiffness 
The mechanical properties of hydrogels were analysed using a strain-controlled 
Kinexus Pro rheometer (Malvern). All tests were conducted with 4 mm diameter hydrogel 
samples (n = 5) in a humidified environment at physiological temperature (37 ºC) to minimize 
hydrogel dehydration during analysis. To ensure an appropriate contact between the parallel 
plates, samples were compressed at 10% of their initial height. Strain amplitude sweeps 
were conducted from 0.1 to 10 % at 1 Hz, while frequency sweeps were carried out from 0.01 
to 10 Hz at 0.5% strain, after determining the linear viscoelastic region.  
3.2.6. Assessment of hydrogel’s biological behaviour 
Human neonatal dermal fibroblasts (hNDFs) isolated from human neonatal foreskin 
samples (Coriell Institute for Medical Research, USA) were cultured in DMEM supplemented 
with 10% fetal bovine serum (FBS, Gibco), antibiotics (100 U/mL penicillin and 100 μg/mL 
streptomycin, Sigma) and amphotericin B (2.5 mg/L, Sigma). Cells were cultured in 5 % CO2 
at 37 ºC in tissue culture polystyrene flasks. To assess the behavior of hNDFs within PECMA 
hydrogels, cells (passage 3 to 8) were trypsinized using a 0.05 wt% trypsin/ethylenediamine 
tetraacetic acid (EDTA) solution (Sigma) before reaching confluence (70–80%) and 
centrifuged at 1200 rpm for 5 min. The cell pellet was suspended and mixed within the 
PECMA solutions (1.5 wt%) containing 0.05 wt% of I2959 at a final density of 1×107 cells/mL. 
Cell-laden polymer solutions (20 μL) were pipetted onto a teflon plate with 500 µm spacers, 
covered with a SigmaCote treated glass slide and exposed to UV light (7 mW cm-2) for 160 s. 
Cell-laden hydrogels were soaked in 0.9 wt% NaCl (0.5 mL) for 30 min, followed by the 
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addition of culture media. At predetermined time periods, cellular hydrogels were collected 
and characterized for their metabolic activity, cell viability and cell morphology. 
3.2.7. Bioink preparation, assessment of rheological properties and bioprinting 
PECMA low macromer biofunctionalized with the RGD-peptide was dissolved in 0.9 
wt% NaCl containing I2959 as radical initiator. After solubilization, CaCl2 (5 mM) was added 
dropwise under vigorous agitation as the ionic crosslinking agent, and the solution incubated 
at 25 ºC and 1400 rpm (> 1 h) until G' stabilization. Then, hNDFs were detached from the 
tissue culture plate, centrifuged at 1200 rpm for 5 min, suspended in 0.9 wt% NaCl, and 
mixed within the bioink at a concentration of 1×107 cells/mL. Final concentrations of PECMA, 
I2959 and CaCl2 were 1.5 wt%, 0.05 wt% and 5 mM, respectively. 
To determine the rheological properties of the cell-laden bioink and to assess the 
effect of CaCl2 concentration on its viscosity, bioink formulations with CaCl2 at 0, 1, 3, 5 or 7 
mM were tested using a Kinexus Pro rheometer (Malvern). Tests were performed at 25 ºC in 
a humidified environment to prevent evaporation, using a shear ramp test (1 to 1000 s-1 
shear rate) over the course of 2 min. Two loading cycles with 1 min intervals were performed 
before the rheological data acquisition. To determine the yield stress, bioinks were subjected 
to a shear stress ramp, ranging from 1 to 100 Pa (2 min) with plate–plate geometry (0.5 mm 
distance). 
For bioprinting, the cell-laden bioink was loaded in a sterile syringe with a 23 G 
cylindrical nozzle (7018314, Nordson EFD) and printed using a commercial bioprinter 
Regemat 3D V1 (Regemat 3D, Spain). Proprietary software was used to automatically 
generate G-code to control the bioprinter to fabricate desired constructs. Immediately after 
bioprinting, constructs were exposed to UV light (7 mW/cm2, 365 nm) using a BlueWave® 
200 curing spot lamp (Dymax Corporation) for covalent crosslinking. Printed constructs were 
incubated in culture media and characterized for cell viability, metabolic activity, morphology 
and ECM deposition. 
3.2.8. Determination of metabolic activity and cell viability 
The metabolic activity of cells within PECMA hydrogels was assessed by the 
resazurin assay. Resazurin (resazurin sodium salt at 0.1 mg/mL, Sigma-Aldrich) was diluted 
(20 v/v%) in DMEM and incubated with the hydrogels for 2 h at 37 ºC. Samples were 
measured using a microplate reader (Synergy MX; Biotek) at 530 nm (excitation) and 590 nm 
(emission). Cell viability was determined with the live/dead assay. CyTRAK OrangeTM (10 
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μM) and DRAQ7TM (3 μM) (Biostatus) were diluted in DMEM and used as dyes for live cell 
and dead cells, respectively. Both dyes were incubated for 10 min at RT before the 
visualization of hydrogels using a laser scanning microscope (CLSM, Leica TCS-SP5 AOBS, 
Leica Microsystems). 
3.2.9. Bioprinted cell morphology and ECM synthesis 
For observation of cell morphology/cytoskeletal structure and ECM deposition, 
immunofluorescence staining of F-actin, fibronectin, collagen type-I, laminin and nuclei was 
performed for the cell-laden hydrogels after predetermined time points of culture. Samples 
were fixed in 4 v/v% paraformaldehyde (PFA, Sigma) in PBS for 30 min, followed by 
extensive washing with PBS. Samples were permeabilized for 10 min with 0.2 v/v% Triton X-
100 (Sigma) in PBS. Samples were incubated in blocking solution (1 w/v% bovine serum 
albumin in PBS) for 1 h at RT, and left overnight at 4 ºC with appropriate primary antibodies. 
Then, samples were rinsed three times with PBS and incubated for 45 min with appropriate 
secondary antibodies and the conjugated probe phalloidin/Alexa Fluor® 488 (1:40, Molecular 
Probes-Invitrogen) for F-actin staining. For nuclei, hydrogel samples were counterstained 
with Vectashield with DAPI (Vector Labs) immediately before confocal visualization (CLSM, 
Leica SP5AOBS, Leica Microsystems). For laminin staining, samples were incubated in 
blocking solution (1 w/v% bovine serum albumin and 4 v/v% FBS in PBS) for 1 h and 
incubated with the primary antibody according the steps described above. Primary and 
secondary antibodies are listed in the Table S1, Supporting Information. 
3.2.10. Statistical Analysis 
Statistical analyses were performed in the GraphPad Prism 7.0 software. The results 
were reported as the mean ± standard deviation (SD). The non-parametric Mann–Whitney 
test was applied with 95% confidence interval and statistically significant differences marked 
with P < 0.05 (*), P < 0.01 (**), P < 0.001 (***) and P < 0.0001 (****).   
3.3. Results and Discussion 
3.3.1. Synthesis of pectin methacrylate and hydrogel design 
Pectin methacrylate (PECMA) was synthetized by partial substitution of secondary 
hydroxyl groups in polymer backbone by pendant methacrylate moieties via reaction with 
methacrylic anhydride (MA) (Figure 3.1A). The presence of new characteristic peaks of MA, 
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originally absent in the pure polymer (Supplementary Figure S3.1), including two peaks at 
5.72 and 6.16 ppm assigned to the methylene group in the vinyl bonds and a sharp peak at 
1.89 ppm corresponding to the methyl group, was confirmed by 1H NMR analysis (Figure 
3.1B). The extent of chemical functionalization, i.e., the degree of methacrylation (DM), was 
modulated between 21.7% and 56.6% by varying the molar ratio of MA to hydroxyl groups 
(MA/OH) of pectin in a range of 2.5–25 and determined by 1H NMR (Supplementary Figure 
S3.2). Reaction conditions were optimized to balance the water-solubility of synthetized 
macromers and sufficient DM to form hydrogels at low polymer concentration. The DM 
increased with the addition of higher MA volumes, reaching a maximum conjugation of 56.6% 
at a molar ratio of 25. Increasing the molar ratio resulted in the introduction of excessive 
hydrophobic methacrylate moieties, yielding pectin derivatives with reduced water-solubility 
(Supplementary Figure S3.3). As the DM dictates the number of methacrylate functions 
available for photocrosslinking, consequently determining the biophysical properties of 
hydrogels [24], pectin macromers were synthetized with low (21.7%, PECMA low), medium 
(42.6%, PECMA medium) and high (50.2%, PECMA high) DM. To evaluate the cytotoxicity, 
macromers were dissolved in culture medium and incubated in the presence of human 
neonatal dermal fibroblasts (hNDFs) for 24 h. No cytotoxic effects to the cells were verified at 
any tested concentration (Supplementary Figure S3.4). All macromers allowed the 
fabrication of structurally robust hydrogels at low polymer concentration (1.5 wt%) upon 
exposure to UV light (160 s, 7 mW/cm2). Macromers retained the ability to form physical 
hydrogels by ionic interaction with calcium ions, allowing the design of dual-crosslinked 
hydrogels, which properties could be modulated by varying the calcium content (Figure 
3.1C). 
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Figure 3.1. Pectin chemical modification and strategies for the preparation of dual-crosslinked 
hydrogels. (A) Chemical modification of pectin with methacrylate groups by reaction with MA, yielding 
pectin methacrylate (PECMA) derivatives. (B) 1H NMR spectra of PECMA synthetized with different 
degrees of methacrylation. (C) Schematic illustration depicting the versatility of PECMA macromers for 
the preparation of hydrogels through independent crosslinking chemistries. Pectin macromers, 
dissolved in the photoinitiator (I2959) solution, can be applied for the formation of chemical hydrogels 
via UV photopolymerization, and subsequently incubated with calcium ions to tune their mechanical 
properties via ionic gelation between adjacent carboxylic groups (optional). PECMA can also be firstly 
reacted with calcium ions to trigger the ionic gelation for bioink design, followed by UV 
photopolymerization.  
3.3.2. Photopolymerization of pectin hydrogels with tuneable properties 
To demonstrate the versatility of PECMA macromers and their application as cell 
carriers, acellular hydrogels were prepared and critical properties susceptible to determine 
the fate of embedded cells characterized. Hydrogels were formed as cylindrical discs using a 
low polymer fraction (1.0–2.5 wt%) by the exposure to cytocompatible doses of UV light 
irradiation using Irgacure 2959 (I2959, 0.05 wt%) as radical initiator. To investigate the 
effects of DM, crosslinking time and polymer concentration in the hydrogel formation, the sol-
gel fraction was determined as a qualitative indicator of the methacrylate conversion and 
crosslinking efficiency. Gel fraction curves showed that the sol-gel conversion depends on 
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both DM and UV exposure time (Figure 3.2A, B). The gel content increased as the DM 
increases due to the formation of a highly crosslinked gel network, which correlates with both 
lower swelling ratio (Supplementary Figure S3.5) and enhanced resistance to enzymatic 
degradation (Figure 3.2C). Similarly, the minimum UV exposure time required to produce 
stable gel networks also decreased with higher DM. For hydrogels prepared from PECMA 
low, measurable gel fractions (24.3%) were only obtained for crosslinking times higher than 
120 s. However, by simply increasing the DM, the minimum crosslinking time required to 
form stable hydrogels was reduced for 60 s (PECMA medium, 30.0% gel fraction) and 40 s 
(PECMA high, 44.9% gel fraction). For the highest DM, a plateau value for the gel fractions 
determined at 1.5 wt% macromer concentration was obtained after 160 s of irradiation, which 
was set as the photopolymerization time. Although methacrylates are less reactive than other 
alkenes (e.g., acrylates, norbornenes) [25], structurally robust hydrogels were obtained at low 
macromer concentrations under a low-dose of UV irradiation, which is relevant for the 
entrapment of cells and bioactive molecules [26]. An important consideration in the design of 
hydrogels to be used as provisional cellularized matrices for tissue engineering is the ability 
to tailor the viscoelastic properties in order to match the biomechanical requirements of the 
target tissue. To study the effect of macromer concentration on the viscoelastic properties, 
PECMA solutions at different concentrations were photopolymerized (160 s) and the 
hydrogel properties determined. The G' of hydrogels was tailored in a broad range (79.6 ± 
7.7 Pa – 2.6 ± 0.3 kPa) by changing the initial polymer concentration from 1.5 to 2.5 wt% 
(Figure 3.2D). Different combinations of polymer concentration and DM were also tested to 
demonstrate that the hydrogel stiffness could be adjusted using macromers with different 
DM. Swollen hydrogels (1.5 wt%) showed a significant reduction on the G’ due to the 
relaxation of the gel network (Figure 3.2E).  
Photopolymerization reactions are widely used to crosslink hydrogel bioinks as they 
provide unique control over the gelation process both in space and time [6, 27]. To illustrate 
the ability to tailor the viscoelastic properties of hydrogels by varying the UV light exposure 
time, precursor solutions (1.5 wt%) were photopolymerized for different times and the 
viscoelastic properties determined. Increasing the irradiation time resulted in stiffer hydrogels 
due to the formation of more crosslinks between the polymer chains. The G' of hydrogels was 
modulated from values lower than 100 Pa to approximately 1000 Pa, while keeping the 
polymer concentration, photoinitiator content, and UV light intensity constant (Figure 3.2F). 
For PECMA low hydrogels, the stiffness increased from 79.6 ± 7.7 Pa to 254.2 ± 9.9 Pa (3.2-
fold increase) by increasing the crosslinking time from 160 s to 300 s. In the opposite way, 
the stiffness of PECMA medium and PECMA high hydrogels was reduced to 86.2 ± 9.9 Pa 
and 98.8 ± 8.7 Pa by decreasing the UV exposure time to 80 s and 40 s, respectively. In 
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addition to the changes in gel fraction and mechanical properties, alterations in the DM also 
affected the microstructure of hydrogels and the pore distribution as observed by CryoSEM 
analysis (Figure 3.2G). The influence of crosslinking time and polymer concentration in the 
microstructure of hydrogels was also assessed using the macromer with medium DM 
(PECMA medium). Increasing the crosslinking time from 80 to 160 s enhanced the average 
number of pores, while increasing the polymer concentration from 1.5 to 2.5 wt% resulted in 
the formation of a highly crosslinked hydrogel network with a more compact pore structure 
(Supplementary Figure S3.6). 
 
 
Figure 3.2. Modulating the physical and mechanical properties of photocrosslinked PECMA 
hydrogels with different DM. (A) Influence of UV exposure time on the gel fraction of hydrogels (1.5 
wt%). (B) Effect of polymer concentration and UV exposure time on gel fraction of hydrogels. (C) In 
vitro enzymatic degradation profiles of PECMA hydrogels (1.5 wt%, 160 s UV) in the presence of 
pectinase (0.05 mg/mL). (D) Elastic moduli of hydrogels with different polymer concentrations (160 s 
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UV). (E) Elastic moduli of swollen hydrogels (1.5 wt%, 160 s UV) after incubation in PBS at 37 °C. (F) 
Influence of UV exposure time on the elastic moduli of hydrogels (1.5 wt%) tested immediately after 
preparation. (G) Microstructure of hydrogels (1.5 wt%) prepared with different DM observed by 
CryoSEM (scale bars: 50 μm). *P < 0.05; **P < 0.01; ****P < 0.0001. 
3.3.3. Biofunctionalized hydrogels support the viability and spreading of 
embedded dermal fibroblasts 
The clinical success of cell-laden hydrogels depends on the ability to tune their 
physicochemical, mechanical, and biological properties in order to create a cell-instructive 
microenvironment that guides morphogenesis [28, 29]. After demonstrating how to tailor the 
physicochemical and mechanical properties of photocrosslinked hydrogels, PECMA 
macromers were biofunctionalized with a cell-adhesive peptide containing the amino acid 
sequence RGD to promote integrin-mediated cell adhesion and cell-matrix interactions within 
the otherwise inert hydrogel network [30]. Since pectin lacks specific integrin-binding sites in 
the native composition [20], the base-catalysed thiol-Michael addition click reaction was used 
to conjugate the cell-adhesive peptide to the polymer backbone. The conjugation reaction 
was performed by exploring the reactivity between activated carbon double bonds (C=C) of 
methacrylates and a thiolate anion of cysteine amino acid in the peptide sequence (Figure 
3.3A) [31]. This chemistry was chosen because it allows the incorporation of RGD motifs via 
the formation of water-stable thioether bonds, preventing non-specific hydrolysis of the 
peptide-polymer bond [32]. Reaction conditions were optimized to allow a constant density of 
cell-adhesive peptide within the hydrogel (200 µM) in the same range of that found in ECM-
derived biological matrices [33], independently of the final polymer concentration. The ability 
to precisely control the density of cell-adhesive peptide in the hydrogel network constitutes a 
major advantage of pectin compared to other natural polymers (e.g., gelatin, fibrin), allowing 
the design of chemically defined hydrogels. RGD-functionalized macromers could be 
converted into cell-laden chemical hydrogels by photopolymerization, and eventually undergo 
a secondary physical crosslinking reaction through subsequent incubation in culture medium 
containing calcium chloride (CaCl2) (Figure 3.3A). To preserve the intrinsic ionic interaction 
ability of pectin, a methacrylate functionalization strategy targeting the hydroxyl groups 
instead of carboxyl functionalities was selected. This chemical modification procedure left the 
carboxylic acid groups available for ionic crosslinking without altering the anionic character of 
the polymer (Figure 3.3B), which is essential to modulate the viscoelastic and rheological 
properties of PECMA via calcium-mediated ionic crosslinking. To characterize the influence 
of ionic crosslinking on the mechanical properties, photocrosslinked hydrogels (1.5 wt%, 160 
s UV) were incubated in Dulbecco’s Minimum Essential Medium (DMEM) containing CaCl2 
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(1.8 mM) and the G’ recorded by rheological analysis. The G' of dual-crosslinked hydrogels 
(“Dual”) was significantly higher than that of photocrosslinked hydrogels (“Photo”) (Figure 
3.3C). As an example, the G' of PECMA medium hydrogels at 1.5 wt% concentration 
increased from 259.1 ± 11.0 Pa to 3552.0 ± 123.9 Pa, which represents a 13.7-fold increase. 
The G' of these hydrogels was further enhanced to 6667.9 ± 149.7 Pa by increasing the initial 
polymer concentration to 2.5 wt% (Figure 3.3D). To test the effect of calcium concentration 
on the stiffness, chemical PECMA medium hydrogels (1.5 wt%, 160 s UV) were incubated in 
DMEM containing different concentrations of CaCl2 (0, 0.45, 0.90, 1.8 mM) and the G' of 
hydrogels recorded. As shown in Figure 3.3E, the G' was modulated between 259.1 ± 11 
and 3552.0 ± 123.9 Pa, highlighting the versatility of this hydrogel platform in tailoring the 
viscoelastic properties in a relevant physiological range for soft tissue applications. As the 
main aim of this study was to design a single-component bioink for extrusion bioprinting of 
3D constructs for dermal repair, hNDFs were selected as they play a pivotal role in 
cutaneous wound healing by the deposition of several ECM components [2]. To assess the 
cytocompatibility of the hydrogel platform and to decouple the influence of cell-adhesion 
ligand and matrix stiffness, hNDFs were embedded within hydrogels containing RGD at 0 or 
200 µM concentration. Cell-laden PECMA solutions (1.5 wt%) with different DM were 
photocrosslinked for 160 s and incubated in culture medium containing CaCl2 (1.8 mM) to 
obtain a dual-crosslinked gel network. Live/dead staining showed that cells present excellent 
viability after 24 h of entrapment, independently of both DM and RGD concentration 
(Supplementary Figure S3.7). Cells embedded within dual-crosslinked RGD-hydrogels 
photocrosslinked for 160 s exhibited high levels of cell viability and metabolic activity 
throughout 14 days of culture within gels with the lowest DM, while cells within PECMA 
medium and PECMA high hydrogels displayed a strong reduction on the metabolic activity 
and viability at day 3 (Supplementary Figure S3.8). To demonstrate that by reducing the 
initial hydrogel stiffness embedded cells remain metabolically active independently of the 
DM, hNDFs were embedded within RGD-PECMA medium and RGD-PECMA high hydrogels 
photocrosslinked for 80 s and 40 s, respectively. Results showed that by decreasing the UV 
exposure time, and consequently the hydrogel stiffness (PECMA medium: 86.2 ± 9.9 Pa, 
PECMA high: 98.8 ± 8.7 Pa), cells maintained high levels of metabolic activity after 7 days of 
culture (Supplementary Figure S3.9). 
By exploiting the ability to independently tune the cell-adhesive ligand density, 
mechanical properties, and polymer fraction of hydrogels, we next showed how to tailor the 
cell response within the hydrogels. Cells cultured within dual-crosslinked PECMA low 
hydrogels without incorporated cell-binding sites adopted a typical rounded morphology, 
while cells within RGD-PECMA hydrogels showed limited cell spreading with typical F-actin 
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structure and fibronectin detected in the vicinity of the cells (Supplementary Figure S3.10), 
which is attributed to the matrix stiffness and resistance of the hydrogel network to 
deformation. As previously reported, the behaviour of fibroblasts within 3D hydrogels 
depends on the hydrogel stiffness and composition [34, 35]. To demonstrate that this 
hydrogel platform supports cell spreading at low levels of matrix stiffness, cells were 
embedded within RGD-PECMA high hydrogels photopolymerized for 40 s (designated 
“Photo”). Fibroblasts remained metabolically active (Supplementary Figure S3.11) and 
adopted a typical spindle-shaped morphology after 7 days of culture, which was 
accompanied by the deposition of fibronectin (Figure 3.3F). In contrast, when these 
hydrogels underwent secondary ionic crosslinking (designated “Dual”), cell spreading was 
significantly inhibited. These outcomes highlight the versatility offered by this hydrogel 
platform in designing cell-responsive hydrogels capable of inducing distinct cell behaviours. 
 
 
Figure 3.3. Biofunctionalization of PECMA with cell-adhesive peptide and its effect on the 
behaviour of embedded dermal fibroblasts. (A) Illustration of the functionalization scheme for the 
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conjugation of cell-adhesion moieties to methacrylate groups via thiol-Michael addition click chemistry. 
Unreacted methacrylates were subsequently used for the formation of hydrogels by 
photopolymerization, allowing the incorporation of hNDFs within the hydrogel network. Cell-laden 
hydrogels can eventually undergo ionic crosslinking with calcium ions. (B) Zeta potential of pure pectin 
and PECMA with different DM. (C) Effect of ionic gelation (1.8 mM CaCl2) in the stiffness of 
photocrosslinked hydrogels prepared with varying DM (1.5 wt%, 160 s UV). (D) Effect of dual-
crosslinking (1.8 mM CaCl2) on the stiffness of PECMA hydrogels with medium DM prepared with 
different macromer concentrations. (E) Elastic moduli of PECMA medium hydrogels (1.5 wt%, 160 s 
UV) recorded as a function of the CaCl2 concentration. (F) Confocal microscopy images depicting the 
morphology of hNDFs embedded within RGD-PECMA high hydrogels (1.5 wt%, 40 s UV), stained for 
nuclei (blue), F-actin (green) and fibronectin (red, FN) (scale bars: 50 µm). *P < 0.05; ****P < 0.0001. 
3.3.4. Bioprinting cell-laden 3D constructs using a dual-crosslinked, single-
component hydrogel bioink 
Several hydrogels have been proposed to develop bioinks for extrusion bioprinting 
[36]. Despite the progress on novel materials, printing strategies and crosslinking 
chemistries, the bioprinting of a single-component bioink at low polymer concentration is 
challenging due to the difficulty in controlling multiple properties using a single polymer, 
including the rheological behaviour (e.g., viscosity, yield stress, printability), biochemical cues 
(e.g., cell-adhesive moieties), mechanical properties (e.g., elastic modulus) and cell response 
(e.g., ECM deposition). Thus, most of the bioinks employ relatively high macromer 
concentrations (2–10 wt%) to achieve enough viscosity for bioprinting [9, 37-39], often 
resulting in highly crosslinked hydrogel constructs in which cell spreading and migration are 
usually restricted. In this study, we took advantage of the complementary ionic and 
photocrosslinking ability of PECMA to design a cell-responsive, single-component hydrogel 
bioink with optimal rheological properties for extrusion bioprinting (Figure 3.4A). A major 
advantage of the developed bioink is the ability to print 3D constructs at low polymer 
concentration (1.5 wt%) maintaining the shape after deposition without requiring additional 
materials for viscosity modulation and precluding washing steps to leach out sacrificial 
materials. This distinctive feature allows the fabrication of soft and highly porous 
microenvironments, which is relevant for soft tissue engineering applications. In addition, the 
printing process is performed directly onto a receiving substrate without the need for heating 
modules, coaxial nozzles, printing baths or in situ photopolymerization to ensure shape 
fidelity of the printed constructs. The bioprinting strategy of the developed single-component 
pectin bioink is based on a modular approach that combines the calcium-mediated ionic 
gelation to adjust the rheological behaviour prior deposition and the post-printing UV 
photopolymerization to provide shape fixation and tailor the viscoelastic properties of 3D 
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constructs. In the first step, the viscosity of a PECMA low solution (1.5 wt%) dissolved in 
I2959 was precisely tailored by adding different concentrations of CaCl2 (0–5 mM). After 
CaCl2 addition, the bioink was vigorously mixed and reacted under agitation during 1 h for G' 
stabilization (Supplementary Figure S3.12). After this period of time, hNDFs were 
homogeneously suspended within the weakly crosslinked bioink for bioprinting. Rheological 
studies (Figure 3.4B, C) showed that the bioink viscosity increased with the addition of 
higher CaCl2 concentrations due to the formation of a more crosslinked gel phase (Figure 
3.4D). All solutions exhibited a shear-thinning behaviour, characterized by a decrease in the 
viscosity as the shear rate increases, which is fundamental for extrusion bioprinting [40, 41]. 
Ionic crosslinking also resulted in a significant increase of the yield stress, i.e., the minimum 
stress to induce flow in the polymer solution (3mM: 1.18Pa to 5mM: 9.16 Pa). The yield 
stress is a key parameter that governs the printability of bioinks and determines the ability to 
homogeneously mix the cell pellet [42, 43]. Notably, we observed that the addition of CaCl2 
within the tested range of concentrations did not result in the formation of highly crosslinked 
bioinks, which could prevent the flow, injectability and the mixing with a cell pellet flow. To 
qualitatively evaluate the printability, bioinks with varying CaCl2 concentrations were 
manually injected through a metal cylindrical nozzle (23 Gauge) and tested for their ability to 
form a continuous filament. Formulations were considered printable when a continuous 
filament, instead of droplets, is formed at the nozzle. Bioinks containing CaCl2 at 0 and 1 mM 
did not display a clear yield stress, formed droplets at the nozzle (Figure 3.4E) and spread 
onto the receiving substrate, which is not suitable for bioprinting. The bioink with 3 mM CaCl2 
formed an irregular filament at very low mass flow rate with printed filaments becoming 
flattened and unable to support the subsequent layers without fusion and collapse of the 
entire construct (Supplementary Figure S3.13). The bioink with 5 mM CaCl2 formed a 
continuous filament at the nozzle, allowing the bioprinting of stable filaments that support the 
subsequent layers without collapsing (Supplementary Figure S3.13). An additional 
concentration of 7 mM CaCl2 that allows the formation of a printable bioink was also tested to 
determine its influence on the G’ of 3D hydrogels. Increasing the CaCl2 content from 5 mM to 
7 mM enhanced the yield stress point of the bioink and the mechanical properties of 
hydrogels (Supplementary Figure S3.14), which indicates the effect of ionic crosslinking not 
only in the rheological properties, but also in the G’ of constructs. In the second step, the 
bioink (PECMA 1.5 wt%, 5 mM CaCl2) was used for the bioprinting of both acellular solid and 
porous 3D constructs with high structural fidelity that maintain the predesigned shape 
immediately after printing without additional gelation mechanisms (Figure 3.4F). The 
constructs exhibited enough integrity to support printed layers and maintain the shape after 
deposition, allowing for post-printing photopolymerization. Solid square-shaped constructs 
were printed with 15 layers without collapsing, clearly demonstrating the ability of the 
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developed bioink for the printing of thick constructs. Porous constructs were also created to 
demonstrate the printing of more complex structures. To evaluate the ability of the bioink to 
support viable cells, hNDFs were suspended within the ionically crosslinked bioink and 
printed into porous constructs. In the third step, printed cellularized 3D constructs were 
exposed to UV light (160 s) to trigger the formation of chemical bonds between adjacent 
methacrylate groups, providing shape consolidation and long-term stabilization. Cell viability 
was qualitatively evaluated by live/dead assay 24h post-printing, showing that the bioink 
successfully supported the printing of viable cells within the deposited filaments (Figure 
3.4G). These data demonstrated the versatility of using physical and chemical crosslinking 
chemistries to tailor the properties of the hydrogel bioink for extrusion bioprinting, while 
holding the polymer fraction and cell-adhesive ligand density constant. This strategy also 
allows to decouple the contribution of each individual parameter on the bioink performance, 
which is particularly challenging when using a single-component bioink based on natural 
polymers. 
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Figure 3.4. Design, formulation and bioprinting of a single-component PECMA bioink into 3D 
constructs. (A) Schematic illustration of the design and preparation of the biofunctional bioink for 
extrusion bioprinting. In a first stage, CaCl2 was added to the polymer solution to adjust the rheological 
properties and allow the printing of 3D constructs. Then, dermal fibroblasts were suspended within the 
pre-crosslinked bioink and printed into 3D constructs. After printing, the constructs were exposed to 
UV light for consolidation and shape maintenance. (B) Viscosity of bioinks (RGD-PECMA low 1.5 wt%) 
prepared using different CaCl2 concentrations. (C) Yield behaviour of bioinks as a function of CaCl2 
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concentration. (D) Influence of CaCl2 concentration on the flow behaviour of the bioink at room 
temperature. E) Effect of CaCl2 on the filament formation of bioink. (F) Images of bioprinted acellular, 
multilayered 3D constructs: solid construct (8 (L) × 8 (W) × 4.5 (H) mm3) printed with 15 layers and 
porous constructs (17 (L) × 17 (W) × 2.4 (H) mm3). (G) Representative confocal microscopy images of 
live/dead staining of fibroblasts embedded within the cell-laden 3D porous constructs (14 (L) × 14 (W) 
× 0.6 (H) mm3) 24 h postprinting (scale bars: 200 µm). Dash lines and square represent the 
pore/filament interface. 
3.3.5. Bioprinted 3D constructs provide a cell-instructive microenvironment for 
the deposition of endogenous dermal ECM components   
Advanced bioinks must allow not only the printing of viable cells, but also guide cell 
functions towards the formation of functional tissues. Despite the fact that several works have 
reported on bioinks capable of supporting live cells, only a limited number of studies have 
evaluated whether printed cells remain functional after deposition [5, 10, 44]. In this regard, 
the control over key properties of bioprinted constructs is essential to direct cell functions and 
new tissue formation. In order to demonstrate the ability to tailor the properties of bioprinted 
3D constructs, RGD-PECMA low bioinks prepared using different macromer concentrations 
(1.5 or 2.5 wt%, 5 mM CaCl2) were printed and photocrosslinked for 80 s, 160 s or 300 s. As 
observed, the gel fraction of hydrogels increased as a function of both higher macromer 
concentration and photocrosslinking time, varying in a range of 23.5 ± 3.0 % to 30.5 ± 1.5 % 
(1.5 wt%) and 21.2 ± 2.1 % to 40.9 ± 0.8 % (2.5 wt%) (Figure 3.5A). However, an opposite 
behaviour was observed for the swelling ratio (Figure 3.5B), indicating the formation of a 
denser gel network. Acellular hydrogels prepared from 1.5 wt% bioink and photocrosslinked 
for 80 s resulted in a loosely crosslinking gel network that exhibited low structural integrity 
upon incubation in ultrapure water, precluding the determination of gel fraction and swelling 
ratio. However, when these hydrogels were incubated in culture medium (1.8mM CaCl2) the 
3D structure was maintained. The mechanical properties of 3D bioprinted constructs 
determined after incubation in culture medium indicated that the G’ can be modulated 
between 154.7 ± 18.7 Pa and 1210.0 ± 148.5 Pa by changing the macromer concentration 
and the photocrosslinking time (Figure 3.5C). The G’ of dual-crosslinked hydrogels prepared 
from the 1.5 wt% bioink was tailored in a narrow range (154.7 ± 18.7 Pa to 297.0 ± 10.2 Pa) 
by increasing the photocrosslinking time when compared to the 2.5 wt% bioink (465.9 ± 43.4 
Pa to 1210.0 ± 148.5 Pa). The G’ of dual-crosslinked hydrogels obtained by ionic crosslinking 
followed by UV photopolymerization displayed a soft gel network compared to hydrogels 
prepared by UV photopolymerization followed by ionic crosslinking (Figure 3.3C, D). These 
data suggest that upon ionic gelation for viscosity modulation, the dual-crosslinked gel 
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network is less susceptible to later stiffening probably due to the spatial constrains in the 
polymer backbone induced by the crosslinking reactions. To determine the influence of 
matrix stiffness on cell response, hNDFs were loaded within bioinks (1.5 or 2.5 wt%), printed 
into 3D constructs (8 mm × 8 mm, three-layer), and photocrosslinked for different times. At 
day 7, cells displayed spread morphology in both periphery and centre of the 1.5 wt% 
constructs, though cell spreading seems to be favoured in constructs photocrosslinked for 
160 s (229.8 ± 44.0 Pa) and 300 s (297.0 ± 10.2 Pa). In the 2.5 wt% constructs, cells were 
able to spread in hydrogels photocrosslinked for 80 s (465.9 ± 43.4 Pa), while limited cell 
elongation was observed in stiffer gels (160 s: 842.0 ± 97.8 Pa; 300 s: 1210.0 ± 148.5 Pa) 
(Supplementary Figure S3.15). At day 14, extensive cell spreading was detected 
throughout the 1.5 wt% constructs regardless the matrix stiffness, while in the 2.5 wt% 
constructs photocrosslinked for 80 s cell elongation was slightly limited, especially in the 
centre of the hydrogels. Physical constrains imposed by stiffer 2.5 wt% constructs (160 s and 
300 s) significantly limited cell spreading and cell-cell interactions with the majority of 
entrapped cells displaying a round morphology (Figure 3.5D). Accordingly, these results 
indicate that the matrix stiffness plays a major role on the cell behaviour with stiffer networks 
severely restricting normal cell functions such as spreading and the establishment of cell-cell 
interactions.  
Based on these data, both the 1.5 wt% bioink formulation and photocrosslinking time 
of 160 s, which support normal cell behaviour, were selected to deeply evaluate the cell 
response and deposition of new ECM components within the 3D constructs. After 14 days of 
culture, printed constructs exhibited good structural integrity, while embedded cells remained 
viable and metabolically active as qualitatively observed by live/dead assay (Figure 3.5Ei) 
and quantitatively determined by the resazurin-based assay (Supplementary Figure S3.16). 
To confirm that cell behaviour was unaffected by the bioprinting process, the cell-laden bioink 
was casted, showing similar cell-spreading compared to printed constructs (Supplementary 
Figure S3.17). Contrary to other gel-phase bioink formulations, in which cells are incubated 
within the bioink for long periods of time (2 h) until achieving a printable consistency [45], in 
our approach cells are directly mixed within the printable bioink immediately before 
bioprinting. This prevents cell settling issues and significantly reduces the time frame 
between cell suspension and bioprinting, potentially increasing the cell viability. More than 
satisfying printability and cytocompatibility requirements, novel bioink formulations should be 
capable of instructing the embedded cells to perform their functions within the construct, 
which is essential for clinical translation of bioprinted tissue constructs. In this context, we 
investigated the ability of the PECMA bioink to induce cell spreading and instruct embedded 
cells to produce new ECM. Printed cells, initially homogenously dispersed within the 3D 
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construct, assumed a spread, spindle-shaped morphology throughout the hydrogel (Figure 
3.5Eii) and formed interconnected multicellular networks embedded by a fibronectin-rich 
network (Figure 3.5Eiii). Fibronectin is an ubiquitous fibrous ECM protein in skin, playing a 
key role in several essential processes such as wound healing, embryogenesis, cell 
adhesion and migration. Moreover, it has been shown that fibronectin may be required for 
subsequent deposition and maintenance of other ECM proteins, including collagen type-I [46, 
47]. Detailed analysis concerning the spatial distribution of both embedded cells and 
fibronectin network confirmed that extensive cell spreading and fibronectin deposition were 
not limited to the periphery of printed constructs and could be detected within the bulk 
hydrogel. The magnified high-resolution confocal reconstruction images of the 3D construct 
clearly revealed the ability of the bioink to induce characteristic cytoskeleton organization and 
to support the deposition of a dense, fibrillar ECM fibronectin matrix surrounding the 
embedded cells, forming an extensive mesh of elongated branching fibrils (Figure 3.5Eiv). 
As dermal fibroblasts are intimately associated to the ECM synthesis and remodelling [2], the 
ability of printed cells to secret and deposit other prominent ECM proteins was further 
evaluated by the immunodetection of collagen type-I and laminin. Collagen is the most 
abundant fibrous protein in the skin, performing multiple functions such as providing tensile 
strength and regulating cell-adhesion, while laminin influences many aspects of cell 
behaviour, including adhesion, differentiation, migration and resistance to apoptosis.[48, 49] 
After 14 days of culture, printed constructs showed the presence of cell-secreted collagen 
type-I located in both intracellular and extracellular spaces (Figure 3.5Ev). At this time point, 
an extracellular network of laminin was also detected (Figure 3.5Evi), revealing the ability of 
dermal fibroblasts to secrete a variety of endogenous ECM proteins within the printed 
constructs. In addition to the deposition of pivotal fibrous ECM proteins present in the dermis, 
proliferative cells were also detected at day 14 of culture through immunodetection of Ki67 
proliferation marker (Supplementary Figure S3.18). These data showed that printed 
constructs provide an adequate microenvironment capable of guiding hNDFs to secret new 
ECM, which indicates the potential of the developed bioink for bioprinting of bioengineered 
dermal substitutes and full-thickness skin. 
Advanced bioinks and bioprinting technologies allow the generation of biomimetic 3D 
skin constructs with controlled positioning of multiple cells, mimicking multiple layers found in 
native tissue, which is extremely difficult to obtain by using conventional fabrication methods 
and traditional hydrogels. A major challenge to create functional skin and dermal constructs 
containing a vascular network, nerves and appendages relies on the control over the 
positioning of multiple cells in 3D [3]. This is essential to promote specific cell-cell and cell-
ECM interactions that could potentially lead to the development of those specialized 
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structures. As both cell-cell and cell-ECM interactions depend not only on the cell location 
and construct dimensionality, but also on the biophysical and biochemical properties of the 
surrounding microenvironment [50, 51], bioinks with controllable and tuneable properties are 
essential to tackle these challenges and generate biomimetic skin constructs. As the 
developed pectin bioink allows the bioprinting of 3D constructs with user-defined biochemical 
and mechanical properties supporting de novo deposition of ECM components, it constitutes 
an alternative bioink to existing protein-based bioinks with distinctive features. Bioprinting, 
using suitable bioinks provides unique advantages compared to non-additive fabrication and 
traditional hydrogels [7], including the generation of large volumes of patient-specific 3D 
constructs with high reproducibility and the automatic dispensing of bioinks in prescribed 
sites to promote skin formation in vitro and in vivo. Bioprinting also allows the fabrication of 
dermal constructs with heterogeneous cellular composition and properties throughout the 
construct, which is essential for the generation of cell-laden substitutes for skin repair and in 
vitro skin models with improved biomimicry [52]. 
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Figure 3.5. Tailoring the physical, mechanical and biological properties of bioprinted 3D 
constructs. (A-C) Influence of polymer fraction and UV photopolymerization time in the gel fraction, 
swelling ratio and elastic modulus of hydrogels (# indicates poor structural integrity of the hydrogel). 
(D) Effect of matrix stiffness on the morphology and spreading of dermal fibroblasts within bioprinted 
3D constructs after 14 days of culture (scale bar: 100 µm). (E) Representative confocal microscopy 
images showing the performance of bioprinted 3D dermal constructs at day 14 of culture: (i) live/dead 
staining of dermal fibroblasts within the construct; (ii) F-actin (green) and DAPI (blue) staining showing 
the spread morphology of fibroblasts; (iii) morphology and spatial distribution of fibroblasts surrounded 
by a fibronectin (red, FN) network; (iv-vi) expression of fibronectin (red, FN), collagen type-I (Coll I, 
red) and laminin (green) throughout the bioprinted constructs (scale bars: (i) 200  µm; (ii-vi) 50 µm). 
 
CHAPTER III 
 
 
 131 
3.4. Conclusions 
In summary, a biofunctional, single-component pectin bioink exhibiting cell-responsive 
properties and capable of instructing printed dermal fibroblasts to secret new ECM was 
developed for the extrusion bioprinting of dermal 3D constructs. The hydrogel bioink is highly 
versatility, allowing a fine tuning of the rheological and viscoelastic properties independently 
of the cell-adhesive ligand density. Remarkably, the rheological properties of the bioink at a 
low polymer concentration were tailored by exploring the ionic crosslinking without 
compromising both homogeneous cell dispersion and cell viability post-printing. The bioink 
also allowed for UV photopolymerization after printing, providing construct consolidation and 
long-term stabilization. A distinctive characteristic of the bioink relies on its ability to instruct 
printed cells to secrete an endogenous ECM distributed throughout the construct in response 
to the microenvironment provided by the gel network. Printed cells were able to transform a 
provisional matrix lacking of ECM proteins into a collagen- and fibronectin-rich network, 
resembling the native dermal tissue. In future studies we envisage that the bioink could be 
used in combination with other skin cells and eventually biofunctionalized with additional 
relevant ligands. In addition, as fibroblasts are the major cells responsible for the production 
of ECM components, the bioink is not limited to skin bioprinting and can be explored to 
generate other tissues. Besides the development of 3D constructs for tissue repair, this 
tuneable bioink can be explored for several applications, ranging from the printing of complex 
3D models for pharmaceutical testing in diagnostic studies, such as in organs-on-chip, or for 
studying tissue morphogenesis in fundamental biological studies. 
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3.7. Supplementary Information 
 
 
Figure S3.1. 1H NMR spectra of purified pectin and pectin methacrylate (PECMA) with different 
degrees of methacrylation. New peaks corresponding to methyl (–CH3) and methylene (–CH2) groups 
are absent in the spectra of pure pectin, but present in the backbone of macromers modified with 
methacrylic anhydride. 
 
 
Figure S3.2. Representative 1H NMR spectrum of PECMA, detailing the peaks corresponding to 
native protons of pectin and new methacrylate function. The identification of native peaks in pectin 
structure was performed based on published data [1]. The degree of methacrylation (DM) was defined 
as the ratio of methyl (–CH3) and methylene (–CH2) groups of methacrylate function introduced in the 
polymer backbone to the pectin protons located in position 3 (H3) and 4 (H4). This value was 
calculated by the integration of peaks at 1.89 ppm (CH3), 6.16 ppm (CH2), 5.72 ppm (CH2), 4.00 ppm 
(H3), and 4.42 ppm (H4). 
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Figure S3.3. Macroscopic images of PECMA solutions in D2O after chemical modification with 
different MA/OH molar ratios. For the ratios 2.5, 10 and 15, the solutions prepared showed complete 
dissolution, while using higher ratios it was possible to observe poor solubilization and polymer 
precipitation. 
 
 
Figure S3.4. Effect of soluble PECMA macromer solutions prepared with varying degrees of 
methacrylation and polymer concentration on the metabolic activity of fibroblasts. Macromer solutions 
were dissolved in culture media at different concentrations and incubated with adherent fibroblasts 
cultured in monolayer for 24 h (*P < 0.05; ***P < 0.001). 
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Figure S3.5. Swelling ratio of PECMA hydrogels with varying degrees of methacrylation tested at 1.5 
and 2.5 wt% concentrations. Hydrogels were photocrosslinked by exposure to UV light for 160 s and 
then incubated in ultrapure water at 37 ºC for 24 h (**P < 0.01).   
 
Figure S3.6. Influence of crosslinking time and macromer concentration on the microstructure of 
PECMA medium hydrogels visualized by CryoSEM analysis. 
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Figure S3.7. Effect of tethered RGD-peptide on the viability of fibroblasts entrapped within dual-
crosslinked PECMA hydrogels (1.5 wt%, 160 s UV) after 24 h. CyTRAK OrangeTM is colored in green 
(live cells) and DRAQ7TM is colored in red (dead cells). Scale bar is 100 μm.  
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Figure S3.8. (A) Live/Dead staining confocal images of fibroblasts entrapped within RGD-
functionalized, dual-crosslinked PECMA hydrogels (1.5 wt%, 160 s UV) with varying degrees of 
methacrylation throughout 7 days of culture. CyTRAK OrangeTM is colored in green (live cells) and 
DRAQ7TM is colored in red (dead cells). Scale bars are 100 μm. (B) Metabolic activity of fibroblasts 
within the dual-crosslinked hydrogels (#represents residual levels of metabolic activity; RFU indicates 
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Random Fluorescence Units). Fibroblasts entrapped within PECMA low hydrogels remained 
metabolically active throughout 14 days of culture, while cells cultured within stiffer PECMA medium 
and PECMA high hydrogels displayed a significant reduction on the metabolic activity at day 3.    
 
Figure S3.9. Metabolic activity of fibroblasts embedded within RGD-functionalized PECMA medium 
(A) and PECMA high (B) hydrogels (1.5 wt%) photocrosslinked for 80 s and 40 s, respectively. Both 
formulations were also photocrosslinked for 160 s for comparison. Chemical hydrogels were incubated 
in culture media containing calcium chloride (1.8 mM), yielding a dual crosslinked hydrogel 
(designated as “Dual”). Cell-laden hydrogels were also incubated in culture media without calcium 
chloride (designated as “Photo”). (# indicates residual levels of metabolic activity; (*P < 0.05; **P < 
0.01; ***P < 0.001). 
 
Figure S3.10. Morphology and spatial distribution of fibroblasts embedded within dual-crosslinked 
PECMA low hydrogels, with or without (BLK) tethered RGD-peptide, after 14 days of culture showing 
DNA (blue), F-actin (green) and fibronectin (red). Scale bars represent 50 µm on the top images and 
10 µm on the bottom images with higher magnification. 
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Figure S3.11. Metabolic activity of hNDFs embedded within photo- or dual-crosslinked RGD-PECMA 
high hydrogels (1.5 wt%, 40 s UV) for 7 days. *P < 0.05; ***P < 0.001. 
 
Figure S3.12. Gelation profile of PECMA low bioink at 1.5 wt% with 5 mM CaCl2. Gelation occurred 
within 1 h upon the addition of CaCl2. The elastic (G') and viscous (G'') modulus increased after the 
addition of CaCl2 and remained stable after 1 h of reaction.  
 
 
Figure S3.13. The effect of CaCl2 concentration on the shape fidelity printed 3D constructs using 
PECMA low macromer solutions (1.5 wt%). Images of constructs (8 (L) × 8 (W) mm2) printed with 
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bioink solutions containing either 3 or 5 mM CaCl2 (scale bar: 4 mm). Hollow tube construct (10 mm Ø, 
10 layers) printed with the bioink solution containing 5 mM CaCl2 (scale bar: 5 mm).   
 
 
Figure S3.14. Effect of CaCl2 concentration (5 mM and 7 mM) on the rheological and mechanical 
properties of printable bioinks prepared at 1.5 wt%: (A) viscosity, (B) yield stress curves, and (C) 
elastic modulus of 3D hydrogel constructs (1.5 wt%, 160 s UV) determined upon 24h of incubation in 
culture medium. Yield stress (5 mM: 9.16 Pa; 7 mM: 10.92 Pa) and elastic modulus (5 mM: 256.2 ± 
23.8 Pa; 7 mM: 398 ± 49.6 Pa) increase as a function of CaCl2 concentration. ****P < 0.0001. 
 
 
Figure S3.15. Effect of bioink concentration and UV photocrosslinking time on the morphology of 
dermal fibroblasts within bioprinted 3D constructs at day 7 of culture (scale bar: 100 µm). 
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Figure S3.16. Photograph of printed the 3D construct (8 (L) × 8 (W) × 0.9 (H) mm3) at day 14 of 
culture and metabolic activity of dermal fibroblasts embedded within the printed construct throughout 
the culture period (n = 1, two independent experiments). 
 
 
Figure S3.17. Morphology of embedded fibroblasts and fibronectin network within manually deposited 
hydrogels, stained for nuclei (blue), F-actin (green) and fibronectin (red). Scale bars represent 50 µm. 
 
Figure S3.18. Confocal microscopy images showing the presence of proliferative fibroblasts (Ki67 
positive, green) within the printed 3D constructs. The boxes mark the magnified areas in the panels on 
CHAPTER III 
 
 
 145 
the right stained for nuclei (blue) and Ki67 (green). Scale bars represent 50 µm for the left image and 
10 µm for magnified images. 
 
Table S3.1. Primary and secondary antibodies used for detection of cell morphology, proliferation and 
ECM protein deposition.  
Target Primary antibody Dilution 
Supplier and 
reference 
number 
Secondary 
antibody Dilution 
Supplier 
and 
reference 
number 
Fibronectin 
Rabbit anti-
fibronectin 
1:400 Sigma-Aldrich 
f3648 
Alexa Fluor 
594 goat 
anti-rabbit 
1:1000 Invitrogen 
A11072 
Collagen-I 
Rabbit anti-
collagen 
type-I 
1:200 
Rockland 
600-401-103-
0.1 
Alexa Fluor 
594 goat 
anti-rabbit 
1:500 Invitrogen 
A11072 
Laminin 
Rabbit anti-
laminin 
1:100 Sigma-Aldrich 
L9393 
Alexa Fluor 
594 goat 
anti-rabbit 
1:500 Invitrogen 
A11072 
Proliferation 
Rabbit anti-
Ki67 
1:200 Abcam 
ab15580 
Alexa Fluor 
647 donkey 
anti-rabbit 
IgG 
1:500 Invitrogen 
A31573 
Keratinocytes 
Rabbit anti-
cytokeratin 
 
1:100 Dako 
Z0622 
Alexa Fluor 
488 donkey 
anti-rabbit 
1:1000 Invitrogen 
A21206 
Fibroblasts Mouse anti-
vimentin 
1:100 Santa-Cruz Biotechnology 
sc-6260 
Alexa Fluor 
488 donkey 
anti-mouse 
1:1000 Invitrogen 
A21202 
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Abstract 
Cell-instructive hydrogels are attractive for skin repair and regeneration, serving as 
interactive matrices to promote cell adhesion, cell-driven remodelling and de novo deposition 
of extracellular matrix components. This paper describes the synthesis and photocrosslinking 
of cell-instructive pectin hydrogels using cell-degradable peptide crosslinkers and integrin-
specific adhesive ligands. Protease-degradable hydrogels obtained by photoinitiated thiol-
norbornene click chemistry are rapidly formed in the presence of dermal fibroblasts, exhibit 
tuneable properties and are capable of modulating the behaviour of embedded cells, 
including the cell spreading, hydrogel contraction and secretion of matrix metalloproteinases. 
Keratinocytes seeded on top of fibroblast-loaded hydrogels are able to adhere and form a 
compact and dense layer of epidermis, mimicking the architecture of the native skin. Thiol-
ene photocrosslinkable pectin hydrogels support the in vitro formation of full-thickness skin 
and are thus a highly promising platform for skin tissue engineering applications, including 
wound healing and in vitro testing models. 
 
Keywords: dermal fibroblasts; hydrogel; pectin; photocrosslinking; skin; thiol-norbornene 
chemistry. 
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4.1. Introduction 
Skin wound healing is a complex, orchestrated cascade of biological processes that 
rely on the interaction between several mediators, such as extracellular matrix (ECM) 
molecules, cells, growth factors, cytokines and chemokines, towards the replacement of lost 
tissue [1]. Despite the variety of commercially available products and therapeutic strategies 
for skin wound healing (e.g., skin substitutes, wound dressings), the formation of functional 
skin remains a major challenge [1-3]. Hydrogels are widely explored as templates for skin 
wound healing due to their chemical versatility, hydrated nature, elasticity and ability to 
conform into complex-shaped defects. In addition, hydrogels can be designed to provide 
instructive environments for tissue formation as well as to deliver cells and growth factors in 
order to stimulate skin regeneration [4-6]. Cell-instructive hydrogels play a pivotal role in 
tissue engineering due to their biochemical and biophysical similarities with the native ECM, 
along with the ability to influence the behaviour of embedded cells [7, 8]. Synthetic materials 
have been widely explored to design such bioactive hydrogels as they provide greater control 
over the chemical composition and materials properties [9, 10]. However, materials derived 
from natural sources possess unique features (e.g., cell remodelling, biological recognition, 
biodegradation) that also make them suitable candidates to engineer ECM analogues [11, 
12].  
Pectin, a structural polysaccharide extracted from the primary cell wall of plants, is 
receiving increased attention for tissue engineering due to its water solubility, 
biocompatibility, biodegradability and anionic nature [13-15]. It is a branched polymer 
composed of multiple polysaccharide domains, providing a multitude of target sites for 
chemical modification. In addition, physical pectin hydrogels are susceptible to in vitro and in 
vivo degradation/dissolution [16, 17], which is useful for tissue engineering applications. A 
distinctive characteristic of pectin compared to other bioactive natural polymers (e.g., gelatin, 
fibrin) relies on the lack of endogenous cell-adhesive and cell-proteolytic sites. This feature 
allows for the precise introduction of specific biochemical moieties onto the otherwise bioinert 
polymer backbone [16] in order to control cell fate and to decouple their effect on cell 
behaviour.   
The selection of suitable chemistries is of critical importance for the formation of 
cellularized ECM-inspired polymer hydrogels under cytocompatible conditions, without 
yielding toxic byproducts. Bio-orthogonal click chemistries assume a central role on the 
modular synthesis of advanced cell-laden hydrogels, as they can develop under mild 
conditions in the presence of cells, proceed with high yield and be easily controlled by 
selecting complementary chemical functionalities [18, 19]. Photoinitiated thiol-norbornene 
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chemistry is a click reaction between multifunctional norbornene-modified macromers and 
sulfhydryl-containing linkers (e.g., dithiothreitol, biscysteine peptides), triggered by UV or 
visible light in the presence of a low photoinitiator concentration [10]. In contrast to chain-
growth hydrogels formed by radical-mediated polymerization, which often contain 
heterogeneous and high molecular weight crosslinks, light-mediated thiol-norbornene 
polymerization is non-oxygen inhibited and proceeds through a step-growth mechanism. 
Hydrogels formed by thiol-norbornene chemistry contain networks with less heterogeneities 
and lead to the formation of engineered tissues with improved overall quality [20, 21]. 
Furthermore, in thiol-norbornene reactions there is no homopolymerization or chain growth 
between strained norbornene groups and the gelation is much faster [22]. Norbornene end 
groups are widely used in the modification of both natural (e.g., hyaluronic acid, alginate) and 
synthetic (e.g., polyethylene glycol) polymers owing their fast reactivity and cytocompatibility. 
Norbornene-functionalized polymers can be rapidly converted into cell-laden hydrogels under 
physiologically relevant conditions and the crosslinking reaction did not affect the cell viability 
[10, 23, 24]. As the norbornene moieties are only reactive in the presence of active radical 
species, hydrogels bearing free norbornene groups can be explored to dynamically modulate 
the material properties and/or cell fate after hydrogel formation without cytotoxic effects for 
the embedded cells [25]. 
Recently, we reported on the development of photocrosslinkable methacrylate-
modified pectin for the bioprinting of cell-responsive tissue constructs for skin applications 
[26]. Although bioprinted RGD-functionalized pectin hydrogels support the spreading of 
embedded dermal fibroblasts and de novo deposition of endogenously synthesized ECM, 
cell-mediated hydrogel remodelling is limited by the lack of protease degradable sites. This 
study describes for the first time the synthesis of norbornene-functionalized pectin (NorPEC) 
macromers for thiol-ene photopolymerization reactions. Macromers are rapidly converted into 
cell-instructive hydrogels through one-pot, photo-click reaction with a monocysteine RGD 
integrin binding peptide and a biscysteine matrix-metalloproteinase (MMP)-cleavable peptide 
as crosslinker. These new polymer-peptide conjugates are rapidly prepared in the presence 
of cells through an efficient thiol-norbornene reaction, providing sites for cell attachment and 
cellular-driven remodelling of the hydrogel network. This photo-click reaction also affords 
spatiotemporal control over the hydrogel formation and allows easy manipulation of 
biophysical and biochemical cues presented to the embedded cells. The proposed novel 
pectin hydrogel system allows the one-step formation of chemically defined cell-laden 
hydrogels capable of supporting the in vitro formation of full-thickness skin.  
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4.2. Materials and Methods 
4.2.1. Synthesis of norbornene functionalized pectin 
The norbornene-functionalized pectin (NorPEC) was synthetized through the reaction 
with carbic anhydride (CA, Acros Organics) in dimethyl sulfoxide (DMSO). Prior to synthesis, 
low methoxyl citrus pectin (Classic CU701, 86 % galacturonic acid unit content and 37 % 
degree of methylation, Herbstreith & Fox, Neuenbürg, Germany) was purified [16] and 
converted into tetrabutylammonium salt (PEC-TBA) for solubilization in organic solvents. 
Pectin was dissolved in ultrapure water at 1 wt%, the Dowex 50W proton exchange resin 
(Acros Organics) was added to the solution (3.5 g resin per 1 g polymer) and allowed to 
exchange under vigorous agitation for 3 h. The solution was centrifuged to remove the resin, 
filtered (0.20 µm) and neutralized to pH 6.50 with tetrabutylammonium (TBA, Sigma-Aldrich). 
The solution was subsequently frozen, lyophilized and stored at -20 °C. For the synthesis of 
NorPEC, PEC-TBA was dissolved in anhydrous DMSO at 1 wt% and CA added at 1-fold 
molar excess to hydroxyl groups in the polymer backbone. The solution reacted under 
vigorous agitation and inert (N2) atmosphere at room temperature for 1 h. After this, the 
solution was immediately transferred to dialysis (MWCO 3500, Spectra/Por®, SpectrumLabs) 
with sodium chloride for 3 days, followed by purification with deionized water for additional 2 
days. Then, the solution was treated with activated charcoal (1 g charcoal per 1 g of polymer, 
Sigma-Aldrich) for 1 h, centrifuged (60 000 rcf, Beckman Avanti J-26XP) and filtered (0.20 
µm). Finally, the pH was adjusted to 7.00 with sodium hydroxide (0.1M), the solution frozen 
and the polymer recovered by lyophilization. The product was dissolved in deuterated water 
(D2O, Euriso-top) containing 3-(trimethylsilyl)propionic-2,2,3,3-d4 acid sodium salt (TSP-d4, 
Euriso-top) as internal standard (δ = 0 ppm) and analyzed by 1H NMR using a 400 MHz 
spectrometer AVANCE III (Bruker). 
4.2.2. Formation and characterization of photocrosslinked hydrogels 
For the fabrication of hydrogels, NorPEC macromer (2.5 wt%) was dissolved in 0.9% 
NaCl containing the photoinitiator VA-086 (0.25 wt%, Wako Chemicals), the peptide 
crosslinker CGPQG↓IWGQC (4–6 mM, arrow indicates enzymatically cleavable site, 
Genscript) and the cell-adhesive peptide ligand CGGGGRGDSP (0–2 mM, underline 
indicates cell-adhesion motif, Genscript) at desired concentrations. After dissolution, the 
solution was pipetted on the top of a glass slide treated with SigmaCote (Sigma-Aldrich) to 
prevent attachment of the gel, covered by a treated glass side with 500 µm spacers and 
polymerized under UV light (365 nm, RoHS) at 7 mW/cm2 for 20s.  
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To characterize the shear modulus, hydrogels were soaked in PBS at 37 °C for 24 h 
and the samples (Ø = 4 mm) tested in a humidified environment at physiological temperature 
(37 °C) using a strain-controlled Kinexus Pro rheometer (Malvern). Both frequency sweeps 
(0.01 to 10 Hz at 1% strain) and strain sweeps (0.1 to 100% at 0.1 Hz) were performed on 
swollen samples (30 % compression) to ensure that all measurements were representative of 
the linear viscoelastic regime. 
The swelling ratio was determined by soaking freeze-dried hydrogel samples in PBS 
(0.5 mL) at 37 °C for 24 h. Hydrogel samples were collected, the superficial excess of water 
was gently removed with a tissue paper, and the swollen weight (WS) determined. Swelling 
ratio (q) was determined by dividing the weight of hydrated hydrogel (WS) by its initial dry 
weight (WD). 
The degradation of MMP-degradable NorPEC hydrogels was evaluated in the 
presence of Type II Collagenase (385 U/mg, Worthington Biochemical). Immediately after 
photopolymerization hydrogels were frozen and lyophilized to determine the initial weight 
(WI). Dry samples were hydrated overnight in HBSS at 37 °C, followed by incubation in 0.5 
mL HBSS containing Type II Collagenase at 2 U/mL, which corresponds to the collagenase 
concentration during the initial phase of the wound healing process [27]. At specific time 
periods, samples were removed from the solution, washed with ultrapure water, frozen and 
lyophilized to determine the final weight (WF) after degradation. The degradation was 
expressed in percentage of the weight loss compared to the initial dry mass and determined 
using the following equation: 
 (1) 
To determine the amount of non-bound RGD peptide during photopolymerization, 
hydrogels were incubated in 0.5 mL PBS at 37 °C for 24 h and the supernatant collected. 
The amount of released peptide in PBS was quantified by reversed phase chromatography 
(Merck-Hitachi HPLC) equipped with a detector at 220nm. Samples were run at 1 mL/min on 
a LiChroCART 250-4 C18 column, eluting with 0.065/0.05% trifluoroacetic acid in 
water/acetonitrile, respectively. The calibration curve for peptide quantification was obtained 
using the peptide dissolved in PBS at different concentrations (0–2 mM).  
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4.2.3. 3D cell embedding within hydrogels, cell viability and morphology 
analysis 
Human neonatal dermal fibroblasts (hNDFs) isolated from human neonatal foreskin 
samples (Coriell Institute for Medical Research, USA) were cultured in DMEM supplemented 
with 10% fetal bovine serum (FBS, Gibco), antibiotics (100 U/mL penicillin and 100 μg/mL 
streptomycin, Sigma-Aldrich) and amphotericin B (2.5 mg/L, Sigma-Aldrich). Cells were 
cultured in 5% CO2 at 37 °C in tissue culture polystyrene flasks. To characterize the 
behaviour of hNDFs within MMP-degradable NorPEC hydrogels, cells (passage 6 to 9) were 
trypsinized before reaching confluence (70–80%) using 0.05 wt% trypsin/ethylenediamine 
tetraacetic acid (EDTA) solution (Sigma-Aldrich) and centrifuged at 1200 rpm for 5 min. The 
cell pellet was suspended and added to the NorPEC gel precursor solution at a final density 
of 1×107 cells/mL.  Cellular gel precursor solution (20 μL) was pipetted between SigmaCote-
treated glass slides and cell-laden hydrogels obtained by UV photopolymerization. At 
predetermined time periods (day 1, 7 and 14), cell-laden hydrogels were collected and 
characterized for their metabolic activity, cell viability and cell morphology. 
Metabolic activity of cells embedded with NorPEC hydrogels was assessed by the 
resazurin assay. Hydrogels were incubated in DMEM medium containing 20 v/v% resazurin 
sodium salt (Sigma-Aldrich) for 2 h at 37 °C. Samples were measured using a microplate 
reader (Synergy MX, Biotek) at 530 nm (excitation) and 590 nm (emission). 
Cell viability was measured using the Live/Dead cytotoxicity kit (Life Technologies) 
according to the manufacturer instructions. Briefly, cell-laden hydrogels were incubated in 
phenol red-free DMEM media (Life Technologies) containing 1 µM calcein and 4 µM ethidium 
homodimer for 30 min. Cell-laden hydrogels were imaged on a laser scanning microscope 
(CLSM, Leica TCS-SP5 AOBS, Leica Microsystems).  
The morphology of cells within NorPEC hydrogels was observed by 
immunofluorescence staining for F-actin and nuclei. Cell-laden hydrogels were fixed in 4 
v/v% paraformaldehyde (PFA, Electron Microscopy Sciences) in HBSS (Life Technologies) 
for 20 min, followed by extensive washing with HBSS. Samples were incubated overnight 
with phalloidin/Alexa Fluor® 488 (1:40, Molecular Probes-Invitrogen) for F-actin staining, 
followed by incubation with Hoechst (Life Technologies) for nuclei staining for 45 min. Then, 
samples were extensively rinsed and imaged on a laser scanning microscope (CLSM, Leica 
TCS-SP5 AOBS, Leica Microsystems).  
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4.2.4. Matrix metalloproteinases secretion by gelatin zymography 
To determine the expression of MMP-2 and MMP-9 from fibroblasts embedded within 
hydrogels of different stiffness, cell culture supernatants were collected at different time 
periods (day 1 and 3) and the levels compared to culture media in the absence of cell-laden 
hydrogels. After collection, conditioned media was centrifuged to remove cell debris and the 
total protein content in lysates of cells recovered from the hydrogels quantified by the DC 
protein assay (BioRad). Sample volumes were adjusted to yield equivalent total cell protein 
contents, loaded into gelatin-SDS polyacrylamide gels, and run in 1× Tris-Glycine SDS 
running buffer at 80 V (Mini Protean Tetra Cell system, BioRad). Following electrophoresis, 
gels were washed in 2% Triton X-100 to remove the SDS and incubated with MMP substrate 
buffer for 16 h at 37 °C. Then, gels were washed and stained with Coomassie Brilliant Blue 
R-250 (Sigma Aldrich). The activity of MMPs was visualized by clear bands in the stained 
gels and compared to molecular weight and standards. The gel was washed with distilled 
water, scanned using the GS-800 Calibrated Densiometer (Bio-Rad), and the activity of 
MMPs estimated by densitometric analysis (Quantity One, Bio-rad). 
4.2.5. Formation of full-thickness skin using cell-instructive pectin hydrogels 
The skin equivalent was constructed by the photopolymerization of MMP-degradable 
NorPEC gel precursor solution loaded with fibroblasts (1×107 cells/mL), as previously 
described. Cell-laden hydrogels were cultured submerged for 7 days. After this time period, 
cell line keratinocytes (HaCaT) were seeded onto the fibroblast-loaded hydrogel (5×105 
cells/cm2), left to attach for 2 h and cultured submerged for 7 days. Then, the constructs were 
cultured at the air-liquid interface (ALI culture) for either 14 days or 28 days [28]. Culture 
medium was changed every two days in submerged culture and daily in ALI culture.  
4.2.6. Histological and immunofluorescence analysis 
Skin equivalents were rinsed with HBSS, fixed in 4 v/v% paraformaldehyde in HBSS 
for 30 min and extensively washed. Then, samples were embedded in paraffin, sectioned 
onto 6 μm slides and representative sections were stained for Hematoxylin and eosin (H&E) 
and Masson’s Trichrome using routine protocols. The sections were mounted on coverslips 
and observed with an optical microscope. For immunofluorescence analysis, deparaffinized 
sections were subjected to heat-induced antigen retrieval, permeabilized with 0.25% Triton 
X-100 (Sigma-Aldrich) in PBS and rinsed with PBS, followed by blocking and overnight 
incubation with primary antibodies at 4 °C (Table S1). Then, sections were rinsed and 
incubated with secondary antibodies for 1 h at room temperature, following extensive 
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washing. After mounting, the sections were observed in a microscope (AxioImager Z1, Carl 
Zeiss). Negative controls were performed by replacing the primary antibody with blocking 
buffer. 
4.2.7. Statistical analysis 
Statistical analyses were performed in the GraphPad Prism 7.0 software. All 
experimental data are reported as the mean ± standard deviation (SD) of at least three 
individual samples. Unless stated, the non-parametric Mann–Whitney test was applied with 
95% confidence interval and statistically significant differences marked with p < 0.05 (*), p < 
0.01 (**), p < 0.001 (***) and p < 0.0001 (****). 
4.3. Results and Discussion 
4.3.1. Synthesis of norbornene-functionalized pectin macromers for thiol-ene 
photopolymerization 
In thiol-ene photopolymerization, the reaction kinetics, the extent of conversion and 
the structure of the polymer network are determined by the reactivity between thiols and 
carbon–carbon double bonds (referred to as alkenes), which in turn depends on both the 
reactivity in thiol–alkene reactions and the alkene chemical structure [29]. Among the variety 
of alkene functional groups capable of reacting with thiols, it is well-stablished that strained 
(norbornene) and electron-rich alkenes (e.g., vinyl ether) react faster than electron-poor 
alkenes [30]. Specifically, the strained norbornene functional group has received increased 
attention for thiol-ene reactions as it follows exclusively step-growth mechanism and displays 
extremely high reactivity, which can be explained by the relief of ring strain after thiyl radical 
addition, absence of abstractable hydrogens and stereoelectronic effects [29, 31]. In this 
work, pectin was functionalized with norbornene functional groups for the fabrication of cell-
laden hydrogels through thiol-ene click reaction in the presence of a low concentration type I 
photoinitiator and UV light. Norbornene-functionalized pectin was synthetized via an 
esterification reaction between pectin and CA in DMSO for 1h at room temperature (Figure 
4.1A). Secondary hydroxyl groups of the polymer served as nucleophiles for reaction with 
CA, without compromising the water-solubility of modified polymer. The reaction was 
performed in organic solvents to overcome the limited solubility of CA in aqueous solutions 
and its pH dependence [32]. This strategy allows the neutralization of carboxylate groups 
with sodium ions, to improve the water-solubility of synthetized macromers and to prevent 
spontaneous ionic gelation of photocrosslinked hydrogels in culture medium mediated by 
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positively charged calcium ions (Supplementary Figure S4.1). Pectin was firstly converted 
to its tetrabutylammonium salt (PEC-TBA) for solubilization in organic solvents via reaction 
with the Dowex ion-exchange resin, followed by neutralization with tetrabutylammonium 
(TBA), as can be seen in the 1H NMR spectra by the appearance of new peaks 
corresponding to the butyl groups (3.20, 1.66, 1.38, and 0.96 ppm) (Figure 4.1B, 
Supplementary Figure S4.2). Then, the lipophilic PEC-TBA was dissolved in anhydrous 
DMSO and reacted with CA under a N2 atmosphere, yielding norbornene-functionalized 
pectin (NorPEC), as confirmed by 1H NMR analysis through the appearance of new peaks 
(6.12–6.37 ppm) of vinyl protons on the norbornene functionality (Figure 4.1B, 
Supplementary Figure S4.3). The product was purified through dialysis against sodium 
chloride to ensure complete removal of the TBA via neutralization of the carboxylate groups 
into the sodium salt form. Further product purification was performed with activated charcoal 
and centrifugation to remove any unreacted CA and potential byproducts (Supplementary 
Figure S4.4). The extent of norbornene substitution was determined to be 20.0 ± 0.6% 
through 1H NMR analysis by comparing the integral values corresponding to norbornene 
protons (6.12–6.37ppm) and native protons in the polymer backbone (3.82–4.43ppm). Higher 
substitution can be achieved by changing either the reaction time or the CA content (Table 
S4.2). The reproducibility and robustness of the chemical reaction was confirmed by 
performing independent synthesis of norbornene-functionalized pectin, followed by 1H NMR 
analysis (Supplementary Figure S4.5). Compared to alternative strategies for norbornene-
functionalization of natural polymers (e.g., gelatin, hyaluronic acid), which are performed 
under aqueous alkaline buffers (pH 8, 6h, 50°C) to ensure CA dissolution [32] or using di-tert-
butyl dicarbonate coupling chemistry in DMSO (20h, 45°C) [23], the modification procedure 
previously described presents several advantages, such as (i) prevents the addition of 
catalysts, (ii) precludes the pH adjustment during the reaction, (iii) proceeds at room 
temperature, and (iv) significantly reduces the reaction time. 
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Figure 4.1. Synthesis and characterization of pectin derivatives for thiol-ene 
photopolymerization. (A) Synthesis of norbornene-functionalized pectin (NorPEC) macromer from 
PEC-TBA through the coupling of norbornene groups (shown in red) to secondary alcohols on pectin 
(R denotes substituting group on carboxylic acid moiety: NH2 or OCH3). (B) 1H NMR spectra (D2O, 400 
MHz) of NorPEC after 1h reaction with carbic anhydride in DMSO and PEC-TBA after 3h treatment 
with Dowex ion exchange resin and neutralization with tetrabutylammonium. Insert shows the native 
protons in pectin backbone. 
4.3.2. Formation and characterization of thiol-ene click pectin hydrogels 
Biomimetic polymer-peptide hydrogels with MMP-cleavable peptide crosslinks are 
widely used as provisional matrices for tissue regeneration because they allow for localized 
cell-driven remodelling at the pericellular space, resembling the dynamic nature of ECM [7]. 
By simply altering the protease specific peptide crosslinker it was shown that engineered 
hydrogels differentially respond to MMPs secreted by distinct cell types, allowing for cell-
specific invasion within the gel network and controllable cell responses [33, 34]. In this work, 
enzymatically degradable, cell-instructive pectin hydrogels were prepared via a fast UV 
photoinitiated thiol-ene reaction between a peptide crosslinker sensitive to cell-secreted 
proteases (CGPQGIWGQC) flanked with biscysteine and the norbornene groups of NorPEC 
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in the presence of VA-086 as a water-soluble photoinitiator (Figure 4.2). To mimic the cell-
mediated remodelling of natural skin ECM, the protease sensitive sequence GPQG↓IWGQ, 
derived from the sequence GPQG↓IAGQ found in type I collagen, was covalently 
incorporated into the polymer backbone due to its susceptibility to cleavage by a wide range 
of MMPs (e.g., 1, 2, 3 and 9) secreted by several cell types involved in skin wound healing, 
including fibroblasts and keratinocytes [35, 36], thus providing a substrate for cell 
degradation. After 20s of UV photopolymerization, the biscysteine MMP-degradable peptide 
become part of the crosslinked hydrogel, allowing for local network degradation and 
determining both biophysical and biochemical properties. The mono-cysteine peptide 
CGGGGRGDSP (fibronectin-derived adhesion ligand based on RGD sequence) was also 
incorporated within the hydrogels as a pendant moiety, via one-pot reaction during gel 
formation, to provide integrin-mediated cell adhesion and cell-matrix crosstalk [10]. Although 
the physical adsorption of native integrin-binding proteins and biomolecules onto biomaterials 
can contribute to a more robust signalling, the hydrophilic nature of hydrogels strongly 
reduces this phenomenon, limiting cell adhesion both in vitro and in vivo [37, 38]. A recent 
work with unmodified calcium-crosslinked pectin hydrogels prepared at different 
concentrations (1%, 2% and 4%) showed that macrophages seeded onto the hydrogel 
surfaces fail to adhere, though the hydrogels adsorbed blood plasma proteins in a polymer 
concentration dependent manner [39]. Therefore, the introduction of cell-adhesive peptides 
into the backbone of hydrogel precursors, including pectin, is recognized as an efficient 
strategy to promote cell adhesion. VA-086 was selected as photoinitiator owing to its strong 
absorbance at 365nm and enhanced biocompatibility compared to the commonly used 
Irgacure 2959 [40]. We took advantage of the orthogonality and ultrahigh reactivity of 
norbornene moiety toward thiol-ene reaction to reduce the concentration of photoinitiator to 
0.25 wt%. This concentration is significantly lower than the ones typically applied in radical-
mediated polymerization (1.0–1.5 wt%), preventing the formation of macroscopic air bubbles 
within the hydrogel due to the N2 generation [41, 42].  
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Figure 4.2. Schematic illustration of thiol-norbornene hydrogel preparation. Photocrosslinking 
and biofunctionalization of click NorPEC hydrogels via UV light photoinitiated thiol-ene reaction of di-
thiol MMP-degradable peptide (CGPQG↓IWGQC, arrow indicates enzymatically cleavable site) and 
norbornene groups on NorPEC. Mono-thiol cell-adhesive peptide (CGGGGRGDSP, underline 
indicates cell-adhesion motif) is bond to the norbornene groups during the photopolymerization, 
providing pendant sites for cell-anchorage. 
 
In order to closely mimic key features of the ECM, hydrogel mechanical properties 
and biological functions should be tailored on relevant time scales by the user or the cells. 
There are several approaches to tailor the rheological properties of photocrosslinkable 
hydrogels, such as varying the crosslinking time, light intensity, polymer fraction, crosslinker 
content or the degree of alkene substitution. Increasing the polymer fraction enhances the 
number of alkene groups available for reaction, potentially leading to increased RGD-peptide 
conjugation. Similarly, increasing the crosslinking time/light intensity could lead to a similar 
outcome as the UV dose to which hydrogels are subjected is higher. Both strategies often 
result in altered ligand density between hydrogels, influencing the hydrogel properties and 
cell fate [10, 43]. In this study, the crosslinking time, light intensity, polymer fraction and 
norbornene functionalization were maintained constant and the hydrogel crosslinking density 
was tailored by varying the content of MMP-peptide crosslinker. To evaluate the ability to 
precisely adjust the rheological properties, hydrogels were prepared with varying bulk 
concentration of MMP-peptide crosslinker (4, 5 and 6 mM), while maintaining constant the 
concentration of polymer (2.5 wt%) and RGD peptide (2 mM). As shown in Figure 4.3A, the 
rheological properties on the swollen state are dependent on the concentration of MMP-
cleavable peptide used during the photopolymerization, with the shear elastic moduli varying 
between 70.03 ± 10.39 to 446.75 ± 35.66 Pa. Results show that higher MMP-cleavable 
peptide content increased the crosslink density and consequently the elastic modulus. To 
confirm such observations, the equilibrium mass swelling ratio of hydrogels was determined 
after 24h of incubation in PBS (Figure 4.3B). It was found that the swelling ratio decreases 
as the concentration of MMP-cleavable peptide increases, which correlates with the 
formation of a highly entangled and more crosslinked network. These data indicate that the 
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elastic modulus and swelling of low polymer fraction hydrogels can be tailored via modulation 
of MMP-degradable peptide content, which is in agreement with previous works [25]. 
Enzymatically degradable hydrogels sensitive to the action of MMPs are of particular 
interest for tissue regeneration because proteases play a key role in numerous biological 
processes during development and morphogenesis, including ECM remodelling, wound 
healing and angiogenesis [44, 45]. To confirm that thiol-ene hydrogels are susceptible to 
enzymatic degradation by collagenase type II, hydrogels with varying elastic moduli were 
incubated with the enzyme at a physiologically relevant concentration found during the 
wound healing [27] and their change in mass was determined as a function of time. It was 
found that all hydrogel formulations are sensitive to collagenase degradation and that the 
extent of degradation is dependent on the crosslinking density (Figure 4.3C). Hydrogels 
crosslinked with 4 mM of MMP-cleavable peptide were completely degraded after 3h of 
incubation, while hydrogels with 5 mM of MMP-cleavable peptide remained stable in solution 
for 5h of incubation. In contrast, highly crosslinked hydrogels (6 mM MMP-sensitive peptide) 
maintained structural integrity throughout the assay, clearly showing a crosslinking density-
dependent degradation. Control hydrogels incubated in HBSS buffer alone exhibited minimal 
mass loss after 9h of incubation (Supplementary Figure S4.6), indicating that the 
degradation is specifically triggered by enzymatic stimuli. Due to the recent introduction of 
pectin-based hydrogels in the field of tissue engineering, evidence regarding the 
mechanisms underlying the clearance/degradation of pectin from the human body is still 
scarce. Since the degradation of pectin is mediated by several pectinases (e.g., pectate 
lyases, polygalacturonases) absent in the human body, the degradation of pectin hydrogels 
by collagenase could facilitate the polymer clearance upon implantation. As pectin polymer 
chains are crosslinked by the MMP-sensitive peptide, it is expected that the cleavage of the 
hydrogel network into soluble pectin chains facilitates the degradation/clearance of pectin via 
interaction with the complex proteolytic environment (e.g., physiological enzymes, cell-
secreted proteases, pH and temperature) found in vivo.  
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Figure 4.3. Physical and mechanical properties of MMP-degradable NorPEC hydrogels. (A) 
Influence of MMP-cleavable peptide concentration on the storage modulus (G') of photocrosslinked 
hydrogels. (B) Swelling of hydrogels upon overnight incubation in PBS. (C) In vitro degradation of 
hydrogels prepared with varying contents of MMP-degradable peptide in the presence of collagenase 
type II. 
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4.3.3. Chemically defined cell-instructive pectin hydrogels promote 3D cell 
attachment and spreading 
A major challenge when using natural polymers as cellularized ECM-analogues relies 
on the difficulty of designing hydrogels with independently tuneable biochemical and 
biophysical properties, an important feature to precisely modulate cell functions [46, 47]. To 
decouple the influence of crosslinking density (MMP-cleavable peptide) from ligand density 
(RGD peptide) on the behaviour of embedded dermal fibroblasts, cell-laden hydrogels were 
produced with varying ligand density (0–2 mM), but using constant polymer concentration 
(2.5 wt%) and MMP-cleavable peptide content (5 mM). Live/Dead analysis showed that the 
majority of the cells remained alive after 7 days of culture, with marked differences on the 
morphology and distribution within the gel network (Figure 4.4A). The incorporation of RGD 
peptide conferred adhesiveness to the otherwise inert pectin network and was necessary to 
promote cell adhesion and spreading within the hydrogels. Fibroblasts cultured within RGD-
functionalized hydrogels showed elongated morphology with major differences on the 
spreading and elongation as a function of the bulk RGD content. At day 7, cells within 
hydrogels containing 0.5 mM RGD displayed heterogeneous spreading at both the centre 
and periphery of the gels, while fibroblasts embedded within hydrogels with higher 
concentrations of RGD peptide (1 and 2 mM) were uniformly spread throughout the gel 
network (Figure 4.4B). In the absence of RGD, cells remained mostly round without 
spreading and lacking cell-cell contacts, though they remained metabolically active 
(Supplementary Figure S4.7). These results indicate that the peptide density determines 
the extent of cell spreading, which could be easily controlled by changing the bulk 
concentration of RGD peptide during the thiol-ene reaction. The influence of ligand density 
(RGD peptide) on cell spreading within thiol-ene 3D hydrogels has been investigated using 
several cell types [48-50]. For instance, Bott et al [49] showed that dermal fibroblasts 
embedded within MMP-degradable PEG hydrogels lacking cell-adhesion sites or containing 
the non-biologically active RDG peptide sequence remain round, while the tethering of RGD 
peptide promoted cell adhesion and spreading. In another work, Kyburz et al [48] reported 
that the adhesivity of MMP-degradable PEG hydrogels determines the spreading and 
migration of hMSCs in 3D. At 0 and 0.001 mM CRGDS concentrations embedded hMSCs 
remained round, while increasing the CRGDS concentration to 1.0 mM promoted a 
significant increase in cell spreading, elongation and migration. These authors hypothesized 
that increased network adhesivity facilitates cell attachment and spreading, providing the 
necessary traction for cells to migrate. In this work, RGD was used at a concentration of 2.0 
mM in order to maximize the number of adhesion sites and promote uniform cell spreading 
within the hydrogel.  
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Figure 4.4. Influence of RGD peptide on dermal fibroblasts encapsulated within MMP-
degradable NorPEC hydrogels. (A) Representative Live/dead images of fibroblasts embedded within 
2.5 wt% NorPEC hydrogels (5 mM MMP peptide, 20s UV), showing the effect of bulk RGD 
concentration (0–2 mM) on cell viability and distribution within the hydrogels at day 7 (scale bar: 
200μm). (B) Bright-field images showing the influence of RGD peptide content on the spreading of 
fibroblasts in the center and periphery of hydrogels at day 7 of culture (scale bar: 100μm). 
 
To investigate the influence of matrix stiffness on cell behaviour, fibroblasts were 
embedded within MMP-degradable hydrogels (2.5 wt%, 2 mM RGD) of varying moduli. 
Adding the MMP-cleavable peptide at three different contents (4, 5 and 6 mM) resulted in the 
formation of hydrogels with low, medium and high crosslinking densities, respectively. 
Fibroblasts cultured within all hydrogel formulations remained metabolically active throughout 
14 days of culture (Supplementary Figure S4.8) and extensively spread within the hydrogel 
network (Figure 4.5A). Major differences between the hydrogels were observed regarding 
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the time required for cells to spread, cell compaction and hydrogel contraction. At early time 
points (day 1), fibroblasts were round in stiffer hydrogels (5 and 6 mM MMP) and displayed 
elongated morphology in loosely crosslinked gels (4 mM MMP). At day 3, extensive cell 
spreading and elongation was observed in hydrogels with low and medium crosslinking 
density, while in hydrogels with high crosslinking density the majority of cells only start 
spreading, with few protrusions. At later time points (day 7), cells extensively spread within all 
hydrogels independently of the crosslinking density (Supplementary Figure S4.9). 
Fibroblasts embedded within MMP-degradable pectin hydrogels formed 3D interconnected 
multicellular networks and assumed a spindle-shaped morphology, characteristic of 
fibroblasts cultured within 3D environments [49]. Although MMP-degradable hydrogels 
supported extensive cell spreading, confocal images showed that cells cultured within stiffer 
hydrogels exhibit more pronounced compaction (Supplementary Figure S4.9), suggesting 
that the extent of cell compaction correlates with the hydrogel stiffness. To prove that 
differences in fibroblasts spreading and morphology were not a result of changes in the 
content of tethered RGD peptide during the thiol-ene photopolymerization, HPLC analysis 
was carried out to confirm that the conjugation efficiency was comparable between all 
hydrogel formulations (4 mM: 54.91 ± 3.40%; 5 mM: 50.77 ± 0.90%; 6 mM: 49.61 ± 2.92%), 
as shown in Figure 4.5B and further confirmed using a fluorescently labelled RGD-peptide 
(Supplementary Figure S4.10). Results show that fibroblasts require more time to spread 
and remodel denser hydrogels, even in presence of MMP-cleavable peptide crosslinkers, 
due to the physical constrains imposed by the matrix. Our observations are in agreement 
with a previous work reporting a significant reduction on the percentage of hMSCs capable of 
elongate and migrate within thiol-ene MMP-degradable PEG hydrogels of increased 
crosslinking density [48]. 
As the rate of cell spreading, elongation and migration in 3D is dictated by both 
biochemical and biophysical cues [48], cell-laden hydrogels with varying crosslinking density 
were also cultured in the presence of a broad-spectrum MMP inhibitor (Marimastat) to assess 
whether cell spreading was exclusively dependent on MMP-mediated hydrogel degradation 
(Supplementary Figure S4.11). Fibroblasts displayed an elongated morphology within 
loosely crosslinked hydrogels throughout the 14 days of culture period, even in the presence 
of MMP inhibitor, suggesting that cells spread essentially by an MMP-independent 
mechanism (e.g., defects in the gel network). In contrast, cells embedded within medium or 
highly crosslinked hydrogels incubated with Marimastat failed to spread and remained mostly 
spherical with a few elongated cells located near the hydrogel surface. F-actin staining 
further confirmed that cells embedded within highly crosslinked hydrogels remained isolated 
and presented only minor protrusions (Figure 4.5C), indicating that cells are only able to 
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overcome the physical barrier of the matrix by enzymatic cleavage. Therefore, cell elongation 
within cell-degradable pectin hydrogels is determined not only by MMP-mediated 
degradation, but also by the hydrogel stiffness. For hydrogels with low crosslinking density 
(G’ = 70.03 ± 10.39 Pa), the stiffness was found to be a key parameter determining cell 
elongation, while in stiffer hydrogels (G’ > 143.09 ± 29.70 Pa) cell spreading was driven by 
MMP-mediated degradation. In a previous work using fully interpenetrating networks made of 
collagen-I and RGD-functionalized alginate with embedded dermal fibroblasts, it was found 
that cells fully spread within hydrogels of low storage modulus (50 Pa), but remained 
spherical when encapsulated in hydrogels of both intermediate (320 Pa) and high (1200 Pa) 
stiffness [51], which is in agreement to our observations regarding the effects of matrix 
stiffness on the response of dermal fibroblasts. The incorporation of MMP-cleavable peptides 
as part of the pectin hydrogel network allows embedded fibroblasts to locally degrade the 
surrounding matrix, which is essential to create space for spreading and elongation. Although 
cells require more time to degrade the matrix of highly crosslinked matrices, they are also 
able to fully spread in stiffer 3D hydrogels (446.80 ± 35.66 Pa), forming interconnected 
cellular networks throughout the hydrogel. 
Fibroblasts play a key role during the healing of deep wounds, being involved in ECM 
synthesis, deposition and remodelling, while exerting forces towards wound contraction [52]. 
The contraction of cell-laden hydrogels was monitored during the culture period and assess 
whether the crosslinking density can be used to control dimensional changes of hydrogel 
network (Figure 4.5D, E). After three days of culture, only hydrogels crosslinked with 4 mM 
MMP-cleavable peptide shrank when compared to day 1, while at day 7 a significant 
reduction on the hydrogel’s area was observed for all compositions. Loosely crosslinked 
hydrogels (4 mM) displayed the highest shrinkage degree, reaching 9.7% of their initial area 
at day 14. Hydrogels with medium and high crosslinking degree reached 24.3% and 36.4% of 
their initial area at the same culture time. Embedded fibroblasts were able to pull on the 
matrix and contract it in a matrix stiffness-dependent manner, as a result of contractile forces 
involved in cell attachment, elongation and migration [53]. These results showed that 
hydrogel contraction by dermal fibroblasts is linked to matrix stiffness, with higher stiffness 
correlating with both increased structural integrity and lower contraction degree. Thus, by 
using MMP-degradable pectin hydrogels of varying stiffness it’s possible to modulate the 
contractility of embedded fibroblasts and associated matrix deformation.    
During the healing of skin wounds, fibroblasts, keratinocytes, endothelial cells and 
inflammatory cells secrete a broad range of MMPs, which expression and activation is tightly 
regulated [54, 55]. MMPs play a pivotal role along the process, namely by changing the 
properties of the wound matrix to allow cell migration and new ECM deposition. In order to 
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evaluate whether fibroblasts embedded within MMP-degradable hydrogels secrete relevant 
MMPs for remodelling, the activity levels of two ubiquitous gelatinases (MMP-2 and MMP-9) 
involved in skin wound healing [54], were determined in culture medium by gelatin 
zymography at different culture times (Figure 4.5F). Zymography analysis clearly showed 
that cells produced MMP-2 (72 kDa) and MMP-9 (92 kDa), with higher expression of MMP-2. 
It was also found that the activity of MMP-2 increased from day 1 to day 3 of culture, which 
corresponds to the time period that fibroblasts start spreading within the gel network. 
Characteristic bands of MMP-9 were detected at low levels in conditioned media, indicating 
that embedded fibroblasts mostly express MMP-2, which is in agreement to previous works 
with dermal fibroblasts cultured in 3D hydrogels [49].  
 
 
Figure 4.5. Cell encapsulation of dermal fibroblasts within MMP-degradable NorPEC hydrogels. 
(A) Representative confocal microscopy images detailing the influence of MMP-peptide content (4, 5 
and 6 mM MMP-cleavable peptide, 2.5 wt% NorPEC, 2 mM RGD peptide, 20s UV) on the morphology 
and spatial distribution of fibroblasts stained for DAPI (blue) and F-actin (green) at day 14 (scale bar: 
50μm). (B) Influence of bulk MMP-degradable peptide content on the conjugation efficiency of RGD-
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peptide during photopolymerization. (C) Representative confocal microscopy images of fibroblasts 
cultured within NorPEC hydrogels (2.5 wt%, 6 mM MMP, 2 mM RGD) in medium containing 50 μM of 
MMP-inhibitor Marimastat at day 7 (scale bar: 50 μm). (D) Effect of MMP-peptide content on the 
contraction of hydrogels during the culture period. Results are expressed as a percentage of area 
reduction compared to day 1. (E) Photographs showing the appearance of low and highly crosslinked 
hydrogels at day 1 and 14 of culture (scale bar: 2.5 mm). (F) Gelatin-zymograms of conditioned media 
collected at day 1 and 3. Data from contraction assays were analyzed using two-way ANOVA with 
Tukey’s multiple comparisons test (***p < 0.001, ****p < 0.0001); compared to day 3: +p < 0.0001, #p < 
0.001; compared to day 7: *p < 0.01, $p < 0.001. 
4.3.4. Thiol-ene click pectin hydrogels support full-thickness skin formation 
To demonstrate the potential of the MMP-degradable pectin hydrogels for skin repair 
and regeneration, dermal fibroblasts were embedded within pectin hydrogels of medium 
crosslinking density (2.5% NorPEC, 2 mM RGD, 5 mM MMP), cultured for 1 week and 
subsequently seeded with keratinocytes. After submerged culture for additional 1 week, cell-
laden hydrogels were exposed to the air-liquid interface to promote the stratification of 
epidermis and characterized by histological and immunofluorescence analysis. Histological 
analyses depicted in Figure 4.6A clearly show that cell-instructive pectin hydrogels 
supported the in vitro formation of full-thickness skin, with morphological resemblance to the 
human skin. H&E staining showed that the dermal compartment is uniformly populated with 
elongated dermal fibroblasts, while a well-defined epidermis was formed on the top of the 
fibroblast-laden hydrogel. Keratinocytes formed a dense epidermal tissue after 14 days of 
ALI culture with marked differences on cell morphology as a function of their location in the 
epidermis. Basal keratinocytes in the close proximity to the dermal-like layer display a 
cuboidal shape, while most of the cells at the epidermis-air interface present a flattened 
morphology, which is characteristic of the differentiation and stratification of keratinocytes 
[56]. A higher number of flattened keratinocytes at the surface of the constructs could be 
observed at day 28 of ALI culture compared to day 14 (Supplementary Figure S4.12a). 
Notably, the thickness of the epidermis-like layer (~120 μm) is within the range of native 
human epidermis, which is in the range of 60–150 μm, depending on the location in the 
human body [57]. Masson’s trichrome staining (Figure 4.6B) revealed that fibroblasts were 
secreting collagen, a key ECM component of skin tissue, with more intense blue staining 
(increased deposition) from day 14 to day 28 of ALI culture (Supplementary Figure S4.12b). 
Immunohistological analysis also showed the presence of specific markers associated to 
epidermal differentiation and proliferation, including cytokeratin (Figure 4.6C) and Ki67 
(Supplementary Figure S4.13), respectively. The presence of Ki67 proliferation marker 
mainly in the suprabasal layers of epidermis correlates with the differentiation state of the 
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keratinocytes, as in native skin only keratinocytes in the stratum basale maintain proliferative 
activity [56]. To confirm that the presence of fibroblasts is limited to the dermal compartment, 
sections were stained against vimentin, a cytoskeletal protein characteristic of fibroblasts 
(Figure 4.6D). No cell invasion across dermal and epidermal layers was observed, since the 
presence of cytokeratin- and vimentin-positive cells was limited to the epidermal and dermal 
layers, respectively. Key characteristic markers of ECM production in dermal compartment 
were also identified such as collagen type-I (Figure 4.6E) and fibronectin (Figure 4.6F), 
indicating that fibroblasts were secreting essential ECM components for new dermal tissue 
formation. Although these results clearly demonstrate that protease-degradable pectin 
hydrogels support the in vitro formation of skin equivalents, a limitation of the present study 
relies on the use of immortalized keratinocyte cell line (HaCaT) to generate the epidermal 
layer instead of primary keratinocytes. It is well recognized that immortalized keratinocytes 
undergo gradual loss of cell phenotype and function throughout passaging and culture, which 
can delay or even compromise the stratification and terminal differentiation [58]. However, we 
anticipate that the use of primary keratinocytes can potentially address this issue.  
In a future work we will focus on the detailed characterization of the performance of 
MMP-sensitive pectin hydrogels in skin formation and adhesion to biological tissues. The 
ability of MMP-degradable pectin hydrogels to support the in vitro skin formation will be 
compared to MMP-insensitive pectin hydrogels (e.g., DTT, non-degradable CGDQGIAGFC 
peptide crosslinker) and standard constructs for skin tissue engineering (e.g., collagen, 
alginate) to elucidate the benefits of the proposed hydrogel. The adhesion of hydrogels to the 
surrounding biological tissues is challenging in wound healing as it requires the 
establishment of chemical bonds between the hydrogel and the tissue surface for sufficient 
bonding strength. In situ photopolymerizable hydrogels are particularly advantageous for 
wound healing as they can be formed under clinically safe 365 nm light irradiation, conform 
to the wound bed, and depending on the chemical composition, can enhance the interaction 
with the tissue surface promoting better integration [59]. The developed MMP-sensitive 
pectin hydrogel exhibits key properties for wound healing such as fast gelation 
(Supplementary Figure S14) and the ability to promote cell spreading, ECM deposition and 
in vitro skin formation. Pectin hydrogel also contains multiple domains that bind do cell-
surface receptors, with potential to promote subsequent cell attachment and tissue 
integration. In addition, the carboxylic groups present in the pectin backbone can also 
contribute for tissue adhesion through interaction with amino groups [39]. In case of poor 
hydrogel adhesion and integration, the chemical versatility of pectin allows for easy 
modification with functional groups (e.g., aldehydes) capable of reacting with the amino 
groups present on the tissue surface. Alternative biomimetic strategies to improve the tissue 
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adhesion can also be translated to pectin hydrogels, including the functionalization with 
mussel adhesive proteins (MAPs) containing the amino acid 3,4-dihydroxyphenylalanine 
(DOPA). Through oxidative crosslinking or metal chelation, the catechol moiety in DOPA 
amino acid chain covalently crosslinks both to itself and to biologically relevant nucleophiles 
(e.g., primary amines and thiols), allowing better tissue adhesion and improving haemostasis 
[60]. Due to the poor yield in the isolation and purification of MAPs, nature-inspired adhesive 
hydrogels have been mostly designed by incorporating DOPA-based peptides and simplified 
DOPA alternatives such as dopamine and catechol functional groups [61-63]. Mussel-
inspired functionalization represents an attractive strategy to improve the wet adhesion of 
hydrogels with particular interest for in situ skin tissue engineering.  
 
 
Figure 4.6. Histological and morphological characterization of skin equivalents formed using 
the protease-degradable pectin hydrogels after 14 days of differentiation at the ALI culture. (A) 
Haematoxylin & eosin and (B) Masson trichrome staining’s showing the histology of skin equivalents. 
CHAPTER IV 
 171 
Immunostaining of paraffin embedded samples using antibodies directed against (C) cytokeratin 
(keratinocytes), (D) vimentin (fibroblasts), (E) collagen type-I (Coll I) and (F) fibronectin (FN). Dash line 
delineates the interface between the dermal and epidermal layers. 
4.4. Conclusions 
A simple, fast and robust method for the synthesis of norbornene-functionalized 
pectin was developed and applied for the fabrication of cell-laden MMP-cleavable hydrogels 
through photoinitiated thiol-ene reaction. Step-growth pectin hydrogels were rapidly formed 
upon exposure to UV light for very short irradiation times, without compromising the viability 
of embedded dermal fibroblasts. By selecting suitable MMP-degradable peptide crosslinkers 
and pendant cell-adhesive peptides, biofunctional hydrogels were engineered with varying 
levels of crosslinking density, resulting in distinct biological responses. Embedded fibroblasts 
displayed elongated morphology and less compaction in more permissive hydrogels, 
contracting the matrix in a higher extent. Cell-instructive hydrogels with embedded dermal 
fibroblasts and seeded with keratinocytes supported the in vitro formation of full-thickness 
skin resembling the architecture and morphology of human skin. Two distinct regions 
corresponding to the dermal and epidermal layers were formed, showing the presence of 
specific markers associated to proliferation and ECM deposition. This versatile hydrogel 
system allows for independent tuning of biochemical and biophysical cues of the gel network, 
allowing the fabrication of chemically defined 3D matrices from pectin as a natural polymer. 
Overall, this study demonstrates the potential of novel biofunctionalized, click pectin 
hydrogels for skin tissue engineering applications.  
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4.7. Supplementary Information 
 
Figure S4.1. Effect of calcium ions on the shear elastic moduli (G') of NorPEC hydrogels (2.5wt%, 5 
mM MMP, 2 mM RGD) prepared with 20s of UV exposure (7 mW/cm2). Hydrogels were incubated in 
PBS (no calcium) and DMEM (31966-021, Gibco, 1.8mM CaCl2•2H2O) culture medium supplemented 
with 10% FBS for 24h and the mechanical properties tested through rheological analysis. No 
statistically significant changes were observed in the G' of hydrogels incubated in both the presence 
and absence of calcium (Mann-Whitney test p = 0.1059). These data suggests that the neutralization 
of carboxylate groups with sodium ions precludes the occurrence of secondary ionic gelation between 
the carboxylic groups on pectin and calcium ions, at tested concentration of calcium.  
 
 
Figure S4.2. Representative 1H NMR spectrum (D2O, 400 MHz) of lipophilic TBA salt of pectin (PEC-
TBA) after 3h treatment with Dowex ion exchange resin and neutralization with tetrabutylammonium, 
resulting in four new peaks that correspond to the butyl groups (3.20, 1.66, 1.38, and 0.96 ppm). Insert 
shows the native protons on pectin backbone. 
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Figure S4.3. Representative 1H NMR spectrum (D2O, 400 MHz) of norbornene-functionalized pectin 
(NorPEC) after 1h reaction in DMSO. Substitution of pectin is calculated from the ratio of norbornene 
integrals (6.12–6.37 ppm) to native protons in pectin (4.56–3.47 ppm).  
 
Macromer purification 
Several purification steps were carried out to ensure the removal of unreacted 
reagent and/or by-products, including (i) dialysis, (ii) activated charcoal and (iii) sterile 
filtration (0.20μm). Dialysis was performed using MWCO 3.5 kDa dialysis membrane to 
ensure the removal of carbic anhydride (CA), which Mw is 164.16 Da. After dialysis, the 
polymer solution was treated with activated charcoal to adsorb potential by-products, 
followed by centrifugation and sterile filtration. Since CA has poor solubility in aqueous 
solutions at physiological pH (e.g., PBS, pH 7.4), the chemical modification was performed in 
DMSO with two major objectives: (1) reduce the amount of CA needed for chemical 
modification and increase the reaction efficiency; (2) facilitate the removal of unreacted 
reagent through water precipitation during the dialysis step, followed by centrifugation. Thus, 
based on the solubility of CA and purification procedures carried out, it is expected complete 
removal of unreacted CA. This was further confirmed by 1H NMR analysis of both pure CA 
and norbornene-modified pectin. Deuterated methanol (CD3OD) was added to pure CA to 
ensure complete dissolution and confirm the presence of characteristic peaks of native 
protons (peak attribution was done based on published data [1]). After chemical reaction, the 
spectrum of norbornene-functionalized pectin was recorded and several alterations were 
observed regarding the multiplicity of CA characteristic peaks and chemical shift of protons in 
the vicinity of reactive centre, indicating the occurrence of chemical reaction with 
consumption of CA.  
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Figure S4.4. Representative 1H NMR spectra of both (A) pure carbic anhydride (CD3OD, 400 MHz) 
and (B) norbornene-functionalized pectin (D2O, 400 MHz).  
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Figure S4.5. Representative 1H NMR spectrum (D2O, 400 MHz) of norbornene-functionalized pectin 
(NorPEC). Macromers were obtained through three independent syntheses to confirm the 
reproducibility and robustness of chemical reaction. No significant alterations between NorPEC 
macromers were verified regarding both the degree of substitution (synthesis 1: 20.5%; synthesis 2: 
20.1%; synthesis 3: 19.4%) and chemical shift of carbon-carbon double bond (synthesis 1: 6.12–6.37 
ppm; synthesis 2: 6.12–6.36 ppm; synthesis 3: 6.11–6.37 ppm).   
 
  
Figure S4.6. Weight loss of photocrosslinked pectin hydrogels incubated in HBSS for 9h at 37ºC. Data 
were analysed using Mann-Whitney test (*p<0.05). 
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Figure S4.7. Metabolic activity of dermal fibroblasts embedded in NorPEC hydrogels containing 
varying concentrations of RGD peptide. Data were analysed using two-way ANOVA with Bonferroni’s 
multiple comparisons test (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001). 
 
 
Figure S4.8. Metabolic activity of dermal fibroblasts embedded in NorPEC hydrogels containing 
varying concentrations of MMP-peptide. Data were analysed using two-way ANOVA with Tukey’s 
multiple comparisons test (*p < 0.05, ***p < 0.001, ****p < 0.0001); compared to day 1: #p < 0.0001; 
compared to day 7: $p < 0.01. 
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Figure S4.9. Representative confocal microscopy images of dermal fibroblasts cultured within MMP-
degradable pectin hydrogels (2.5% NorPEC, 20s UV) prepared with different contents of MMP-
sensitive peptide (4, 5 and 6 mM) showing the morphology and spatial distribution of fibroblasts 
stained for DAPI (blue) and F-actin (green) at day 7 (scale bar: 100μm for 20x objective and 50μm for 
40x objective). 
 
 
Figure S4.10. Influence of bulk MMP-degradable peptide content on the conjugation efficiency of 
RGD-peptide during photopolymerization (4 mM: 54.77 ± 0.56%; 5 mM: 55.15 ± 2.40%; 6 mM: 57.00 ± 
1.35%). A fluorescently labelled RGD-peptide (CGGGGRGDSP{LYS(FITC)}, Genscript) was added to 
the hydrogel precursor solution, photocrosslinked and incubated in PBS for 24h. Then, the supernatant 
was collected and the amount of released peptide quantified by measuring the supernatant 
CHAPTER IV 
 183 
fluorescence (λex = 494 nm, λem = 521 nm) in comparison to a calibration curve using a microplate 
reader. Data were analysed using Mann-Whitney test. 
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Figure S4.11. Bright-field images showing the influence of MMP-mediated degradation on cell spreading of dermal fibroblasts embedded within 2.5% NorPEC 
hydrogels of varying crosslinking densities prepared with different content of MMP-sensitive peptide (4, 5 and 6 mM). Cell-laden hydrogels were incubated in 
control medium and medium containing the MMP inhibitor (Marimastat) for 1, 7 and 14 days of culture (scale bar represents 100μm). 
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Figure S4.12. Histological and morphological characterization of skin equivalents formed after 14 and 
28 days of differentiation at the air-liquid interface. (A) Hematoxylin & eosin and (B) Masson trichrome 
staining showing the histology of skin equivalents (scale bars represent 100 μm). 
 
 
Figure S4.13. Immunostaining of paraffin embedded samples cultured at ALI interface for 28 days, 
using antibody directed against Ki67 (proliferation marker). Proliferative cells are mostly located at the 
basal region of the epidermal layer. Dash line indicates the interface between the dermal and 
epidermal layers (scale bars represent 50 μm). 
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Figure S4.14. Consumption of vinyl protons on the norbornene functionality of NorPEC hydrogels (2.5 
wt%, 2mM RGD, 5mM MMP) determined as a function of UV irradiation time. Representative 1H NMR 
spectra of NorPEC hydrogels prepared by varying the UV exposure time. After photopolymerization, 
deuterated dimethyl sulfoxide (500 μl) was added to the hydrogel (100 μl) to partially dissolve the 
network prior 1H NMR analysis [2]. For quantification of the double bond (6.12 ppm) consumption, all 
spectra were normalized to 3-(trimethylsilyl)propionic-2,2,3,3-d4 acid sodium salt (TSP-d4, Euriso-top) 
as internal standard (δ = 0 ppm). Based on 1H NMR data, crosslinking degree was calculated 
according to the following equation [2]: 
 
The crosslinking degree was 82% and 92% after 10s and 20s of UV irradiation, respectively, indicating 
the fast kinetics of thiol-norbornene reaction of the developed hydrogel system. After 60s of UV 
irradiation the crosslinking degree was 99%, which indicates that the hydrogel crosslinking was 
completed. Interestingly, the crosslinking degree between 20s and 60s of photopolymerization is 
similar, suggesting that the reaction rate is stabilizing due to the consumption of vinyl bonds and the 
formation of a crosslinked gel network. 
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Table S4.1. Antibodies used for immunofluorescence staining. 
Primary 
Antibody 
Company Antigene Retrieval Secondary antibody 
Cytokeratin 
(1:100) 
Dako 
(Wide Spectrum 
Screening)  
Citrate buffer 
pH 6.0 
Alexa Fluor 488 donkey 
anti-rabbit 
Fibronectin 
(1:200) 
Sigma-Aldrich 
Citrate buffer 
pH 6.0 
Alexa Fluor 488 donkey 
anti-rabbit 
Collagen type I 
(1:100) 
Rockland 
Citrate buffer 
pH 6.0 
Alexa Fluor 488 donkey 
anti-rabbit 
Ki67 
(1:800) 
Abcam 
Citrate buffer 
pH 6.0 
Alexa Fluor 488 donkey 
anti-rabbit 
Vimentin 
(1:100) 
Santa-Cruz 
Biotechnology 
Citrate buffer 
pH 6.0 
Alexa Fluor 488 donkey 
anti-mouse 
 
Table S4.2. Influence of reaction conditions on the norbornene functionalization of pectin. Percentage 
of norbornene functionalization as a function of reaction time (1, 3, 6 and 12h) and carbic anhydride 
content (1, 2.5, and 5-fold excess of CA relatively to the hydroxyl groups in pectin backbone). 
Carbic anhydride fold excess Reaction time (h) Functionalization (%) 
1 
1 20.0 
3 30.3 
6 35.7 
5 
3 43.8 
12 41.2 
1 
6 
35.7 
2.5 29.8 
5 32.7 
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Abstract 
Bioinks are an essential tool for bioprinting functional tissue constructs for tissue 
engineering and regenerative medicine applications. The design of cell-instructive bioinks for 
extrusion bioprinting is demanding as they must exhibit suitable rheological behaviour, fast 
post-printing crosslinking, and provide a cell-responsive microenvironment that supports and 
directs cell functions. In this work, a novel photocrosslinkable bioink was designed for the 
bioprinting of 3D ECM-like microenvironments with tuneable biochemical and biophysical 
properties. The bioink was developed using norbornene-modified pectin, living cells, and 
peptide crosslinkers and ligands as basic building compounds. Ionic gelation was employed 
to achieve suitable yield stress point and bioink printability using a lower concentration of 
CaCl2 (13 mM) compared to BaCl2 (15 mM). Bioinks with similar rheological behaviour loaded 
with dermal fibroblasts were printed into 3D constructs and rapidly crosslinked via UV thiol-
norbornene click chemistry. Stiffer constructs were created by simply increasing the 
photopolymerization time from 30 s to 90 s, allowing a significant increase in the elastic 
moduli of Ca2+- (294.3 Pa to 869.9 Pa) and Ba2+-crosslinked (391.0 to 1098.5 Pa) hydrogels. 
By selecting suitable thiolated protease-degradable peptide crosslinkers (CGPQGIWGQC) 
and thiolated cell-adhesive peptide pendant moieties (CGGGGRGDSP), printed 3D 
constructs supported the adhesion of embedded cells, allowed cell-driven gel network 
remodelling, supported extensive spreading of dermal fibroblasts, and stimulated the 
deposition of fibronectin. Overall, this bioink provides a new platform to generate biomimetic 
and customized cell- and tissue-specific 3D constructs with controllable tethering of 
biochemical cues and tuneable mechanical properties.  
 
Keywords: bioink; bioprinting; pectin norbornene; photocrosslinking; thiol-norbornene 
chemistry. 
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5.1. Introduction 
Biofabrication is a multidisciplinary field that employs bioassembly or bioprinting 
approaches to generate biologically functional tissue constructs [1]. Extrusion bioprinting 
allows the automated layer-by-layer production of 3D constructs with precise control over the 
positioning of living cells and functional components (e.g., biomolecules and biomaterials), 
providing a promising strategy to create tissue constructs mimicking key features of the 
native extracellular matrix (ECM) [2]. The ability to print 3D cell-biomaterial constructs that 
resemble the complex hierarchical architecture of human tissues and organs depends on the 
design of bioink formulations that meet both processing and biological requirements. 
Advanced bioinks must ensure not only high shape fidelity and allow fast crosslinking, but 
also provide a cell-specific and dynamic microenvironment that directs cell fate [3]. The 
design of bioinks resembling key features of the ECM, including cell-adhesion and cell-
remodelling capabilities, hydrated nature, and fibrillar structure, is challenging due to the 
tissue-specificity of the biochemical and biophysical features of native ECM, and narrow 
processing window.  
Hydrogels are the most explored bioink materials as they resemble many features of 
the ECM and can be crosslinked using a broad range of cytocompatible chemistries. They 
can also be functionalized with specific reactive end groups and bioactive ligands to further 
control the network formation and cell interactions [4, 5]. A variety of natural and synthetic 
hydrogel materials have been adopted for bioprinting, including alginate, gelatin, hyaluronic 
acid, and poly(ethylene glycol) [6]. Traditionally, these materials are formulated as either 
highly viscous single-component bioinks or hybrid multimaterial bioinks to achieve enough 
viscosity for bioprinting and allow subsequent construct consolidation. However, suitable 
printability of these bioinks is often associated to increased shear stress during the printing 
process, which reduces cell viability and might compromise the overall quality of newly 
formed tissue [7]. In order to address these limitations, elegant approaches based on 
physical crosslinking mechanisms have been developed to modulate the bioink viscosity prior 
printing, including ionic crosslinking [8], thermal gelation [9], and dynamic covalent bonds 
[10]. These approaches allow the design of physically crosslinked hydrogel bioinks with 
suitable rheological properties that can be directly printed into 3D constructs without 
additional materials for viscosity modulation. Nevertheless, secondary crosslinking 
postprinting is often required to consolidate the construct and eventually modulate the 
stiffness of the gel network. 
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Photopolymerization reactions are widely explored in bioprinting for the crosslinking of 
hydrogel constructs post-deposition, independently on whether the bioink was subjected to 
physical or chemical crosslinking before printing. Free-radical polymerization of 
meth(acrylate)-functionalized hydrogels is the most common approach, enabling the 
cytocompatible formation of chemically crosslinked constructs [11]. However, the 
homopolymerization of vinyl bonds on meth(acrylate) groups is associated to the generation 
of network heterogeneities due to the random chain polymerization, which negatively impacts 
the hydrogel mechanical properties [12]. Thiol-ene click reaction represents an alternative 
crosslinking scheme that was recently adopted for bioprinting [13, 14]. It is characterized by 
orthogonal reactivity and proceeds via step-growth mechanism, yielding structurally uniform 
hydrogels with minimal network defects. Importantly, thiol-ene reaction is insensitive to 
oxygen, requires lower concentration of initiator, and develops with faster kinetics when 
compared to free-radical polymerization. Photoinitiated thiol-norbornene reaction is one 
example of thiol-ene chemistry with tremendous potential for bioprinting due to the faster rate 
of thiol-ene conjugation of norbornene end groups compared to other alkenes (norbornene > 
vinyl ether > alkene > vinyl ester > allyl ether > acrylate > N-substituted maleimide > 
methacrylate > conjugated dienes) [15]. It involves light-mediated orthogonal reactions 
between multifunctionalized macromers end-capped with norbornene groups and sulfhydryl-
containing linkers in the presence of an initiator, yielding water-stable thioether bonds. Thiol-
norbornene reaction has been successfully used to encapsulate cells within manually casted 
hydrogels using both natural and synthetic polymers [16, 17], but a very limited number of 
works have explored this reaction in the context of bioprinting. In a recent study thiol-
norbornene was employed as a secondary crosslinking reaction to control the functionality of 
bioprinted hydrogel constructs via photostiffening and photopatterning [10], while other work 
demonstrated its applicability for the in situ photocrosslinking of hyaluronic acid bioinks using 
a more complex bioprinting setup [13].   
In this work, a new approach is reported to design a modular, protease-degradable 
bioink for the bioprinting of 3D hydrogel constructs mimicking fundamental aspects of the 
native ECM, including the ability to promote integrin-mediated cell-adhesion, allow protease-
mediated network degradation, and provide a surrounding microenvironment of biologically 
relevant stiffness to the embedded cells. A single-component bioink was designed based on 
norbornene-modified pectin (NorPEC), enabling dual crosslinking via ionic gelation and 
photoinitiated thiol-norbornene click chemistry. Ionic gelation was explored to finely tune the 
rheological behaviour of the bioink for extrusion bioprinting, while the norbornene end groups 
enabled fast post-printing secondary crosslinking. By exploring the thiol-norbornene click 
chemistry, it was possible to rapidly introduce a myriad of biochemical cues (e.g., pendant 
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cell-adhesive ligands and protease-degradable peptides) during hydrogel formation, and 
simultaneously control the mechanical properties of the printed construct. This strategy 
provides the possibility to design ECM-like bioinks displaying the ability to control and direct 
the functions of embedded cells, which is essential in many bioprinting applications.  
5.2. Materials and Methods 
5.2.1. Bioink synthesis and preparation 
Norbornene-modified pectin (NorPEC) with 20.0 ± 0.6% of functionalization degree 
was synthetized using a method previously developed [18]. Briefly, purified low methoxyl 
citrus pectin (Classic CU701, 86 % galacturonic acid unit content and 37 % degree of 
methylation, Herbstreith & Fox, Neuenbürg, Germany) was firstly converted to its 
tetrabutylammonium salt (PEC-TBA) through 3h of reaction with Dowex 50 W (3.5 g resin per 
1 g polymer) proton exchange resin (Acros Organics) and neutralized to pH 6.50 with 
tetrabutylammonium (TBA, Sigma-Aldrich). Lyophilized PEC-TBA was dissolved in 
anhydrous dimethyl sulfoxide (DMSO) at 1 wt% and carbic anhydride (CA, Acros Organics) 
added at 1-fold molar excess to hydroxyl groups in the polymer backbone. After 1h of 
reaction at room temperature under vigorous agitation and inert (N2) atmosphere, the solution 
was dialyzed (MWCO 3500, Spectra/Por®, SpectrumLabs) for 5 days, washed with activated 
charcoal (1 g charcoal per 1 g of polymer, Sigma-Aldrich) for 1 h, centrifuged (60 000 g, 
Beckman Avanti J-26XP), and filtered (0.20 µm). Finally, the pH was adjusted to 7.00 with 
sodium hydroxide (0.1 M) and the modified polymer was recovered by lyophilization. 
For the bioink preparation, NorPEC (final concentration 2.5 wt%) was dissolved in 25 
mM of 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES, Sigma Aldrich) 
containing 0.9 wt% sodium chloride (NaCl) and VA-086 (0.25 wt%, Wako Chemicals) as a 
photoinitiator. To this solution, the peptide crosslinker CGPQG↓IWGQC (arrow indicates 
enzymatically cleavable site, Genscript) and the cell-adhesive peptide ligand 
CGGGGRGDSP (underline indicates cell-adhesion motif, Genscript) were added to achieve 
a final concentration of 2 mM and 5 mM, respectively. After solubilization, desired 
concentrations of either calcium chloride (CaCl2) dihydrate or barium chloride (BaCl2) 
dihydrate (10 v/v% of the total bioink volume) were added dropwise under vigorous agitation 
as ionic crosslinking agent, and the solution incubated at 25 ºC and 900 rpm for 180 min. 
Final concentrations of ionic crosslinking agents were in a range of 11–25 mM. The bioink 
was maintained at 25 ºC before use. 
CHAPTER V 
 195 
5.2.2. Rheological measurements   
The rheological properties of bioinks containing different concentrations of ionic 
crosslinking agents were analysed with a Kinexus Pro rheometer (Malvern) at 25 ºC in a 
humidified environment. To determine the yield stress, bioinks were subjected to a shear 
stress ramp, ranging from 1 to 100 Pa (2 min) with plate–plate geometry (0.5 mm distance). 
The yield point, which indicates the point at which the material first started to flow, was 
defined as the intersection between two linear regressions at the plateau-region and 
viscosity-drop regions of the viscosity-shear stress diagrams. The viscosity rotational shear-
viscosity measurements were performed using a shear ramp test (1 to 1000 s-1 shear rate, 2 
min) after applying one loading cycle with 2 min intervals before the rheological data 
acquisition. Rotational recovery measurements were performed to characterise the bioink 
recovery behaviour by applying a low shear rate of 1 s-1 for 100 s, following by a high shear 
rate of 100 s-1 for 100 s, and finally a low shear rate of 1 s-1 for 100 s. The gelation kinetics of 
bioinks was determined by measuring the evolution of storage (G′) and loss modulus (G″) at 
a constant strain of 2 % and frequency of 0.1 Hz 
5.2.3. Mechanical properties of hydrogels 
The mechanical properties of hydrogels were analysed in a Kinexus Pro rheometer 
using 4 mm diameter hydrogel samples (n = 4) in a humidified environment at 37 ºC. 
Hydrogel samples were compressed at 30 % of their initial height and strain amplitude 
sweeps were conducted from 0.1 to 100% at 0.1 Hz, while frequency sweeps were carried 
out from 0.01 to 10 Hz at 2 % strain, after determining the linear viscoelastic region. Bioink 
solutions were manually casted between 1 mm spaced glass slides treated with SigmaCote 
(Sigma-Aldrich) to prevent gel attachment and photopolymerized under UV light (365 nm, 
UV-LED spot light source L11921, Hamamatsu) at 7 mW/cm2 for desired time periods (30 s, 
60 s, and 90 s). Hydrogels were incubated in culture medium Dulbecco’s Modified Eagle’s 
Medium (DMEM, Gibco) without fetal bovine serum (FBS) for 24 h before testing. 
5.2.4. Bioprinting of cellularized 3D constructs 
Bioprinting was performed in a commercial bioprinter Regemat 3D V1 (Regemat 3D, 
Spain) at 25 ºC using physically crosslinked bioinks containing either 13 mM CaCl2 or 15 mM 
BaCl2 loaded with human neonatal dermal fibroblasts (Coriell Institute for Medical Research). 
Cells were cultured in DMEM supplemented with 10% FBS, antibiotics (100 U/mL penicillin, 
100 μg/mL streptomycin, Sigma Aldrich), and amphotericin B (2.5 mg/L, Sigma Aldrich) in 5 
% CO2 at 37 ºC in tissue culture polystyrene flasks. Cells (passage 7) were trypsinized using 
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a 0.05 wt% trypsin/ethylenediamine tetraacetic acid (EDTA) solution before reaching 80 % 
confluency, centrifuged (1200 rpm, 5 min), and the cell pellet was suspended in the bioink at 
a final density of 1 × 107 cells/mL, corresponding to 10 % of the final bioink volume. Cell-
laden bioinks were loaded in sterile syringes with a 25 G tapered tip (7018391, Nordson 
EFD), and printed into 3D constructs (8 × 8 × 1 mm3). Proprietary software was used to 
define the operating parameters (deposition speed 3 mm/s), construct attributes (4 printed 
layers, pore size 0.6 mm), and generate G-code to control the bioprinter. After deposition, 3D 
constructs were photocrosslinked using UV light irradiation (30 s, 60 s, and 90 s), and 
incubated in culture media for 14 days. After predetermined time points, constructs were 
fixed in 4 %v/v paraformaldehyde (PFA, Electron Microscopy Sciences) in Hank's Balanced 
Salt Solution (HBSS, Life Technologies) for 20 min, washed with HBSS, and stored at 4 ºC. 
5.2.5. Characterization of bioprinted 3D constructs 
The metabolic activity of printed cells was determined by the resazurin assay. 3D 
constructs were incubated in DMEM medium containing 20 %v/v resazurin sodium salt 
(Sigma-Aldrich) for 2 h at 37 ºC, and sample fluorescence was measured using a microplate 
reader (Synergy MX, Biotek) at 530 nm (excitation) and 590 nm (emission). The morphology 
of the cells within the printed constructs was visualized by immunofluorescence staining of F-
actin and nuclei staining. Samples were incubated overnight with phalloidin/Alexa Fluor® 488 
(Molecular Probes-Invitrogen) for F-actin staining, followed by incubation with Hoechst (Life 
Technologies) for nuclei staining for 45 min. Samples were rinsed and imaged on a confocal 
laser scanning microscope (CLSM, Leica TCS-SP5 AOBS, Leica Microsystems). The 
deposition of ECM was analysed by immunofluorescence staining of fibronectin. Briefly, 
samples were permeabilized for 10 min with 0.2 %v/v Triton X-100 (Sigma) in HBSS, 
washed, incubated in blocking solution (1 %w/v bovine serum albumin in HBSS) for 1 h at 
room temperature, and left overnight at 4 ºC with rabbit anti-fibronectin antibody (F3648, 
Sigma-Aldrich) and phalloidin/Alexa Fluor® 488. Then, samples were rinsed with HBSS and 
incubated for 45 min with Alexa Fluor 594 goat anti-rabbit secondary antibody (Molecular 
Probes-Invitrogen) and Hoechst for nuclei staining. Samples were rinsed and imaged on 
CLSM. For double-stranded DNA (dsDNA) quantification, cells were recovered from the 
printed 3D constructs by enzymatic degradation with a pectinase (Sigma Aldrich)/type II 
collagenase (Worthington Biochemical) cocktail (37 ºC, 30 min), centrifuged (10 000 rpm, 5 
min), washed twice with 1X phosphate buffered saline (PBS) and stored at -20ºC until 
quantification. Cells were lysed in 1 %v/v Triton X-100 for 1 h at 4 ºC, diluted 1:10 in 1X PBS, 
and dsDNA quantification was performed using the Quant-iT PicoGreen dsDNA kit (Thermo 
Scientific), according to manufacturers’ instructions.  
CHAPTER V 
 197 
5.2.6. Statistical analysis  
Statistical analyses were performed in the GraphPad Prism 7.0 software and the 
results presented as the mean ± standard deviation (SD). The non-parametric Mann–
Whitney test was applied with 95 % confidence interval and statistically significant differences 
marked with p < 0.05 (*), p < 0.01 (**), p < 0.001 (***) and p < 0.0001 (****).   
5.3. Results and discussion 
5.3.1. Design of a modular bioink crosslinked by thiol-norbornene click 
chemistry 
The design of bioinks that recapitulate many of the structural and functional 
characteristics of the ECM in target tissue is essential for the bioprinting of biomimetic tissue 
constructs. In this work, a single-component bioink was designed to meet the processing 
criteria for extrusion bioprinting and simultaneously provide a modular platform where a 
broad range of crosslinkers (e.g., non-degradable DTT, MMP-degradable peptide 
sequences), pendant ligands (e.g., growth factors, cell-specific adhesion moieties), and cells 
can be used as basic building blocks to create customized cell- and tissue-specific 3D 
constructs. The design principle for the bioink synthesis and bioprinting strategy is illustrated 
in Figures 5.1A and 5.1B, respectively. Bioink formulation is crucial to ensure the viability 
and functionality of cells in printed constructs as well as to enable the user-controlled bioink 
functionalization for a target application. The developed bioink consisted of a multicomponent 
system based on norbornene-modified pectin as a sole material, VA-086 as initiator, a 
biscysteine protease-degradable crosslinker, a thiolated cell-adhesive peptide ligand, and 
living cells. The components were selected to serve different purposes in the bioink: (i) 
norbornene-modified pectin allows the formation of a physically crosslinked hydrogel via ionic 
gelation with divalent ions before printing to provide ideal rheological behaviour, while 
norbornene end groups enable both the formation of crosslinks between polymer chains and 
the tethering of pendent moieties via a fast thiol-norbornene photoclick reaction; (ii) VA-086 
as a photoinitiator allows the photocrosslinking and/or photopatterning of printed constructs 
after printing; (iii) biscysteine protease-degradable crosslinker (CGPQG↓IWGQC) performs a 
dual function by forming a chemically crosslinked hydrogel post-printing upon UV light 
exposure and providing a protease sensitive sequence for cell-mediated remodelling of the 
gel network, similarly to what happens in native ECM; (iv) thiolated cell-adhesive peptide 
ligand (CGGGGRGDSP) confers anchorage sites to the hydrogel, allowing integrin-mediated 
cell-adhesion and cell-matrix crosstalk, which mimics the cell-adhesive nature of ECM; (v) 
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dermal fibroblasts are used as cell component of the bioink due to their key role in skin 
wound healing and ability to sense and respond to the biochemical and biophysical cues 
from the surrounding microenvironment.   
The bioprinting strategy consists of three steps: (i) ionic crosslinking of the bioink in 
the absence of living cells via reaction with divalent ions, (ii) extrusion bioprinting of the cell-
laden bioink, and (iii) fast UV thiol-norbornene polymerization of printed 3D constructs. Since 
NorPEC solutions cannot be printed due to the low viscosity, two cations, namely Ca2+ and 
Ba2+, were selected for ionic crosslinking of the polymer solution before printing and to 
compare their effects on both rheological behaviour and cell response. By optimizing the final 
concentrations, both cations allowed the formation of consistent filaments at the nozzle and 
the direct printing of tubular 3D hollow structures without the need for support structures or 
photocrosslinking during the printing process. After printing, the structures were exposed to 
very short UV light irradiation time periods at cytocompatible light intensity (7 mW/cm2), 
which is essential for preclude cell dead and DNA damage. Since the thiol-norbornene 
reaction is non-oxygen inhibited, photopolymerization was carried out immediately 
postprinting at room conditions, yielding water-stable thioether bonds via reaction between 
the alkene groups in norbornene function and thiol group in peptides. The resultant 3D 
structures were mechanically robust and stretchable, as shown in Figure 5.1C.  
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Figure 5.1. Design, synthesis and bioprinting of the thiol-norbornene photoclickable 
pectin bioink. (A) Synthesis of norbornene-modified pectin through reaction with carbic 
anhydride. (B) Schematic illustration of bioprinting strategy and crosslinking chemistries 
involved during the bioprinting process. (C) Photograph of the printed hollow tube structure 
before (left) and during (right) stretching. 
 
A variety of natural polymers have been explored as hydrogel bioinks for extrusion 
bioprinting due to their biocompatibility, biodegradability and bioactive properties. Contrary to 
unmodified synthetic polymers, which lack of bioactive properties, many natural polymers 
such as collagen and gelatin intrinsically contain arginine–glycine–aspartate (RGD) 
sequences and cell-remodelling sites, conferring superior biological properties. Protein-
derived materials are the first choice for the design of cell-responsive bioinks either 
individually or combined with other materials owing their fibrillar structure and cell-interactive 
domains [9, 19]. Although these characteristics resemble key features of the native ECM, 
alterations in macromer concentration inevitably change the content of biochemical cues in 
the surrounding cell microenvironment, making difficult to decouple both biophysical and 
biochemical properties from macromer concentration. One alternative to tackle these 
limitations consists on the chemical functionalization of protein-derived materials (e.g., 
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gelatin) with vinyl bonds for photopolymerization reactions to control the hydrogel stiffness 
independently on the macromer concentration [20]. Despite useful, the major bottleneck of 
this strategy is the poor control over the biochemical composition of the bioink towards a 
specific application. As a result, a great deal of interest has been focused on alternative 
natural materials which biochemical composition and biophysical properties can be controlled 
independently on the macromer concentration or crosslinking chemistry, allowing the design 
of customized bioinks that mimic cell- and tissue-specific features. In this work, pectin was 
proposed as an alternative biomaterial for the formulation of advanced bioinks for 3D 
bioprinting due to its biocompatibility, gelation properties, and lack of cell-adhesion moieties 
and cell-remodelling sites [21]. The absence of cell-responsive moieties was a fundamental 
criterion in polymer selection, enabling the user-specific functionalization of the bioink for a 
desired application. A second criterion for the selection of pectin consisted on its ionic 
crosslinking ability under cytocompatible conditions, which was explored for the formation of 
weakly crosslinked physical hydrogels with adjustable rheological properties. Finally, pectin 
has a rich chemical composition that provides a multitude of functional groups for chemical 
modification, which is fundamental in the synthesis of photosensitive pectin derivatives for 
thiol-norbornene polymerization. 
5.3.2. Tuning the bioink printability via ionic crosslinking  
One fundamental requisite of bioinks for extrusion bioprinting is the ability to form 
mechanically stable filaments capable of maintaining the predesigned shape after deposition 
and supporting the subsequent printed filaments without collapsing. This is a major challenge 
as the bioink must exhibit enough structural integrity both during and postprinting without 
compromising the mixing with the cells and simultaneously precluding mechanically induced 
cell membrane damage. The ability of NorPEC solutions to form physical gels in the 
presence of divalent ions was explored as a straightforward strategy to adjust the rheological 
behaviour of the developed bioink. To this end, two cations widely used in the formation of 
ionically crosslinking hydrogels were selected namely Ca2+ and Ba2+. These cations have 
been applied to induce the crosslinking of printed 3D constructs through immersion in 
gelation baths [22], while Ca2+ has also been employed to crosslink alginate-containing 
bioinks during the printing process [23]. In order to explore the ability of Ba2+ to form stronger 
physical alginate microbeads when compared to Ca2+ [24], in this work we evaluated the 
effect of cation type and concentration on the rheological behaviour and printability of bioinks, 
while fixing the bioink composition (2.5 wt% NorPEC, 5 mM peptide crosslinker, 2 mM cell-
adhesion peptide, and 0.25 wt% VA-086 initiator) and nozzle diameter (250 μm). The 
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concentrations of polymer precursor, peptide crosslinker, cell-adhesion peptide, and initiator 
were selected based on our previous work [18]. 
To systematically compare the influence of Ca2+ and Ba2+ on the rheological 
properties of bioinks, the concentration of both cations was varied in a range of 11–20 mM 
and the yield stress point determined by rheological analysis. The yield stress is intimately 
related to the flow initiation of the bioink and was selected to determine the required stress to 
induce the material flow as a function of both cation source and concentration. A shear stress 
ramp was applied to each bioink formulation containing different cation concentrations to test 
whether the material exhibits yield stress behaviour. In parallel, the printability of each bioink 
was manually assessed by dispensing the material through a printing nozzle to verify 
whether a continuous filament or droplets are formed during deposition (Figure 5.2A). It was 
observed that Ca2+-crosslinked bioinks exhibit suitable printability when Ca2+ concentration is 
in the range of 13–15 mM. At lower concentrations, the degree of ionic crosslinking is too 
low, leading to the formation of droplets rather than a consistent filament. On contrary, for 
Ca2+ concentration in a range of 17.5–20 mM, the bioink is too crosslinked, which results in 
the formation of irregular filaments that easily fracture during deposition. Ba2+-crosslinked 
bioinks required higher concentration to form stable filaments compared to Ca2+. Suitable 
gelation for Ba2+-crosslinked bioinks was obtained using concentrations in a range of 15–17.5 
mM. Using optimal concentrations of Ca2+ and Ba2+, smooth and uniform filaments were 
continuously extruded, which is fundamental for the bioprinting of 3D constructs. To 
quantitatively determine the yield stress of bioinks, below which the material behaves like a 
solid rather than a liquid, a shear stress ramp was applied to the physically crosslinked 
bioinks and the results summarized in Table 5.1 and Figure 5.2B. Consistent with data from 
the manual deposition, the bioink yield stress point increased with higher concentrations of 
Ca2+- and Ba2+ due to the formation of a more crosslinked gel network. For the same cation 
concentration, the yield stress point of Ca2+-crosslinked bioink is higher than the Ba2+-
crosslinked bioink, except for the concentration of 20 mM, suggesting a more efficient 
crosslinking reaction of the NorPEC in the presence of calcium ions. From Figures 5.2C and 
5.2D it is possible to observe that all formulations displayed a clear drop in viscosity upon 
flow initiation, which is indicative of the yield stress behaviour. Printable bioinks presented 
higher yield stress point and viscosity compared to unprintable low crosslinked bioinks. For 
the developed bioinks, yield stress values around 25 Pa result in highly crosslinked materials 
that form irregular filaments, difficult the mixing with the cell pellet, and can eventually reduce 
the viability of printed cells due to high shear stresses generated during the printing process. 
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Table 5.1. Influence of cation source and concentration of the yield stress point of calcium (Ca2+)- and 
barium (Ba2+)-crosslinked pectin bioinks. 
Cation concentration 
(mM) 
Ca2+-crosslinked bioink 
Yield stress (Pa)  
Ba2+-crosslinked bioink 
Yield stress (Pa)  
11 11.92 ± 2.39 5.19 ± 1.57 
13 16.60 ± 0.87 11.23 ± 0.57 
15 20.23 ± 1.07 16.97 ± 0.43 
17.5 26.20 ± 3.15 24.38 ± 3.71 
20 31.77 ± 5.23 36.17 ± 7.86 
 
As recent works have demonstrated that the printability of bioinks is highly dependent 
on the crosslinking degree and yield stress point [25, 26], the selection of printable Ca2+ and 
Ba2+ concentrations was done based on the yield stress data. Theoretically, if bioinks can be 
printed using the same operating conditions and photocrosslinked upon exposure to equal 
doses of UV light, effects on cell behaviour can be almost exclusively attributed to the 
microenvironment provided by the 3D construct rather than to the printing process. To ensure 
that both Ca2+- and Ba2+-crosslinked bioinks can be printed using the same processing 
parameters (e.g., dispensing rate, printing speed), optimal cation concentrations of 13 mM 
and 15 mM were selected, respectively. These concentrations fall in the suitable crosslinking 
region on the printability window diagram and result in no statistical significant differences on 
the yield stress point (Ca2+: 16.60 ± 0.87; Ba2+: 16.97 ± 0.43), as observed in Figure 5.2E. 
Although the viscosity at the yield stress point of Ba2+-crosslinked bioink is slightly higher 
when compared to the Ca2+-crosslinked bioink, this difference is not statistical significant 
(Figure 5.2F) and does not compromised the mixing with the cell pellet. In order to determine 
the gelation kinetics, Ca2+ and Ba2+ were individually added to the bioink solution and the 
evolution on the elastic (G') and viscous (G'') moduli determined by rheometry. From Figure 
5.2G it is possible to observe that both G′ and G″ increased drastically in the beginning of the 
test, followed by a slow increase until achieving the plateau. Ca2+-crosslinked bioink showed 
a faster increase of G′ and G″ immediately after mixing, followed by a slow crosslinking until 
became constant (>139.7 min). On the other hand, the Ba2+-crosslinked bioink exhibited a 
slower increase of G′ and G″ after mixing, suggesting a slower reaction kinetics. Both bioinks 
required similar reaction times to achieve the plateau, with the Ba2+-crosslinked bioink 
exhibiting higher G′ at the plateau (Ca2+: G’ 73.3 ± 2.3 Pa, G″ 4.07 ± 0.1 Pa, gelation time 
139.7 min; Ba2+: G’ 102.4 ± 3.0 Pa, G″ 4.88 ± 0.1 Pa, gelation time 133.4 min). This data 
CHAPTER V 
 203 
indicate that Ba2+ resulted in stiffer physically crosslinked bioinks, which could be attributed to 
its higher concentration in solution rather than the superior affinity of barium ions to the 
carboxyl groups in the pectin backbone. Contrary to the expected, a higher content of Ba2+ 
was needed to obtain a similar yield stress value of bioinks compared to Ca2+. We 
hypothesize that this outcome can be related with constrains in the accessibility of carboxyl 
groups by the cations in solution imposed by the introduction of norbornene end groups. 
However, further investigation is needed to elucidate these effects.  
After determining the effect of cations and their concentration on the flow initiation of 
bioinks, shear viscosity tests were performed to characterise the shear thinning properties of 
developed bioinks during the extrusion. Both Ca2+- and Ba2+-crosslinked bioinks present a 
shear thinning behaviour, characterised by a decrease in viscosity as a function of increased 
shear rate (Figure 5.2H). This behaviour is essential to allow the bioink extrusion at low 
levels of viscosity, precluding cell dead during the printing process. Bioinks exhibited a 
similar shear thinning behaviour over the applied shear rate range (1–1000 s-1), allowing one 
to predict that bioinks would have similar printability independently on the cation source. 
A key characteristic of advanced bioinks is the ability to retain the predesigned shape 
after printing, allowing high shape fidelity and eventually secondary crosslinking without 
structure deformation. The behaviour of developed bioinks postprinting was characterised 
using recovery tests. During the test, regimes of high and low shear rates are applied to 
analyse the bioink recovery after printing. To simulate the shear conditions that the bioink is 
subjected during the printing, a low shear rate of 1 s−1 was firstly applied for 100 s to simulate 
at-rest conditions before extrusion, analogous to being held in the syringe without extrusion. 
Then, a high shear rate of 100 s−1 for additional 100 s was applied to simulate the shear 
forces in the nozzle tip during the extrusion, followed by a low shear rate of 1 s−1 for 100 s to 
determine the recovery ability of the bioinks. Figure 5.2I shows that bioinks exhibited a fast 
recovery after exposure to high shear stress, indicating their ability to rapidly increase the 
viscosity after printing. This behaviour is essential to ensure high shape fidelity and shape 
maintenance of the printed structure. If bioinks do not rapidly recover their initial viscosity 
after deposition, permanent changes in the material can be induced due to the application of 
a high shear rate, which often leads to poor shape fidelity.  
Multiple strategies have been explored to control the rheological properties of bioinks 
towards suitable printability. Most common approaches rely on highly viscous bioinks 
obtained by either increased macromer content or addition of high molecular weight polymers 
(e.g., alginate, hyaluronic acid) [27]. Despite these approaches improve the viscosity and 
consequently the rheological properties of bioinks, cell viability and function is often 
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compromised due to the high shear stress during printing. In this work, a simple yet efficient 
ionic crosslinking strategy was employed to control the rheological properties of pectin 
bioinks. In addition to the commonly used calcium ion, we introduced barium as an 
alternative ionic crosslinker of bioinks for extrusion bioprinting. Although barium has been 
applied to crosslink alginate constructs after printing, this is the first work reporting its ability 
to generate physically crosslinked bioinks with suitable printability for extrusion bioprinting. 
Rheological data indicated that higher concentration of Ba2+ compared to Ca2+ is needed to 
achieve similar printability and yield stress point, though Ba2+ forms a slightly more viscous 
bioink solution when the same cation concentration is used. Importantly, both Ca2+- and Ba2+-
crosslinked bioinks exhibited shear thinning behaviour and fast recovery regardless cation 
source, indicating that bioinks with optimal rheological properties for extrusion bioprinting can 
be designed by both Ca2+- and Ba2+-mediated ionic crosslinking.  
 
Figure 5.2. Rheological behaviour of thiol-norbornene photocrosslinkable pectin bioinks. (A) 
Phase diagram for the printability window of Ca2+- and Ba2+-crosslinked bioinks. The bioinks can be 
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printed when the cation concentration is located in the suitable crosslinking region. (B) Effect of cation 
source and concentration on the yield stress value of bioinks. (C) Shear stress ramp data for a Ca2+-
crosslinked bioinks. (D) Shear stress ramp data for a Ba2+-crosslinked bioinks. (E) Yield stress point 
for bioinks crosslinked with 13 mM Ca2+ and 15 mM Ba2+. (F) Viscosity at the yield stress point for 
bioinks crosslinked with 13 mM Ca2+ and 15 mM Ba2+. (G) Gelation of Ca2+- and Ba2+-crosslinked 
bioinks with evolution of elastic (G') and viscous (G'') moduli as a function of time. (H) Viscosity of 13 
mM Ca2+- and 15 mM Ba2+-crosslinked bioinks as function of shear rate. (I) Recovery tests of 13 mM 
Ca2+- and 15 mM Ba2+-crosslinked bioinks.  
5.3.3. Modulating the viscoelastic properties of thiol-ene bioinks 
One important advantage of the developed NorPEC bioink is the fast curing kinetics 
of the photoinitiated thiol-norbornene reaction, enabling the rapid formation of chemical 
hydrogels postprinting. Another important benefit of the bioink is the ability to decouple 
biochemical composition and mechanical properties from polymer content as the hydrogel 
stiffness exclusively depends on the crosslinker (type and content) and photopolymerization 
conditions. Thus, defined biochemical cues can be tethered to the polymer backbone at a 
fixed macromer concentration either before or during photocrosslinking independently on the 
final hydrogel stiffness. The ability to precisely control the biochemical and biophysical 
properties of bioinks in an independent manner is of outstanding importance to print ECM-
like microenvironment for a desired application. 
 Contrary to other photocrosslinkable hydrogel systems, in which increasing the 
polymer weight percentage represents the unique possibility to significantly improve the 
mechanical properties, in the developed bioink and bioprinting strategy the hydrogel stiffness 
can be modulated independently on the polymer content using different approaches. 
Previously, we showed that varying the concentration of the protease-degradable peptide 
crosslinker (4–6 mM) enables to tailor the mechanical properties of non-printable NorPEC 
hydrogels in a physiologically relevant range [18]. In this study, the photopolymerization time 
was explored to control the stiffness of hydrogels prepared from the developed bioink. Since 
the application of UV irradiation for cell encapsulation raises concerns about potential light-
induced cellular DNA damage [28], the bioink composition, crosslinking chemistry, and 
cytocompatible UV curing conditions (λ = 365 nm, light intensity of 7 mW/cm2) were carefully 
selected and optimized to minimize the crosslinking time, and thereby mitigate potential 
harmful effects to embedded cells. Mechanically stable hydrogels were formed after 30 s of 
UV irradiation, resulting in dual-crosslinked hydrogel networks containing physical crosslinks 
from either Ca2+- or Ba2+-mediated ionic gelation and thioether chemical crosslinks of thiol-
norbornene polymerization. From Figure 5.3A it is observed that the G' of hydrogels 
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increased with increasing photopolymerization time regardless the cation source used for 
ionic crosslinking. Soft hydrogels (< 400 Pa) were obtained after 30 s of UV curing, while 
stiffer (> 850 Pa) hydrogels were produced by increasing the photocrosslinking time to 90 s. 
In all tested conditions, Ba2+-crosslinked hydrogels presented statistically significant higher G' 
than Ca2+-crosslinked hydrogels, independently on the photopolymerization time. For 
example, Ca2+-crosslinked hydrogels prepared with 30 s of UV curing exhibited G' of 294.3 ± 
40.7 Pa, while in Ba2+-crosslinked hydrogels the G' was 391.0 ± 37.1 Pa. The same trend 
was verified for the stiffer hydrogel networks obtained with 90 s of photopolymerization (Ca2+: 
G' = 869.9 ± 121.5 Pa; Ba2+: G' = 1098.0 ± 159.7 Pa), while intermediate stiffness was 
achieved with 60 s of UV curing. The differences on the mechanical properties as a function 
of the ionic crosslinker agent can be attributed to the higher concentration of Ba2+ (15 mM 
Ba2+ versus 13 mM Ca2+) required to obtain comparable rheological behaviour between both 
bioinks. This observation is corroborated by the gelation tests that indicated the formation of 
stiffer networks in physically Ba2+-crosslinked hydrogels. One possible solution to mitigate 
potential effects of different hydrogel stiffness on cell behaviour that arises from the 
concentration of ionic crosslinking agents can be the optimization of the photocrosslinking 
time in order to obtain hydrogels with similar stiffness. As shown in Figure 5.3B, decreasing 
the photocrosslinking time of 15 mM Ba2+-crosslinked bioinks to 20 s instead of 30 s led to a 
significant reduction of the G' of hydrogels from 391.0 ± 37.1 Pa to 307.5 ± 47.6 Pa, which is 
comparable to the G' of 13 mM Ca2+-crosslinked hydrogels prepared with 30 s 
photopolymerization (294.3 ± 40.7 Pa).  
 
 
Figure 5.3. Tuneable mechanical properties of dual-crosslinked pectin hydrogels obtained by 
thiol-norbornene photopolymerization. Hydrogels were prepared from either 13 mM Ca2+- or 15 mM 
Ba2+-crosslinked bioink solutions containing 2.5 wt% norbornene-modified pectin, 2 mM cell-adhesion 
peptide, 5 mM protease-degradable peptide crosslinker, and 0.25 wt% VA-086. (A) Influence of 
photocrosslinking time on the elastic modulus of hydrogels. (B) Hydrogel networks prepared from 13 
p = 0.1767 
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mM Ca2+- or 15 mM Ba2+-crosslinked bioinks with equivalent elastic modulus obtained by changing the 
photocrosslinking time (13 mM Ca2+: 30 s; 15 mM Ba2+: 20s).   
5.3.4. Bioprinted cell-responsive 3D microenvironments support cell spreading 
and ECM deposition 
A distinctive characteristic of the developed bioink compared to existing bioinks is the 
ability to precisely control the biochemical composition and mechanical properties of printed 
3D constructs with the ultimate goal of creating cell-specific microenvironments that support 
and direct cell behaviour. In this work, individual peptide sequences to promote cell-adhesion 
or cell-driven network remodelling were included in the bioink formulation enabling the 
printing of biochemical defined hydrogel microenvironments that stimulate cell-cell and cell-
ECM interactions, mimicking these features of native ECM. To validate these features, the 
single-component NorPEC bioink was printed into cell-laden 3D constructs (8 × 8 mm2, 4 
layers) and their biological performance evaluated throughout 14 days of culture. Human 
neonatal dermal fibroblasts were selected due to its key role on cutaneous wound healing. 
Cells were carefully added to either Ca2+- or Ba2+-crosslinked bioink solutions containing both 
protease-degradable peptide (5 mM) and cell-adhesion peptide (2 mM), printed into 3D 
constructs with 1 mm thickness, and subjected to photocrosslinking. Two different UV 
irradiation times (30 s and 90 s) were selected to demonstrate the ability to tune the 
mechanical properties of printed hydrogels and evaluate its effect on cell response. 
Immunofluorescence analysis of printed 3D constructs at day 3 of culture clearly 
showed the influence of mechanical properties on cell behaviour (Figure 5.4). Cells 
embedded within soft hydrogel networks photocrosslinked for 30 s displayed elongated 
morphology and formed interconnected multicellular networks regardless the cation source 
used in ionic crosslinking. Notably, deposition of fibronectin was observed in UV 
photopolymerized Ca2+-crosslinked 3D constructs (Ca2+/UV) as soon as day 3, while residual 
amounts of fibronectin were identified in UV photopolymerized Ba2+-crosslinked 3D 
constructs (Ba2+/UV). On the other hand, stiffer hydrogel constructs photocrosslinked for 90 s 
almost inhibited cell spreading with a low number of detectable cells start spreading with few 
protrusions. Fibronectin was present in residual amounts and limited to the vicinity of the 
cells. Together, these data indicated that, at early time points, the microenvironment provided 
by the printed constructs determines cell function either by stimulating or restricting cell 
spreading and fibronectin deposition via hydrogel stiffness. Although the hydrogel provides 
both cell-adhesion moieties and protease-degradable sites to enable cell adhesion and 
localized cell-mediated matrix remodelling, the density of crosslinks and the mechanical 
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constrains imposed by the stiffer constructs severely restricted cell spreading and ECM 
deposition.   
 
 
Figure 5.4. Immunofluorescence images showing the Influence of hydrogel stiffness on dermal 
fibroblast behaviour within printed 3D constructs at day 3 of culture. After printing, 3D constructs 
prepared from either 13 mM Ca2+- or 15 mM Ba2+-crosslinked bioinks were photocrosslinked for 30 s 
or 90 s to produce soft or stiff constructs, respectively. Dermal fibroblasts were stained for DAPI (blue), 
F-actin (green), and fibronectin (FN, red) (scale bar: 100μm).  
  
To demonstrate that printed 3D constructs are capable of supporting the functions of 
embedded cells for long time periods, the metabolic activity and DNA content were evaluated 
after 14 days of culture. Results showed that printed cells were metabolically active within all 
constructs without statistically significant differences between cells embedded within Ca2+- 
and Ba2+-crosslinked soft hydrogels (30 s UV) (Figure 5.5A). However, in Ba2+-crosslinked 
stiff hydrogels (90 s UV) cell metabolic activity was significantly lower compared to the other 
tested groups, suggesting that a more restrictive microenvironment is provided to the cells 
limiting their functions, which is corroborated by the lowest DNA content (Figure 5.5B).  
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Figure 5.5. Biological characterization of cells within printed 3D hydrogel constructs. (A) 
Metabolic activity and (B) DNA content of dermal fibroblasts within soft (30 s UV photocrosslinking) 
and stiff (90 s UV photocrosslinking) printed 3D constructs at day 14 of culture.  
 
An essential function of artificial ECM-like matrices is the ability to establish reciprocal 
and dynamic cell-cell and cell-ECM interactions to guide cell functions similarly to what 
occurs in vivo [29]. Bioprinted 3D constructs for cutaneous wound healing must not only 
support viable cells, but also stimulate the cell-mediated production of new ECM components 
to replace the lost tissue. During this process, the artificial microenvironment provided by the 
printed 3D construct should be gradually degraded via hydrolysis and/or enzymatic 
degradation, providing free space for new tissue growth and integration within the host. To 
demonstrate that the developed bioinks are capable of direct cell functions, we firstly 
evaluated whether printed cells display spread morphology throughout the construct 
thickness rather than limited to the proximity of the hydrogel surface. To this end, each 
construct was cut and the cross section corresponding to its thickness (view A, Figure 5.6) 
was imaged through confocal microscopy with cells stained for DNA and F-actin. Cells within 
printed soft constructs (both Ca2+- and Ba2+-crosslinked) and Ca2+-crosslinked stiff constructs 
assumed a characteristic spindle-shaped morphology, established extensive cell-cell 
interactions, and formed interconnected multicellular networks along the gel thickness. 
Contrary, Ba2+-crosslinked stiff constructs were sparsely populated with cells and exhibited 
limited spreading, which indicates that these hydrogels restrict cell spreading in 3D. 
To evaluate the ability of the developed bioink to stimulate the production of new ECM 
by embedded dermal fibroblasts, de novo deposition of fibronectin, a prominent protein of the 
dermal tissue, was analysed by immunofluorescence staining from the surface of the 
construct towards its centre (view B, Figure 5.6). At day 14, printed cells extensively spread 
throughout the hydrogel, forming interconnected multicellular networks embedded by a 
fibronectin-rich network, except in the Ba2+-crosslinked stiff construct. In addition to the cell 
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spreading observed at day 3, soft hydrogels constructs also provided a suitable 
microenvironment that stimulated printed cells to secrete a continuous network of fibronectin. 
In Ca2+-crosslinked stiff constructs, it was found that cells displayed an elongated 
morphology along with the deposition of fibronectin. As the majority of cells were round at 
day 3, this data indicated the ability of cells to locally degrade the hydrogel network to enable 
cell spreading and ECM deposition. Although in Ba2+-crosslinked stiff constructs the majority 
of embedded cells also present spread morphology compared to day 3, a significantly 
reduction of cell number can be observed with almost inexistent fibronectin. Consistently with 
data from cell metabolic activity and DNA content, Ba2+-crosslinked stiff constructs imposed 
severe restrictions to cell functions by limiting their spreading and ECM deposition, probably 
due to the higher stiffness. Together, these results demonstrate how the biochemical and 
biophysical properties of printed 3D constructs can be separately modulated to influence the 
behaviour of dermal fibroblasts.  
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Figure 5.6. Representative confocal microscopy images of the morphology of dermal 
fibroblasts and fibronectin deposition within printed dual-crosslinked pectin hydrogel 
constructs. Hydrogel were obtained by thiol-norbornene photopolymerization of either 13 mM Ca2+- or 
15 mM Ba2+-crosslinked bioink solutions containing 2.5 wt% norbornene-modified pectin, 2 mM cell-
adhesion peptide, 5 mM protease-degradable peptide crosslinker, and 0.25 wt% VA-086 (scale bar: 
100μm). Left images: cross section of the construct to depict the morphology of cells stained for DAPI 
(blue) and F-actin (green) throughout its thickness (view A). Middle images: immunofluorescence 
staining from the surface of the construct towards its centre (view B) with cells stained for DAPI (blue), 
F-actin (green), and fibronectin (FN, red). Right images: immunofluorescence staining from the surface 
of the construct towards its centre (view B) with cells stained for DAPI (blue) and fibronectin (FN, red). 
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5.4. Conclusions 
In this study, a cell-instructive bioink was designed for the extrusion bioprinting of 
protease-degradable hydrogel constructs from a norbornene-modified pectin precursor 
photocrosslinked via thiol-norbornene click reaction. The developed bioink, consisting of 
modified pectin macromers, cell-degradable peptide crosslinkers, and integrin-specific 
adhesive ligands, allowed the printing of complex and elastic 3D constructs that hold the 
shape after deposition for subsequent fast photocrosslinking upon exposure to UV light. The 
bioink rheological properties were precisely adjusted via ionic gelation using either Ca2+ or 
Ba2+, while the construct stiffness was controlled by varying the photocrosslinking time. 
Bioprinted 3D constructs supported metabolically active cells throughout 14 days of culture 
and extensive spreading of embedded dermal fibroblasts in a stiffness-dependent manner. 
The modular nature of the bioink allowed precise adjustment of the rheological properties, 
and facile functionalization with a multitude of peptide crosslinkers and pendant ligands 
through an ultrafast thiol-norbornene photoclick chemistry. Furthermore, the biochemical, 
biophysical, and rheological properties of the modular norbornene-functionalized pectin 
bioink can be easily controlled by changing the type of crosslinker, peptide ligands or ionic- 
and photo-crosslinking conditions, providing a versatile bioink for the bioprinting of tissue 
constructs mimicking key features of the native ECM. 
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6.1. General discussion 
The clinical requirement for cost-effective skin substitutes that promote the repair of 
acute and chronic wounds continues growing mostly due to the low level of compositional 
and architectural biomimicry of available products, which results in limited functional and 
aesthetic outcomes. In an attempt to closely resemble the composition and, in part, the 
architecture of the native skin ECM, most of the commercial wound care products both 
acellular and cellular (i.e., modern dressings and bioengineered skin substitutes) are based 
on ECM-derived materials such as collagen. Acellular products are easy to use and less 
expensive, but do not deliver either autologous or allogeneic skin cells to the injured site, 
which has been demonstrated to be beneficial for the wound healing by providing cell-
secreted factors to the host cells [1]. On the other hand, cellularized products are expensive 
and characterized by key limitations like the poor engraftment, adhesion to the wound bed, 
limited cell-recruitment, and poor vascularization [2, 3]. As cellularized products are 
manufactured using traditional fabrication methods (e.g., manual cell seeding), which fail in 
controlling the position of skin cells throughout the construct, the level of architectural and 
composition skin biomimicry is still low. In addition, the inability to precisely control the 
position of cells in a 3D microenvironment and consequently cell-cell and cell-ECM 
interactions precludes the integration of skin pigmentation, vasculature and skin appendages 
(e.g., sweat glands) in bioengineered products. 
In this research work, the ability of extrusion bioprinting to automatically control the 
deposition of bioinks composed of materials, cells and/or biochemicals in predesigned 3D 
locations in a layer-by-layer procedure was explored to create 3D constructs resembling the 
anatomy of the native skin. Although extrusion bioprinting holds the promise to solve the 
limitations of manual fabrication methods, it faces major challenges on the design of suitable 
bioinks that can be printed into complex structures with high shape fidelity and simultaneous 
provide control over the biochemical and biophysical composition of printed 
microenvironments. As discussed in the Chapter II, bioinks for skin bioprinting are based on 
a limited number of materials including alginate, collagen, fibrin, gelatin, and hyaluronic acid. 
Importantly, the majority of these bioinks have been processed through inkjet bioprinting [1, 
4], which precludes the fabrication of 3D constructs resembling the complex architecture of 
the skin due to the need for printing low-viscous bioink formulations to preclude nozzle 
clogging [5]. Bioinks were also processed using other bioprinting modalities, including LAB 
[6, 7] and extrusion bioprinting [8, 9]. Extrusion bioprinting is regarded as the most affordable 
due to its low cost and ability to print highly viscous bioinks containing high cellular densities 
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[10], which is fundamental to generate complex 3D structures that mimic the cell-cell and 
cell-ECM interactions in the skin tissue. However, bioinks for extrusion bioprinting of skin 
substitutes are limited to collagen, gelatin, and alginate-based materials, which restrict the 
range of processable materials. Recently, decellularized skin tissue was also explored for 
extrusion bioprinting of skin, improving the range of printable materials [9]. Despite these 
advances, available bioinks still offer limited control over the biochemical and biophysical 
properties as they are usually based on protein-derived materials (e.g., collagen, gelatin) that 
inherently contain biochemical cues in the native composition. Over the last years, several 
works have demonstrated the importance of chemically defined microenvironments in 
controlling the cell fate and guide new tissue formation [11-14], highlighting the need to 
translate these concepts to develop a new generation of advanced bioinks with cell-
instructive properties.  
To explore alternative materials and expand the range of printable bioinks, in Chapter 
III, a simple and efficient strategy was described to design dual-crosslinked pectin hydrogels 
that could be explored for both fundamental cell studies and extrusion bioprinting of skin 
constructs. Pectin, a polysaccharide used in wounds dressings and hydrogels for cell 
entrapment, was selected mostly due to its biocompatibility, ionic gelation ability, and the 
presence of multiple functional groups amenable to chemical modification. 
Photocrosslinkable pectin macromers were synthetized by the introduction of methacrylate 
functional groups via reaction with MA under aqueous conditions. The degree of 
methacrylate substitution was optimized considering the water solubility of the synthetized 
macromers and the hydrogel formation. Three methacrylate-modified pectin macromers 
(PECMA) were produced to provide a low, medium, and high number of methacrylate groups 
for photopolymerization. All macromers allowed the formation of chemically crosslinked 
hydrogels at low polymer concentration (1–2.5 wt%) through UV photopolymerization in 
presence of I2959 as a photoinitiator. Several formulations containing variable PECMA 
concentration and methacrylate substitution were photocrosslinked for different UV curing 
times (80 s to 300 s) and tested for their gel fraction, mechanical properties, and swelling 
behaviour. All the properties were dependent on the crosslinking degree of the hydrogel 
network and could be easily controlled by changing the photopolymerization conditions, 
PECMA concentration or degree of methacrylate substitution. The biofunctionalization of 
methacrylated pectin with a thiolated cell-adhesive peptide via a base-catalysed thiol-Michael 
reaction demonstrated to be an efficient strategy to promote the attachment of dermal 
fibroblasts to the otherwise biologically inert hydrogel network. This conjugation strategy 
provided a facile approach to control the biochemical cues in the PECMA backbone. Taking 
advantage of the ionic gelation ability of PECMA, a dual-crosslinking strategy was designed 
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to develop a single-component methacrylated pectin bioink for bioprinting. Ionic gelation was 
explored to adjust the rheological properties of a low concentration (1.5 wt%) pectin solution 
via ionic interaction with calcium ions, yielding an extrudable, physically crosslinked bioink. 
Different calcium chloride concentrations (0–5 mM) were optimized to allow the formation of 
stable filaments that could be printed into 3D constructs and to study their effect on the bioink 
rheological properties. The bioink printability was dependent on the calcium content and 
consequently degree of physical crosslinking. An optimized bioink formulation functionalized 
with a cell-adhesive peptide and loaded with dermal fibroblasts was applied for the 
bioprinting of 3D dermal constructs. Printed constructs supported viable cells during the 
culture period and promoted extensive cell spreading throughout the constructs. More 
importantly, dermal fibroblasts within printed constructs secreted several ECM components 
of the dermal tissue including fibronectin, type-I collagen, and laminin. These date showed 
that the developed bioink and printing strategy enable the bioprinting of cellularized 3D 
constructs that stimulate de novo deposition of key ECM components of dermis, proposing 
PECMA as an alternative bioink for skin bioprinting. 
In view of a clinical application and in vivo implantation of bioprinted pectin 3D 
constructs, the degradation of dual-crosslinked hydrogels must be taken in consideration. 
Pectin is inherently non-degradable in mammals due to the lack of the enzyme (i.e., 
pectinase) that can cleave the polymer chains, but ionically crosslinked pectin gels can 
dissolve and disintegrate upon implantation by the release of the divalent ions that participate 
in the hydrogel crosslinking [15]. Although in vivo biodegradation studies were not performed 
using the PECMA bioink described in Chapter III, the formation of chemical bonds during 
photopolymerization resulted in gel networks with higher resistance to in vitro degradation by 
pectinase. Covalent crosslinks were introduced to preclude the dissolution of the physically 
crosslinked hydrogel bioink postprinting, providing long term stability and superior 
mechanical properties. As a result of both non-degradable nature of chemical bonds resulting 
from the homopolymerization of methacrylates and the absence of cell-degradable sites in 
the hydrogel network, potential limitations of the PECMA bioink consisted on its in vivo 
biodegradation and inability of embedded cells to locally degrade the surrounding 
microenvironment to create space for spreading and migration. To address these limitations, 
in Chapter IV, a new class of norbornene-modified pectin (NorPEC) was synthetized to allow 
the formation of protease-degradable hydrogels through UV photoinitiated thiol-norbornene 
chemistry using a cell-degradable peptide sequence as crosslinker. A fast and robust 
chemical modification strategy was developed for the modification of pectin with norbornene 
end groups via reaction with CA in organic solvents, improving the reaction efficiency and 
reducing the reaction time compared to published protocols [16, 17]. Enzymatically 
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degradable hydrogels were prepared by a fast UV photoinitiated thiol-ene reaction between a 
peptide crosslinker sensitive to cell-secreted proteases flanked with biscysteine and the 
norbornene groups in pectin using VA-086 as a photoinitiator. During the 
photopolymerization, the biscysteine protease-degradable peptide becomes part of the 
crosslinked hydrogel, allowing for gel network degradation as demonstrated by the enzymatic 
digestion using the enzyme collagenase, which is present in wound healing process [18]. 
Contrary to the free-radical polymerization of PECMA hydrogels, which proceeds via a chain-
growth mechanism, the thiol-norbornene polymerization develops through a step-growth 
mechanism resulting in less network heterogeneities. Importantly, in thiol-norbornene 
polymerization there is no homopolymerization or chain growth between strained norbornene 
groups and the reaction is non-oxygen inhibited which increases the reaction kinetics and 
reduces the UV photocrosslinking time [19]. We took advantage of these characteristics to 
develop photoclickable pectin hydrogels that mimic key functions of the native ECM, 
including the cell-adhesion and cell-driven matrix remodelling. The behaviour of dermal 
fibroblasts embedded within thiol-ene NorPEC hydrogels was controlled by altering the 
density of cell-adhesive peptide ligand and/or the hydrogel crosslinking degree via adjusting 
the concentration of protease-degradable peptide. Through the pharmacologically inhibition 
of the action of cell-secreted proteases, it was demonstrated that both matrix stiffness and 
protease-degradable peptide determine cell spreading and hydrogel remodelling. The ability 
of the developed NorPEC hydrogels to support the formation of full-thickness skin was also 
demonstrated in vitro. Skin models showed morphological resemblance to the human skin 
with a well-defined epidermis formed on the top of the fibroblast-laden hydrogel. Specific 
markers associated to epidermal differentiation and proliferation, including cytokeratin and 
Ki67 were detected in the epidermal compartment, while characteristic ECM markers for 
type-I collagen and fibronectin were observed in the dermal compartment. These results 
demonstrated that by selecting suitable protease-degradable peptide crosslinkers and 
pendant cell-adhesive peptides, biomimetic NorPEC hydrogels can be designed to induce 
distinct biological responses and support the in vitro formation of skin equivalents. 
One critical limitation of current bioinks relies on the difficulty to precisely define and 
control the biochemical composition and biophysical properties without compromising the 
printability and cell response. In parallel, another important drawback in the design of 
advanced bioinks consists on the need for modular strategies that enable the customization 
of the bioink composition for a desired application. In Chapter V, a modular bioink was 
designed for the extrusion bioprinting of 3D ECM-like microenvironments using NorPEC, 
living cells, peptide crosslinkers and peptide ligands as basic building blocks. A major 
advantage of this bioink compared to existing ones resides on its versatility as a general 
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platform where a range of user-defined thiolated crosslinkers and thiolated ligands can be 
chemically bond to the NorPEC backbone and loaded in desired cells to engineer cell- and 
tissue-specific 3D constructs with controllable biochemical and mechanical properties. Based 
on the ionic gelation mechanism described in Chapter III, one additional cation (Ba2+) was 
selected to modulate the rheological properties of the NorPEC bioink which composition was 
optimized to allow in vitro skin formation in Chapter IV. An extensive rheological study was 
carried out to compare the effects of Ca2+ and Ba2+ on the printability of physically 
crosslinked bioinks. Suitable printability was achieved for Ca2+ concentrations in a range of 
13–15 mM and Ba2+ concentrations in a range of 15–17.5 mM. Printable formulations (13 mM 
Ca2+ and 15 mM Ba2+), selected based on the yield stress data, allowed the formation of 
smooth and continuous filaments that enable the printing of elastic 3D structures. Both bioink 
formulations exhibited proper rheological properties for extrusion bioprinting namely shear 
thinning behaviour and fast recovery after exposure to high shear stress. The mechanical 
properties of hydrogels were precisely controlled by changing the photopolymerization time, 
while keeping fixed the bioink composition, demonstrating the ability to independently 
modulate the hydrogel stiffness without altering the biochemical properties. Dermal 
fibroblasts printed using either Ca2+- or Ba2+-crosslinked bioinks photocrosslinked into soft or 
stiff hydrogel networks showed distinct cell spreading and fibronectin as a function of the 
matrix stiffness. Together, these results demonstrated that the developed modular strategy 
for the design of advanced bioinks based on NorPEC provides a cutting-edge natural-derived 
bioink which biochemical and biophysical properties can be independently controlled and 
decoupled from the NorPEC concentration to induce distinct cell responses.  
Overall, this thesis ended up with novel cell-responsive pectin-based bioinks designed 
to meet the printability criteria for extrusion bioprinting and to provide ECM-like 
microenvironments that instruct and guide the cell behaviour. The designed single-
component bioinks, crosslinking chemistries and bioprinting strategies were successfully 
applied to generate 3D skin constructs that hold promising properties for several skin tissue 
engineering applications including bioengineered skin substitutes for cutaneous repair and in 
vitro testing models. 
6.2. Future perspectives 
Although the work developed in this thesis addressed important limitations in skin 
bioprinting, the proposed bioinks, crosslinking chemistries and their application also have 
some limitations that have to be surpassed in the future. 
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The most obvious limitation is the need for in vivo studies devoted to evaluate the 
biodegradation behaviour of developed bioinks both subcutaneously and applied as a topical 
skin substitute. In this thesis, pectin was proposed as a promising biomaterial to design cell-
responsive bioinks for 3D bioprinting by exploring ionic gelation and photopolymerization 
crosslinking reactions. As previously discussed, pectin is inherently non-degradable in 
mammals, but ionically crosslinked pectin hydrogels disintegrate upon subcutaneous in vivo 
implantation. However, the formation of chemical bonds in the hydrogel network resulted in 
stable dual-crosslinked hydrogels with increased resistance to enzymatic degradation in vitro. 
The in vivo evaluation of the degradation profile of bioprinted dual-crosslinked 3D hydrogels 
constructs constitutes an important topic of research for future work. This study will provide 
valuable information regarding the contribution of chemical bonds on the in vivo hydrogel 
degradation. These data could be used to correlate the mechanical properties of printed 
constructs, ECM deposition, and in vivo degradation profiles in order to design constructs 
with proper degradation rates. Although NorPEC enabled the formation of cell-degradable 
hydrogels through UV photoinitiated thiol-ene reaction with biscysteine protease-degradable 
peptide crosslinkers, the in vivo degradation kinetics of such hydrogels remains unknown. As 
these hydrogels as susceptible to remodelling through embedded cells, the characterization 
of biodegradation profiles using cell-laden hydrogels should also be considered in futures 
studies.   
Other limitation refers to use of UV photopolymerization reactions to induce the 
chemical crosslinking of developed bioinks. Although hydrogels were formed under 
cytocompatible conditions and the photopolymerization parameters were optimized to 
preclude UV light-mediated cell damage, one alternative is to explore visible light 
photopolymerization schemes for hydrogel crosslinking. Preliminary work using NorPEC 
hydrogels photocrosslinked in the presence of Eosin Y as a sole photoinitiator and visible 
light showed promising results regarding the structural integrity of prepared hydrogel 
networks.  
Another limitation consists in studies focusing on the ability of printed 3D constructs to 
stimulate in vivo skin formation. Although in vitro skin formation was demonstrated in this 
work, animal experimentation is required to test whether the constructs either cellular or 
acellular can be used for the repair of cutaneous wounds. In addition, the adhesion 
properties of hydrogel constructs to the wound bed must be also considered in a future work.  
 An alternative proposed application of bioprinted 3D skin constructs is in vitro testing 
models. In this context, the cellular composition of printed constructs must be further 
complexed by the inclusion of additional cells present in the skin. Endothelial and immune 
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cells could be explored to better mimic the dermis, while pigmentation should be considered 
in the epidermal layer by the printing of melanocytes. Novel strategies to integrate skin 
appendages such as sweat glands and hair follicles in printed skin models also constitute an 
important topic of future research.  
Finally, the developed bioinks display ideal properties for in situ bioprinting, by 
providing a modular platform with controlled properties, suitable printability and fast gelation. 
The concept of in situ skin bioprinting was proposed few years ago by researchers from the 
Wake Forest Institute (US) using an inkjet bioprinting device specifically developed to 
dispense cell-laden solutions onto the wound bed [20]. As previously discussed, inkjet 
bioprinting has limitations on the fabrication of 3D constructs with complex architecture 
similar to the skin due to the processing of low viscosity bioinks. As the bioinks developed in 
this thesis present many of the ideal properties of advanced bioinks such as (1) allow the 
printing of complex 3D constructs with high shape fidelity, (2) undergo fast crosslinking 
postprinting, (3) permit cell-adhesion and cell-mediated remodelling, (4) exhibit tuneable 
mechanical properties, (5) provide control over the biochemical composition, and (6) support 
the deposition of ECM components by embedded cells, they can also be explored for in situ 
skin bioprinting. Furthermore, the developed bioinks can be processed through extrusion 
bioprinting, allowing the generation of 3D constructs with high levels of skin biomimicry at 
clinically relevant dimensions.  
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